-DOCSTART- -X- -X- O

Patient NN NN O
is NN NN O
a NN NN O
45-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
with NN NN O
a NN NN O
history NN NN O
of NN NN O
anaplastic NNP NNP B-DIAGNOSIS
astrocytoma NNP NNP I-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
the NNP NNP I-DIAGNOSIS
spine NNP NNP I-DIAGNOSIS
complicated NN NN O
by NN NN O
severe NN NN O
lower NNP NNP B-DIAGNOSIS
extremity NNP NNP I-DIAGNOSIS
weakness NNP NNP I-DIAGNOSIS
and NN NN O
urinary NNP NNP B-DIAGNOSIS
retention NNP NNP I-DIAGNOSIS
s/p NN NN O
Foley NN NN O
catheter NN NN O
, NN NN O
high-dose NN NN O
steroids NN NN O
, NN NN O
hypertension NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
chronic NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
tumor NNP NNP B-DIAGNOSIS
is NN NN O
located NN NN O
in NN NN O
the NN NN O
T-L NN NN O
spine NN NN O
, NN NN O
unresectable NN NN O
anaplastic NNP NNP B-DIAGNOSIS
astrocytoma NNP NNP I-DIAGNOSIS
s/p NN NN O
radiation NN NN O
. NN NN O

Complicated NN NN O
by NN NN O
progressive NN NN O
lower NNP NNP B-DIAGNOSIS
extremity NNP NNP I-DIAGNOSIS
weakness NNP NNP I-DIAGNOSIS
and NN NN O
urinary NNP NNP B-DIAGNOSIS
retention NNP NNP I-DIAGNOSIS
. NN NN O

Patient NN NN O
initially NN NN O
presented NN NN O
with NN NN O
RLE NNP NNP B-DIAGNOSIS
weakness NN NN O
where NN NN O
his NN NN O
right NN NN O
knee NN NN O
gave NN NN O
out NN NN O
with NN NN O
difficulty NNP NNP B-DIAGNOSIS
walking NNP NNP I-DIAGNOSIS
and NN NN O
right NN NN O
anterior NN NN O
thigh NN NN O
numbness NNP NNP B-DIAGNOSIS
. NN NN O

MRI NN NN O
showed NN NN O
a NN NN O
spinal NNP NNP B-DIAGNOSIS
cord NNP NNP I-DIAGNOSIS
conus NNP NNP I-DIAGNOSIS
mass NNP NNP I-DIAGNOSIS
which NN NN O
was NN NN O
biopsied NN NN O
and NN NN O
found NN NN O
to NN NN O
be NN NN O
anaplastic NNP NNP B-DIAGNOSIS
astrocytoma NNP NNP I-DIAGNOSIS
. NN NN O

Therapy NN NN O
included NN NN O
field NN NN O
radiation NN NN O
t10-l1 NN NN O
followed NN NN O
by NN NN O
11 NN NN O
cycles NN NN O
of NN NN O
temozolomide NN NN O
7 NN NN O
days NN NN O
on NN NN O
and NN NN O
7 NN NN O
days NN NN O
off NN NN O
. NN NN O

This NN NN O
was NN NN O
followed NN NN O
by NN NN O
CPT-11 NN NN O
Weekly NN NN O
x4 NN NN O
with NN NN O
Avastin NN NN O
Q2 NN NN O
weeks/ NN NN O
2 NN NN O
weeks NN NN O
rest NN NN O
and NN NN O
repeat NN NN O
cycle NN NN O
. NN NN O

48 NNP NNP B-AGE
M NNP NNP B-GENDER
with NN NN O
a NN NN O
h/o NN NN O
HTN NNP NNP B-DIAGNOSIS
hyperlipidemia NNP NNP B-DIAGNOSIS
, NN NN O
bicuspid NNP NNP B-DIAGNOSIS
aortic NNP NNP I-DIAGNOSIS
valve NNP NNP I-DIAGNOSIS
, NN NN O
and NN NN O
tobacco NNP NNP B-DIAGNOSIS
abuse NNP NNP I-DIAGNOSIS
who NN NN O
presented NN NN O
to NN NN O
his NN NN O
cardiologist NN NN O
on NN NN O
[**2148-10-1**] NN NN O
with NN NN O
progressive NN NN O
SOB NNP NNP B-DIAGNOSIS
and NN NN O
LE NN NN O
edema NNP NNP B-DIAGNOSIS
. NN NN O

TTE NN NN O
revealed NN NN O
severe NN NN O
aortic NNP NNP B-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
with NN NN O
worsening NN NN O
LV NN NN O
function NN NN O
. NN NN O

EF NN NN O
was NN NN O
25% NN NN O
. NN NN O

RV NN NN O
pressure NN NN O
was NN NN O
41 NN NN O
and NN NN O
had NN NN O
biatrial NNP NNP B-DIAGNOSIS
enlargement NNP NNP I-DIAGNOSIS
. NN NN O

Noted NN NN O
to NN NN O
have NN NN O
2+ NN NN O
aortic NNP NNP B-DIAGNOSIS
insufficiency NNP NNP I-DIAGNOSIS
with NN NN O
mild NN NN O
MR NN NN O
. NN NN O
He NNP NNP B-GENDER
was NN NN O
sent NN NN O
home NN NN O
from NN NN O
cardiology NN NN O
clinic NN NN O
with NN NN O
Lasix NN NN O
and NN NN O
BB NN NN O
( NN NN O
which NN NN O
he NNP NNP B-GENDER
did NN NN O
not NN NN O
tolerate NN NN O
), NN NN O
continued NN NN O
to NN NN O
have NN NN O
worsening NN NN O
SOB NNP NNP B-DIAGNOSIS
and NN NN O
LE NN NN O
edema NNP NNP B-DIAGNOSIS
and NN NN O
finally NN NN O
presented NN NN O
here NN NN O
for NN NN O
evaluation.During NN NN O
this NN NN O
admission NN NN O
repeat NN NN O
echo NN NN O
confirmed NN NN O
critical NN NN O
aortic NNP NNP B-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
showing NN NN O
left NNP NNP B-DIAGNOSIS
ventricular NNP NNP I-DIAGNOSIS
hypertrophy NNP NNP I-DIAGNOSIS
with NN NN O
cavity NN NN O
dilation NN NN O
and NN NN O
severe NN NN O
global NN NN O
hypokinesis NNP NNP B-DIAGNOSIS
, NN NN O
severe NN NN O
aortic NNP NNP B-DIAGNOSIS
valve NNP NNP I-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
with NN NN O
underlying NN NN O
bicuspid NNP NNP B-DIAGNOSIS
aortic NNP NNP I-DIAGNOSIS
valve NNP NNP I-DIAGNOSIS
, NN NN O
dilated NNP NNP B-DIAGNOSIS
ascending NNP NNP I-DIAGNOSIS
aorta NNP NNP I-DIAGNOSIS
, NN NN O
mild NN NN O
pulmonary NNP NNP B-DIAGNOSIS
artery NNP NNP I-DIAGNOSIS
systolic NNP NNP I-DIAGNOSIS
hypertension NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
patient NN NN O
underwent NN NN O
a NN NN O
preop NN NN O
workup NN NN O
for NN NN O
valvular NN NN O
replacement NN NN O
with NN NN O
preop NN NN O
chest NN NN O
CT NN NN O
scan NN NN O
and NN NN O
carotid NN NN O
US NN NN O
( NN NN O
showing NN NN O
moderate NN NN O
heterogeneous NN NN O
plaque NNP NNP B-DIAGNOSIS
with NN NN O
bilateral NN NN O
1-39% NN NN O
ICA NNP NNP B-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
). NN NN O

He NNP NNP B-GENDER
also NN NN O
underwent NN NN O
a NN NN O
cardiac NN NN O
cath NN NN O
with NN NN O
right NN NN O
heart NN NN O
cath NN NN O
to NN NN O
evaluate NN NN O
his NN NN O
pulm NN NN O
art NN NN O
pressures NN NN O
which NN NN O
showed NN NN O
no NNP NNP B-NEGATIVE
angiographically NNP NNP I-NEGATIVE
apparent NNP NNP I-NEGATIVE
flow-limiting NNP NNP I-NEGATIVE
coronary NNP NNP I-NEGATIVE
artery NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
. NN NN O

A NN NN O
32 NNP NNP B-AGE
yo NNP NNP I-AGE
woman NNP NNP B-GENDER
who NN NN O
presents NN NN O
following NN NN O
a NN NN O
severe NN NN O
' NN NN O
exploding NN NN O
' NN NN O
headache NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
and NN NN O
her NN NN O
husband NN NN O
report NN NN O
that NN NN O
yesterday NN NN O
she NNP NNP B-GENDER
was NN NN O
in NN NN O
the NN NN O
kitchen NN NN O
and NN NN O
stood NN NN O
up NN NN O
and NN NN O
hit NN NN O
her NN NN O
head NN NN O
on NN NN O
the NN NN O
corner NN NN O
of NN NN O
a NN NN O
cabinet NN NN O
. NN NN O

The NN NN O
next NN NN O
morning NN NN O
she NNP NNP B-GENDER
developed NN NN O
a NN NN O
sudden NN NN O
' NN NN O
exploding NN NN O
' NN NN O
headache NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
hospital NN NN O
where NN NN O
head NN NN O
CT NN NN O
showed NN NN O
a NN NN O
significant NN NN O
amount NN NN O
of NN NN O
blood NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
her NNP NNP I-DIAGNOSIS
right NNP NNP I-DIAGNOSIS
ventricle NNP NNP I-DIAGNOSIS
. NN NN O

NSGY NN NN O
evaluated NN NN O
her NN NN O
for NN NN O
spontaneous NN NN O
intraventricular NNP NNP B-DIAGNOSIS
hemorrhage NNP NNP I-DIAGNOSIS
with NN NN O
a NN NN O
concern NN NN O
for NN NN O
an NN NN O
underlying NN NN O
vascular NNP NNP B-DIAGNOSIS
malformation NNP NNP I-DIAGNOSIS
. NN NN O

Cerebral NN NN O
angiogram NN NN O
was NN NN O
done NN NN O
which NN NN O
showed NN NN O
abnormal NNP NNP B-DIAGNOSIS
vasculature NNP NNP B-DIAGNOSIS
with NN NN O
a NN NN O
draining NN NN O
vein NN NN O
from NN NN O
L NN NN O
temporal NN NN O
lobe NN NN O
penetrating NN NN O
deep NN NN O
white NN NN O
matter NN NN O
consistent NN NN O
with NN NN O
AVM NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
patient NN NN O
did NN NN O
continue NN NN O
to NN NN O
have NN NN O
a NN NN O
headache NNP NNP B-DIAGNOSIS
but NN NN O
they NN NN O
were NN NN O
improving NN NN O
with NN NN O
pain NN NN O
medication NN NN O
. NN NN O

The NN NN O
patient NN NN O
refused NN NN O
PT NN NN O
evaluation NN NN O
but NN NN O
was NN NN O
ambulating NN NN O
independently NN NN O
without NN NN O
difficulty NN NN O
. NN NN O

She NNP NNP B-GENDER
was NN NN O
discharged NN NN O
to NN NN O
home NN NN O
with NN NN O
her NN NN O
husband NN NN O
on NN NN O
[**2155-12-6**] NN NN O
. NN NN O

This NN NN O
is NN NN O
a NN NN O
44 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
female NNP NNP B-GENDER
with NN NN O
PMH NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
PCOS NNP NNP I-DIAGNOSIS
, NN NN O
Obesity NNP NNP B-DIAGNOSIS
, NN NN O
HTN NNP NNP B-DIAGNOSIS
who NN NN O
presented NN NN O
with NN NN O
symptoms NN NN O
of NN NN O
cholecystitis NNP NNP B-DIAGNOSIS
and NN NN O
was NN NN O
found NN NN O
incidentally NN NN O
to NN NN O
have NN NN O
a NN NN O
large NN NN O
pericardial NNP NNP B-DIAGNOSIS
effusion NNP NNP I-DIAGNOSIS
. NN NN O

A NN NN O
pericardiocentesis NN NN O
was NN NN O
performed NN NN O
and NN NN O
the NN NN O
fluid NN NN O
analysis NN NN O
was NN NN O
consistent NN NN O
with NN NN O
Burkitt's NNP NNP B-DIAGNOSIS
lymphoma NNP NNP I-DIAGNOSIS
. NN NN O

Pericardial NN NN O
fluid NN NN O
was NN NN O
kappa NN NN O
light NN NN O
chain NN NN O
restricted NN NN O
CD10 NN NN O
positive NN NN O
monotypic NN NN O
B NN NN O
cells NN NN O
expressing NN NN O
FMC-7 NN NN O
, NN NN O
CD19 NN NN O
, NN NN O
CD20 NN NN O
, NN NN O
and NN NN O
myc NN NN O
rearrangement NN NN O
consistent NN NN O
with NN NN O
Burkitt's NNP NNP B-DIAGNOSIS
Lymphoma NNP NNP I-DIAGNOSIS
. NN NN O

A NN NN O
subsequent NN NN O
lumbar NN NN O
puncture NN NN O
and NN NN O
bone NN NN O
marrow NN NN O
biopsy NN NN O
were NN NN O
negative NNP NNP B-NEGATIVE
for NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
involvement NNP NNP I-NEGATIVE
which NN NN O
made NN NN O
this NN NN O
a NN NN O
primary NN NN O
cardiac NNP NNP B-DIAGNOSIS
lymphoma NNP NNP I-DIAGNOSIS
. NN NN O

A NN NN O
cardiac NN NN O
MRI NN NN O
showed NN NN O
a NN NN O
mass NN NN O
that NN NN O
was NN NN O
3cm NN NN O
x NN NN O
1cm NN NN O
on NN NN O
the NN NN O
lateral NN NN O
wall NN NN O
of NN NN O
the NN NN O
right NN NN O
atrium NN NN O
adjacent NN NN O
to NN NN O
the NN NN O
AV NNP NNP B-DIAGNOSIS
junction NNP NNP I-DIAGNOSIS
. NN NN O
Past NN NN O
Medical NN NN O
History: NN NN O
1 NN NN O
. NN NN O

Rare NN NN O
migraines NNP NNP B-DIAGNOSIS
2 NN NN O
. NN NN O

HTN NNP NNP B-DIAGNOSIS
. NN NN O

Obesity NNP NNP B-DIAGNOSIS
. NN NN O

PCOS NNP NNP B-DIAGNOSIS
. NN NN O

infertility NNP NNP B-DIAGNOSIS
. NN NN O

Viral NNP NNP B-DIAGNOSIS
encephalitis NNP NNP I-DIAGNOSIS
/ NN NN O
meningitis NNP NNP B-DIAGNOSIS
-- NN NN O
> NN NN O
ICH NNP NNP B-DIAGNOSIS
-- NN NN O
> NN NN O
seizure NNP NNP B-DIAGNOSIS
/ NN NN O
stroke NNP NNP B-DIAGNOSIS
( NN NN O
[**2137**] NN NN O
) NN NN O
= NN NN O
- NN NN O
from NN NN O
severe NN NN O
sinus NNP NNP B-DIAGNOSIS
infxn NNP NNP I-DIAGNOSIS
, NN NN O
caused NN NN O
mild NN NN O
non-focal NN NN O
residual NNP NNP B-DIAGNOSIS
deficits6 NNP NNP B-DIAGNOSIS
. NN NN O

CSF NNP NNP B-DIAGNOSIS
leak NNP NNP I-DIAGNOSIS
w/ NNP NNP I-DIAGNOSIS
meningitis NNP NNP I-DIAGNOSIS
s/p NN NN O
lumbar NN NN O
drain NN NN O
placement NN NN O
. NN NN O

R NN NN O
LE NN NN O
DVT NN NN O
s/p NN NN O
IVC NN NN O
filter NN NN O
placement NN NN O
. NN NN O

Knee NNP NNP B-DIAGNOSIS
surgery NNP NNP I-DIAGNOSIS

74 NNP NNP B-AGE
M NNP NNP B-GENDER
hx NN NN O
of NN NN O
CAD NN NN O
s/p NN NN O
CABG NN NN O
, NN NN O
EF NN NN O
60% NN NN O
prior NN NN O
CVA NNP NNP B-DIAGNOSIS
( NN NN O
no NN NN O
residual NN NN O
deficits NN NN O
), NN NN O
HTN NNP NNP B-DIAGNOSIS
, NN NN O
HL NNP NNP B-DIAGNOSIS
, NN NN O
DMII NNP NNP B-DIAGNOSIS
, NN NN O
Moderate NN NN O
to NN NN O
Severe NN NN O
PVD NNP NNP B-DIAGNOSIS
was NN NN O
referred NN NN O
to NN NN O
cardiology NN NN O
for NN NN O
evaluation NN NN O
of NN NN O
PVD NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
on NN NN O
examination NN NN O
patient NN NN O
was NN NN O
found NN NN O
to NN NN O
have NN NN O
carotid NNP NNP B-DIAGNOSIS
bruits NNP NNP I-DIAGNOSIS
. NN NN O

Upon NN NN O
further NN NN O
review NN NN O
of NN NN O
symptoms NN NN O
the NN NN O
pt NN NN O
reports NN NN O
+ NN NN O
Occasional NN NN O
dizziness NNP NNP B-DIAGNOSIS
, NN NN O
no NNP NNP B-NEGATIVE
prior NNP NNP I-NEGATIVE
syncope NNP NNP I-NEGATIVE
occasional NN NN O
HA NNP NNP B-DIAGNOSIS
, NN NN O
Denies NNP NNP B-NEGATIVE
CP/ NNP NNP I-NEGATIVE
SOB NNP NNP I-NEGATIVE
. NN NN O

No NNP NNP B-NEGATIVE
sensory NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
motor NNP NNP I-NEGATIVE
defects NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
recalls NN NN O
that NN NN O
he NNP NNP B-GENDER
might NN NN O
have NN NN O
had NN NN O
a NN NN O
stroke NNP NNP B-DIAGNOSIS
10-15 NN NN O
years NN NN O
ago NN NN O
without NN NN O
any NN NN O
residual NN NN O
deficit NN NN O
. NN NN O

Prior NN NN O
to NN NN O
CABG NNP NNP B-DIAGNOSIS
he NNP NNP B-GENDER
only NN NN O
had NN NN O
diaphoresis NNP NNP B-DIAGNOSIS
. NN NN O
Further NN NN O
review NN NN O
of NN NN O
systems NN NN O
is NN NN O
notable NN NN O
for NN NN O
absence NN NN O
of NN NN O
chest NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
, NN NN O
dyspnea NNP NNP B-DIAGNOSIS
on NN NN O
exertion NN NN O
, NN NN O
paroxysmal NNP NNP B-DIAGNOSIS
nocturnal NNP NNP I-DIAGNOSIS
dyspnea NNP NNP I-DIAGNOSIS
, NN NN O
orthopnea NNP NNP B-DIAGNOSIS
, NN NN O
palpitations NNP NNP B-DIAGNOSIS
, NN NN O
syncope NNP NNP B-DIAGNOSIS
or NN NN O
pre NNP NNP B-DIAGNOSIS
syncope NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
underwent NN NN O
Carotid NN NN O
U/S NN NN O
that NN NN O
showed NN NN O
significant NN NN O
bilateral NNP NNP B-DIAGNOSIS
carotid NNP NNP I-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
, NN NN O
L>R NN NN O
. NN NN O

Angiography NN NN O
revealed NN NN O
an NN NN O
80% NN NN O
stenosis NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
the NNP NNP I-DIAGNOSIS
R NNP NNP I-DIAGNOSIS
ICA NNP NNP I-DIAGNOSIS
and NN NN O
a NN NN O
90% NN NN O
L NNP NNP B-DIAGNOSIS
ICA NNP NNP I-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
. NN NN O

Cerebral NN NN O
angiography NN NN O
further NN NN O
revealed NN NN O
patent NN NN O
right NN NN O
ACA NN NN O
and NN NN O
MCA NN NN O
and NN NN O
patent NN NN O
left NN NN O
ACA NN NN O
and NN NN O
left NN NN O
MCA NN NN O
. NN NN O
Past NN NN O
Medical NN NN O
History: NN NN O
CAD NNP NNP B-DIAGNOSIS
s/p NN NN O
CABG NNP NNP B-DIAGNOSIS
in NN NN O
[**2154**] NN NN O
( NN NN O
[**Hospital1 NN NN O
112**])Prior NN NN O
CVA NNP NNP B-DIAGNOSIS
Bilateral NNP NNP B-DIAGNOSIS
carotid NNP NNP I-DIAGNOSIS
artery NNP NNP I-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
Anemia NNP NNP B-DIAGNOSIS
PVD NNP NNP B-DIAGNOSIS
Hypertension NNP NNP B-DIAGNOSIS
Diabetes NNP NNP B-DIAGNOSIS
c/b NN NN O
retinopathy NNP NNP B-DIAGNOSIS
and NN NN O
peripheral NNP NNP B-DIAGNOSIS
neuropathy NNP NNP I-DIAGNOSIS
Cataracts NN NN O
s/p NN NN O
surgeryThyroid NN NN O
noduleColon NN NN O
polyps NNP NNP B-DIAGNOSIS
s/p NN NN O
resection NN NN O
Intermittent NN NN O
Lower NN NN O
back NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
Proteinuria NNP NNP B-DIAGNOSIS
s/p NN NN O
right NN NN O
elbow NNP NNP B-DIAGNOSIS
fracture NNP NNP I-DIAGNOSIS
as NN NN O
a NN NN O
child NN NN O
Arthritis NNP NNP B-DIAGNOSIS

Patient NN NN O
is NN NN O
a NN NN O
55yo NNP NNP B-AGE
woman NNP NNP B-GENDER
with NN NN O
h/o NN NN O
ESRD NNP NNP B-DIAGNOSIS
on NN NN O
HD NN NN O
and NN NN O
peritoneal NNP NNP B-DIAGNOSIS
dialysis NNP NNP I-DIAGNOSIS
who NN NN O
presented NN NN O
with NN NN O
watery NN NN O
, NN NN O
non NN NN O
bloody NN NN O
diarrhea NNP NNP B-DIAGNOSIS
and NN NN O
weakness NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
has NN NN O
a NN NN O
history NN NN O
of NN NN O
2 NN NN O
prior NN NN O
C NNP NNP B-DIAGNOSIS
diff NNP NNP I-DIAGNOSIS
infections NNP NNP I-DIAGNOSIS
, NN NN O
the NN NN O
most NN NN O
recent NN NN O
just NN NN O
1 NN NN O
month NN NN O
ago NN NN O
. NN NN O

Recent NN NN O
antibx NN NN O
use NN NN O
in NN NN O
the NN NN O
last NN NN O
month NN NN O
on NN NN O
prior NN NN O
admission NN NN O
. NN NN O

Was NN NN O
also NN NN O
txd NN NN O
for NN NN O
Cdiff NNP NNP B-DIAGNOSIS
at NN NN O
that NN NN O
time NN NN O
for NN NN O
14 NN NN O
d NN NN O
. NN NN O

course NN NN O
with NN NN O
po NN NN O
vanco NN NN O
. NN NN O

Pt NN NN O
was NN NN O
initially NN NN O
admitted NN NN O
to NN NN O
the NN NN O
ICU NN NN O
and NN NN O
was NN NN O
septic NNP NNP B-DIAGNOSIS
on NN NN O
pressors NN NN O

( NN NN O
levophed NN NN O
) NN NN O
until NN NN O
the NN NN O
morning NN NN O
of NN NN O
[**8-26**] NN NN O
with NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
but NN NN O
no NNP NNP B-NEGATIVE
fever NNP NNP I-NEGATIVE
. NN NN O

C NNP NNP B-DIAGNOSIS
diff NNP NNP I-DIAGNOSIS
assay NN NN O
positive NN NN O
on NN NN O
admission NN NN O
, NN NN O
and NN NN O
pt NN NN O
had NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
consistent NN NN O
with NN NN O
C NNP NNP B-DIAGNOSIS
diff NNP NNP I-DIAGNOSIS
. NN NN O

Patient NN NN O
was NN NN O
placed NN NN O
on NN NN O
Vanco NN NN O
po NN NN O
, NN NN O
Flagyl NN NN O
IV NN NN O
and NN NN O
Flagyl NN NN O
po NN NN O
initially NN NN O
, NN NN O
and NN NN O
when NN NN O
patient NN NN O
improved NN NN O
she NNP NNP B-GENDER
was NN NN O
transitioned NN NN O
to NN NN O
Vanco NN NN O
oral NN NN O
and NN NN O
Flagyl NN NN O
oral NN NN O
on NN NN O
[**8-29**] NN NN O
. NN NN O

Patient NN NN O
was NN NN O
treated NN NN O
with NN NN O
Vanco NN NN O
for NN NN O
an NN NN O
extended NN NN O
course NN NN O
of NN NN O
6 NN NN O
weeks NN NN O
given NN NN O
her NN NN O
recurrent NN NN O
C NNP NNP B-DIAGNOSIS
diff NNP NNP I-DIAGNOSIS
. NN NN O

Pt NN NN O
was NN NN O
also NN NN O
encouraged NN NN O
to NN NN O
take NN NN O
probiotics NN NN O
and NN NN O
to NN NN O
bleach NN NN O
her NN NN O
home NN NN O
when NN NN O
she NNP NNP B-GENDER
was NN NN O
discharged NN NN O
. NN NN O

60 NNP NNP B-AGE
yo NNP NNP I-AGE
M NNP NNP B-GENDER
with NN NN O
Hep NN NN O
C NNP NNP B-DIAGNOSIS
cirrhosis NNP NNP I-DIAGNOSIS
, NN NN O
grade NN NN B-DIAGNOSIS
II NNP NNP I-DIAGNOSIS
esophageal NNP NNP I-DIAGNOSIS
varices NNP NNP I-DIAGNOSIS
, NN NN O
recent NN NN O
admission NN NN O
for NN NN O
UGIB NN NN O
[**2-9**] NN NN O
NSAID NN NN O
gastritis NNP NNP B-DIAGNOSIS
, NN NN O
referred NN NN O
for NN NN O
admission NN NN O
throught NN NN O
the NN NN O
ED NN NN O
by NN NN O
hepatology NN NN O
clinic NN NN O
for NN NN O
new NN NN O
slurred NNO NNP B-DIAGNOSIS
speech NNP NNP I-DIAGNOSIS
and NN NN O
tangential NNP NNP B-DIAGNOSIS
thought NNP NNP I-DIAGNOSIS
process NNP NNP I-DIAGNOSIS
. NN NN O

Patient NN NN O
also NN NN O
describes NN NN O
new NN NN O
imbalance NNP NNP B-DIAGNOSIS
leading NN NN O
to NN NN O
a NN NN O
fall NN NN O
during NN NN O
which NN NN O
he NNP NNP B-GENDER
may NN NN O
have NN NN O
hit NN NN O
his NN NN O
head NN NN O
on NN NN O
. NN NN O

Per NN NN O
last NN NN O
liver NN NN O
clinic NN NN O
note NN NN O
has NN NN O
been NN NN O
off NN NN O
ETOH NN NN O
for NN NN O
a NN NN O
year NN NN O
( NN NN O
corroborated NN NN O
with NN NN O
pt NN NN O
), NN NN O
utox NN NN O
was NN NN O
negative NN NN B-NEGATIVE
for NNP NNP I-NEGATIVE
alocohol NNP NNP I-NEGATIVE
. NN NN O

CT NN NN O
was NN NN O
within NN NN O
normal NN NN O
limits NN NN O
, NN NN O
and NN NN O
neuro NN NN O
evaluation NN NN O
determined NN NN O
this NN NN O
was NN NN O
not NNP NNP B-NEGATIVE
ischemic NNP NNP I-NEGATIVE
infart NNP NNP I-NEGATIVE
. NN NN O

Patient NN NN O
was NN NN O
given NN NN O
a NN NN O
presumptive NN NN O
diagnosis NN NN O
of NN NN O
hepatic NNP NNP B-DIAGNOSIS
encephalopathy NNP NNP I-DIAGNOSIS
and NN NN O
started NN NN O
on NN NN O
lactulose NN NN O
. NN NN O

Liver NN NN O
function NN NN O
tests NN NN O
showed NN NN O
a NN NN O
striking NN NN O
increase NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
his NN NN O
total NN NN O
and NN NN O
direct NN NN O
bilirubin NNP NNP I-DIAGNOSIS
since NN NN O
last NN NN O
visit NN NN O
. NN NN O

Another NN NN O
worrisome NN NN O
feature NN NN O
was NN NN O
the NN NN O
increase NN NN B-DIAGNOSIS
in NN NN I-DIAGNOSIS
the NN NN O
patient's NN NN O
AFP NN NN I-DIAGNOSIS
. NN NN O

This NN NN O
could NN NN O
be NN NN O
progression NN NN O
of NN NN O
cirrhosis NNP NNP B-DIAGNOSIS
as NN NN O
he NNP NNP B-GENDER
failed NN NN O
interferon NN NN O
twice NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
to NN NN O
follow-up NN NN O
as NN NN O
an NN NN O
outpatient NN NN O
to NN NN O
work NN NN O
this NN NN O
up.Past NN NN O
Medical NN NN O
History NN NN O
: NN NN O
HCV NNP NNP B-DIAGNOSIS
Cirrhosis NNP NNP I-DIAGNOSIS
( NN NN O
tx NN NN O
with NN NN O
interferon NN NN O
x2 NN NN O
with NN NN O
no NN NN O
response)Portal NN NN O
Gastropathy NNP NNP B-DIAGNOSIS
Grade NNP NNP I-DIAGNOSIS
II NNP NNP I-DIAGNOSIS
Esophageal NNP NNP B-DIAGNOSIS
varices NNP NNP I-DIAGNOSIS
HTN NNP NNP B-DIAGNOSIS
Recent NN NN O
admission NN NN O
[**4-/2150**] NN NN O
: NN NN O
UGIB NN NN O
[**2-9**] NN NN O
non-steroidal NN NN O
induced NN NN O
gastritis NNP NNP B-DIAGNOSIS

This NN NN O
is NN NN O
a NN NN O
57-year-old NNP NNP B-AGE
gentleman NNP NNP B-GENDER
with NN NN O
CLL NNP NNP B-DIAGNOSIS
and NN NN O
large NNP NNP B-DIAGNOSIS
cell NNP NNP I-DIAGNOSIS
transformation NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
presented NN NN O
with NN NN O
his NN NN O
disease NN NN O
back NN NN O
in NN NN O
[**10/2119**] NN NN O
with NN NN O
an NN NN O
elevated NNP NNP B-DIAGNOSIS
white NNP NNP I-DIAGNOSIS
count NNP NNP I-DIAGNOSIS
and NN NN O
LDH NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
was NN NN O
without NN NN O
any NN NN O
splenomegaly NNP NNP B-DIAGNOSIS
or NN NN O
any NN NN O
cytopenias NNP NNP B-DIAGNOSIS
at NN NN O
that NN NN O
time NN NN O
. NN NN O

He NNP NNP B-GENDER
did NN NN O
have NN NN O
some NN NN O
bulky NN NN O
lymphadenopathy NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
then NN NN O
completed NN NN O
four NN NN O
cycles NN NN O
of NN NN O
FCR NN NN O
therapy NN NN O
, NN NN O
which NN NN O
he NNP NNP B-GENDER
completed NN NN O
back NN NN O
in NN NN O
09/[**2119**] NN NN O
. NN NN O

He NNP NNP B-GENDER
had NN NN O
an NN NN O
excellent NN NN O
response NN NN O
to NN NN O
therapy NN NN O
and NN NN O
was NN NN O
monitored NN NN O
off NN NN O
treatment NN NN O
for NN NN O
approximately NN NN O
two NN NN O
years NN NN O
. NN NN O

He NNP NNP B-GENDER
then NN NN O
presented NN NN O
in NN NN O
[**7-/2122**] NN NN O
with NN NN O
a NN NN O
rising NNP NNP B-DIAGNOSIS
white NNP NNP I-DIAGNOSIS
count NNP NNP I-DIAGNOSIS
, NN NN O
approximately NN NN O
50% NNP NNP B-DIAGNOSIS
lymphocytes NNP NNP I-DIAGNOSIS
, NN NN O
and NN NN O
a NN NN O
mildly NNP NNP B-DIAGNOSIS
elevated NNP NNP I-DIAGNOSIS
LDH NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
also NN NN O
had NN NN O
some NN NN O
mild NNP NNP B-DIAGNOSIS
worsening NNP NNP I-DIAGNOSIS
palpable NNP NNP I-DIAGNOSIS
lymphadenopathy NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
then NN NN O
received NN NN O
four NN NN O
cycles NN NN O
of NN NN O
PCR NN NN O
, NN NN O
but NN NN O
did NN NN O
not NN NN O
have NN NN O
much NN NN O
in NN NN O
the NN NN O
way NN NN O
of NN NN O
response NN NN O
and NN NN O
his NN NN O
treatment NN NN O
regimen NN NN O
was NN NN O
switched NN NN O
to NN NN O
R-CVP NN NN O
of NN NN O
which NN NN O
he NNP NNP B-GENDER
received NN NN O
two NN NN O
cycles NN NN O
. NN NN O

He NNP NNP B-GENDER
did NN NN O
again NN NN O
not NN NN O
have NN NN O
a NN NN O
significant NN NN O
response NN NN O
, NN NN O
though NN NN O
continued NN NN O
to NN NN O
have NN NN O
an NN NN O
excellent NN NN O
performance NN NN O
status NN NN O
, NN NN O
and NN NN O
he NNP NNP B-GENDER
was NN NN O
ultimately NN NN O
switched NN NN O
to NN NN O
Campath NN NN O
therapy NN NN O
. NN NN O

He NNP NNP B-GENDER
did NN NN O
have NN NN O
resolution NN NN O
of NN NN O
his NN NN O
lymphocytosis NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
his NN NN O
white NN NN O
count NN NN O
has NN NN O
come NN NN O
down NN NN O
nicely NN NN O
, NN NN O
but NN NN O
did NN NN O
not NN NN O
have NN NN O
much NN NN O
in NN NN O
the NN NN O
way NN NN O
of NN NN O
response NN NN O
in NN NN O
terms NN NN O
of NN NN O
reducing NN NN O
his NN NN O
bulky NN NN O
lymphadenopathy NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
then NN NN O
eventually NN NN O
had NN NN O
developed NN NN O
an NN NN O
enlarging NNP NNP B-DIAGNOSIS
left NNP NNP I-DIAGNOSIS
cervical NNP NNP I-DIAGNOSIS
node NNP NNP I-DIAGNOSIS
which NN NN O
was NN NN O
biopsied NN NN O
and NN NN O
was NN NN O
found NN NN O
to NN NN O
have NN NN O
Richter's NNP NNP B-DIAGNOSIS
transformation NNP NNP I-DIAGNOSIS
. NN NN O

41 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
man NNP NNP B-GENDER
with NN NN O
history NN NN O
of NN NN O
severe NN NN O
intellectual NNP NNP B-DIAGNOSIS
disability NNP NNP I-DIAGNOSIS
, NN NN O
CHF NNP NNP B-DIAGNOSIS
, NN NN O
epilepsy NNP NNP B-DIAGNOSIS
presenting NN NN O
with NN NN O
facial NNP NNP B-DIAGNOSIS
twitching NNP NNP I-DIAGNOSIS
on NN NN O
the NN NN O
right NN NN O
and NN NN O
generalized NN NN O
shaking NNP NNP B-DIAGNOSIS
in NN NN O
at NN NN O
his NN NN O
NH NN NN O
which NN NN O
required NN NN O
20 NN NN O
mg NN NN O
valium NN NN O
to NN NN O
cease NN NN O
seizure NNP NNP B-DIAGNOSIS
activity NN NN O
. NN NN O

Per NN NN O
outside NN NN O
medical NN NN O
patient NN NN O
was NN NN O
felt NN NN O
to NN NN O
have NN NN O
focal NNP NNP B-DIAGNOSIS
epilepsy NNP NNP I-DIAGNOSIS
with NN NN O
secondary NN NN O
generalization NN NN O
, NN NN O
likely NN NN O
due NN NN O
to NN NN O
anoxic NNP NNP B-DIAGNOSIS
brain NNP NNP I-DIAGNOSIS
injury NNP NNP I-DIAGNOSIS
at NN NN O
birth NN NN O
, NN NN O
and NN NN O
probably NN NN O
related NN NN O
to NN NN O
the NN NN O
atrophic NNP NNP B-DIAGNOSIS
changes NNP NNP I-DIAGNOSIS
seen NN NN O
on NN NN O
MRI NN NN O
, NN NN O
particularly NN NN O
in NN NN O
the NN NN O
left NN NN O
temporal NN NN O
lobe.The NN NN O
patient NN NN O
first NN NN O
developed NN NN O
seizures NNP NNP B-DIAGNOSIS
at NN NN O
age NN NN O
13 NN NN O
found NN NN O
by NN NN O
family NN NN O
to NN NN O
have NN NN O
a NN NN O
generalized NN NN O
convulsion NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
had NN NN O
a NN NN O
second NN NN O
seizure NNP NNP B-DIAGNOSIS
two NN NN O
years NN NN O
after NN NN O
his NN NN O
first NN NN O
episode NN NN O
. NN NN O

He NNP NNP B-GENDER
was NN NN O
maintained NN NN O
on NN NN O
Dilantin NN NN O
and NN NN O
phenobarbital NN NN O
. NN NN O

The NN NN O
patient NN NN O
went NN NN O
20 NN NN O
years NN NN O
without NN NN O
another NN NN O
seizure NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
was NN NN O
recently NN NN O
tapered NN NN O
off NN NN O
Dilantin NN NN O
, NN NN O
and NN NN O
it NN NN O
was NN NN O
felt NN NN O
that NN NN O
perhaps NN NN O
this NN NN O
medication NN NN O
was NN NN O
necessary NN NN O
to NN NN O
maintain NN NN O
him NN NN O
seizure NN NN O
free NN NN O
. NN NN O

The NN NN O
patient NN NN O
had NN NN O
no NN NN O
further NN NN O
events NN NN O
during NN NN O
the NN NN O
hospital NN NN O
course NN NN O
and NN NN O
was NN NN O
back NN NN O
at NN NN O
his NN NN O
baseline NN NN O
at NN NN O
the NN NN O
time NN NN O
of NN NN O
discharge NN NN O
. NN NN O

Full NN NN O
EEG NN NN O
reports NN NN O
are NN NN O
pending NN NN O
at NN NN O
the NN NN O
time NN NN O
of NN NN O
dictation.Past NN NN O
Medical NN NN O
History: NN NN O
Epilepsy NNP NNP B-DIAGNOSIS
as NN NN O
above NN NN O
, NN NN O
CHF NNP NNP B-DIAGNOSIS
, NN NN O
depression NNP NNP B-DIAGNOSIS

Pt NN NN O
is NN NN O
a NN NN O
22yo NNP NNP B-AGE
F NNP NNP B-GENDER
otherwise NN NN O
healthy NN NN O
with NN NN O
a NN NN O
5 NN NN O
yr NN NN O
history NN NN O
of NN NN O
the NN NN O
systemic NNP NNP B-DIAGNOSIS
mastocytosis NNP NNP I-DIAGNOSIS
, NN NN O
with NN NN O
flares NN NN O
normally NN NN O
3/year NN NN O
, NN NN O
presenting NN NN O
with NN NN O
flushing NNP NNP B-DIAGNOSIS
and NN NN O
tachycardia NNP NNP B-DIAGNOSIS
concerning NN NN O
for NN NN O
another NN NN O
flare NN NN O
. NN NN O

This NN NN O
is NN NN O
patient's NN NN O
3rd NN NN O
flare NN NN O
in NN NN O
2 NN NN O
months NN NN O
, NN NN O
while NN NN O
still NN NN O
on NN NN O
steroid NN NN O
taper NN NN O
which NN NN O
is NN NN O
new NN NN O
for NN NN O
her NN NN O
. NN NN O

She NNP NNP B-GENDER
responded NN NN O
well NN NN O
to NN NN O
125 NN NN O
mg NN NN O
IV NN NN O
steroids NN NN O
q NN NN O
8 NN NN O
hrs NN NN O
and NN NN O
IV NN NN O
diphenydramine NN NN O
in NN NN O
addition NN NN O
to NN NN O
her NN NN O
continuing NN NN O
home NN NN O
regimen NN NN O
. NN NN O

CBC NN NN O
was NN NN O
at NN NN O
her NN NN O
baseline NN NN O
, NN NN O
w/normal NN NN O
differential NN NN O
. NN NN O

Serum NN NN O
tryptase NN NN O
revealed NN NN O
a NN NN O
high NN NN O
value NN NN O
at NN NN O
84 NN NN O
. NN NN O
The NN NN O
patient NN NN O
failed NN NN O
aspirin NN NN O
challenge NN NN O
due NN NN O
to NN NN O
adverse NN NN O
reaction NN NN O
. NN NN O

She NNP NNP B-GENDER
was NN NN O
stabilized NN NN O
on NN NN O
IV NN NN O
steroids NN NN O
and NN NN O
IV NN NN O
benadryl NN NN O
and NN NN O
transferred NN NN O
back NN NN O
to NN NN O
the NN NN O
medical NN NN O
floor NN NN O
. NN NN O

She NNP NNP B-GENDER
continued NN NN O
on NN NN O
her NN NN O
home NN NN O
histamine NN NN O
receptor NN NN O
blockers NN NN O
and NN NN O
was NN NN O
transitioned NN NN O
from NN NN O
IV NN NN O
to NN NN O
PO NN NN O
steroids NN NN O
and NN NN O
benadryl NN NN O
and NN NN O
observed NN NN O
overnight NN NN O
and NN NN O
was NN NN O
discharged NN NN O
on NN NN O
her NN NN O
home NN NN O
meds NN NN O
, NN NN O
prednisone NN NN O
taper NN NN O
, NN NN O
GI NN NN O
prophylaxis NN NN O
with NN NN O
PPI NN NN O
, NN NN O
Calcium NN NN O
and NN NN O
vitamin NN NN O
D NN NN O
, NN NN O
and NN NN O
SS NN NN O
bactrim NN NN O
for NN NN O
PCP NNP NNP B-DIAGNOSIS
. NN NN O

A NN NN O
75 NNP NNP B-AGE
yo NNP NNP I-AGE
M NNP NNP B-GENDER
w/ NN NN O
metastatic NNP NNP B-DIAGNOSIS
papillary NNP NNP I-DIAGNOSIS
thyroid NNP NNP I-DIAGNOSIS
cancer NNP NNP I-DIAGNOSIS
s/p NN NN O
XRT NN NN O
19 NN NN O
sessions NN NN O
who NN NN O
presented NN NN O
with NN NN O
2 NN NN O
days NN NN O
of NN NN O
worsening NN NN O
dysphagia NNP NNP B-DIAGNOSIS
for NN NN O
solids NN NN O
, NN NN O
poor NNP NNP B-DIAGNOSIS
oral NNP NNP I-DIAGNOSIS
intake NNP NNP I-DIAGNOSIS
, NN NN O
weight NNP NNP B-DIAGNOSIS
loss NNP NNP I-DIAGNOSIS
20 NN NN O
pounds NN NN O
over NN NN O
last NN NN O
several NN NN O
weeks NN NN O
and NN NN O
some NN NN O
lethargy NNP NNP B-DIAGNOSIS
. NN NN O

Papillary NNP NNP B-DIAGNOSIS
thyroid NNP NNP I-DIAGNOSIS
cancer NNP NNP I-DIAGNOSIS
dx NN NN O
w/ NN NN O
right NN NN O
neck NN NN O
mass--s/p NN NN O
neck NN NN O
mass NN NN O
resection NN NN O
; NN NN O

unable NN NN O
to NN NN O
perform NN NN O
thyroidectomy--high NN NN O
bleed NNP NNP B-DIAGNOSIS
risk NN NN O
, NN NN O
proximity NN NN O
to NN NN O
trachea NN NN O
and NN NN O
recurrent NN NN O
laryngeal NN NN O
nerve NN NN O
and NN NN O
large NN NN O
tumor NNP NNP B-DIAGNOSIS
size--s/p NN NN O
XRT NN NN O
to NN NN O
neck NN NN O
-- NN NN O
s/p NN NN O
RAI NN NN O
ablation--Metastatic NN NN O
to NN NN O
lymph NN NN O
nodes NN NN O
and NN NN O
adrenal NN NN O
glands NN NN O
* NN NN O
s/p NN NN O
hernia NNP NNP B-DIAGNOSIS
repair NN NN O
* NN NN O
s/p NN NN O
tonsillectomy NNP NNP B-DIAGNOSIS

34 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
woman NNP NNP B-GENDER
with NN NN O
Marfan's NNP NNP B-DIAGNOSIS
syndrome NNP NNP I-DIAGNOSIS
and NN NN O
known NN NN O
severe NN NN O
mitral NNP NNP B-DIAGNOSIS
valve NNP NNP I-DIAGNOSIS
prolapse NNP NNP I-DIAGNOSIS
with NN NN O
regurgitation NN NN O
, NN NN O
who NN NN O
was NN NN O
planned NN NN O
for NN NN O
a NN NN O
MV NN NN O
repair NN NN O
but NN NN O
was NN NN O
lost NN NN O
to NN NN O
follow-up NN NN O
. NN NN O

She NNP NNP B-GENDER
remains NN NN O
symptomatic NN NN O
and NN NN O
is NN NN O
now NN NN O
prepared NN NN O
to NN NN O
undergo NN NN O
mitral NN NN O
valve NN NN O
repair/replacement NN NN O
surgery NN NN O
. NN NN O

EF NN NN O
of NN NN O
65% NN NN O
on NN NN O
TTE NN NN O
. NN NN O

Past NN NN O
Medical NN NN O
History NN NN O
: NN NN O
Marfans NNP NNP B-DIAGNOSIS
Syndrome NNP NNP I-DIAGNOSIS
with NN NN O
severe NN NN O
mitral NNP NNP B-DIAGNOSIS
regurgitation NNP NNP I-DIAGNOSIS
Gastric NNP NNP B-DIAGNOSIS
reflux NNP NNP I-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
History NN NN O
of NN NN O
gestational NNP NNP B-DIAGNOSIS
diabetes NNP NNP I-DIAGNOSIS
mellitus NNP NNP I-DIAGNOSIS
Hypertension NNP NNP B-DIAGNOSIS
with NN NN O
pregnancy NNP NNP B-DIAGNOSIS
Obesity NNP NNP B-DIAGNOSIS
c-section NN NN O
x NN NN O
2laser NN NN O
eye NN NN O
surgerycataract NN NN O
surgeryfoot NN NN O
surgery NN NN O
( NN NN O
shorten NN NN O
bone NN NN O
length NN NN O
) NN NN O

62 NNP NNP B-AGE
yo NNP NNP I-AGE
male NNP NNP B-GENDER
with NN NN O
hx NN NN O
of NN NN O
CVA NNP NNP B-DIAGNOSIS
, NN NN O
neurogenic NNP NNP B-DIAGNOSIS
bladder NNP NNP I-DIAGNOSIS
with NN NN O
indwelling NN NN O
suprapubic NNP NNP B-DIAGNOSIS
catheter NNP NNP I-DIAGNOSIS
with NN NN O
multiple NN NN O
prior NN NN O
admissions NN NN O
for NN NN O
UTIs NNP NNP B-DIAGNOSIS
, NN NN O
altered NN NN B-DIAGNOSIS
mental NNP NNP I-DIAGNOSIS
status NNP NNP I-DIAGNOSIS
, NN NN O
and NN NN O
urosepsis NNP NNP B-DIAGNOSIS
presents NN NN O
to NN NN O
the NN NN O
hospital NN NN O
in NN NN O
urosepsis NNP NNP B-DIAGNOSIS
now NN NN O
resolved NN NN O
after NN NN O
treatment NN NN O
with NN NN O
vanc/meropenem NN NN O
. NN NN O

Per NN NN O
CT NN NN O
there NN NN O
is NN NN O
a NN NN O
non-obstructing NN NN O
stone NN NN O
in NN NN O
the NN NN O
L NN NN O
ureter NN NN O
, NN NN O
no NNP NNP B-NEGATIVE
evidence NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
urethral NNP NNP I-NEGATIVE
strictures NNP NNP I-NEGATIVE
. NN NN O

Significant NN NN O
leaking NNP NNP B-DIAGNOSIS
around NN NN O
suprapubic NN NN O
cath NN NN O
site NN NN O
. NN NN O

Started NN NN O
on NN NN O
ditropan NN NN O
changed NN NN O
over NN NN O
to NN NN O
detrol NN NN O
. NN NN O

Urologist NN NN O
not NN NN O
concerned NN NN O
with NN NN O
leaking NN NN O
and NN NN O
will NN NN O
f/u NN NN O
with NN NN O
pt NN NN O
next NN NN O
week.s/p NN NN O
CVA NNP NNP B-DIAGNOSIS
Neurogenic NNP NNP B-DIAGNOSIS
bladder NNP NNP I-DIAGNOSIS
s/p NN NN O
suprapubic NN NN O
cathRecurrent NN NN O
UTIs NNP NNP B-DIAGNOSIS
with NN NN O
Klebsiella NNP NNP B-DIAGNOSIS
/ NN NN O
Pseudomonas NNP NNP B-DIAGNOSIS
Non-hodgkins NNP NNP I-DIAGNOSIS
Marginal NNP NNP I-DIAGNOSIS
Zone NNP NNP I-DIAGNOSIS
Lymphoma NNP NNP B-DIAGNOSIS
of NN NN O
the NN NN O
left NN NN O
orbit NN NN O
Dx NN NN O
in NN NN O
03(s/p NN NN O
R-CHOP NN NN O
x NN NN O
6 NN NN O
cycles)
Bells NNP NNP B-DIAGNOSIS
Palsy NNP NNP I-DIAGNOSIS
BPH NNP NNP B-DIAGNOSIS
Hypertension NNP NNP B-DIAGNOSIS
Partial NNP NNP B-DIAGNOSIS
Bowel NNP NNP I-DIAGNOSIS
obstruction NNP NNP I-DIAGNOSIS
s/p NN NN O
colostomy NNP NNP B-DIAGNOSIS
Hepatitis NNP NNP B-DIAGNOSIS
Cryoglobulinemia NNP NNP B-DIAGNOSIS
SLE NNP NNP B-DIAGNOSIS
with NN NN O
transverse NNP NNP B-DIAGNOSIS
myelitis NNP NNP I-DIAGNOSIS
, NN NN O
anti-dsDNA NN NN O
Ab+Insulin NN NN O
Dependant NN NN O
Diabetic NNP NNP B-DIAGNOSIS
Fungal NNP NNP I-DIAGNOSIS
Esophagitis NNP NNP I-DIAGNOSIS
Stage NNP NNP I-DIAGNOSIS
IV NNP NNP I-DIAGNOSIS
? NN NN O

Urinary NNP NNP B-DIAGNOSIS
Tract NNP NNP I-DIAGNOSIS
Infections NNP NNP I-DIAGNOSIS
- NN NN O
pseudomonas NNP NNP B-DIAGNOSIS
& NN NN O
enterococcus NNP NNP B-DIAGNOSIS

70 NNP NNP B-AGE
y/o NNP NNP I-AGE
with NN NN O
COPD NNP NNP B-DIAGNOSIS
on NN NN O
2.5-3.5L NN NN O
O2 NN NN O
at NN NN O
baseline NN NN O
, NN NN O
OSA NNP NNP B-DIAGNOSIS
and NN NN O
obesity NNP NNP B-DIAGNOSIS
hypoventilation NNP NNP I-DIAGNOSIS
syndrome NNP NNP I-DIAGNOSIS
, NN NN O
CHF NNP NNP B-DIAGNOSIS
, NN NN O
discharged NN NN O
[**2132-8-24**] NN NN O
now NN NN O
presents NN NN O
with NN NN O
agitation NNP NNP B-DIAGNOSIS
and NN NN O
altered NNP NNP B-DIAGNOSIS
mental NNP NNP I-DIAGNOSIS
status NNP NNP I-DIAGNOSIS
with NN NN O
hypoxia NNP NNP B-DIAGNOSIS
and NN NN O
O2 NN NN O
sats NN NN O
70s NN NN O
on NN NN O
BipAp NN NN O
with NN NN O
5L NN NN O
. NN NN O

Pt NN NN O
agitated NN NN O
then NN NN O
somnolent NN NN O
at NN NN O
initial NN NN O
presentation NN NN O
. NN NN O

Daughter NN NN O
reported NN NN O
increased NN NN O
agitation NNP NNP B-DIAGNOSIS
and NN NN O
altered NNP NNP B-DIAGNOSIS
mental NNP NNP I-DIAGNOSIS
status NNP NNP I-DIAGNOSIS
x NN NN O
2-3 NN NN O
days NN NN O
with NN NN O
O2 NN NN O
sats NN NN O
60s-70s NN NN O
at NN NN O
home NN NN O
. NN NN O

Daughter NN NN O
has NN NN O
also NN NN O
noted NN NN O
increased NN NN O
LE NNP NNP B-DIAGNOSIS
edema NNP NNP I-DIAGNOSIS
and NN NN O
weight NNP NNP B-DIAGNOSIS
gain NNP NNP I-DIAGNOSIS
which NN NN O
prompted NN NN O
a NN NN O
phone NN NN O
call NN NN O
to NN NN O
her NN NN O
PCP NN NN O
and NN NN O
increased NN NN O
lasix NN NN O
dose NN NN O
from NN NN O
80daily NN NN O
to NN NN O
100mg NN NN O
daily NN NN O
with NN NN O
some NN NN O
mild NN NN O
improvement NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
edema NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
has NN NN O
had NN NN O
decreased NNP NNP B-DIAGNOSIS
appetite NNP NNP I-DIAGNOSIS
, NN NN O
PO NN NN O
intake NN NN O
, NN NN O
energy NN NN O
level NN NN O
at NN NN O
home NN NN O
with NN NN O
difficulty NNP NNP B-DIAGNOSIS
with NNP NNP B-DIAGNOSIS
ADLs NNP NNP I-DIAGNOSIS
. NN NN O

No NNP NNP B-NEGATIVE
recent NNP NNP I-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
fever NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
cough NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
chills NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
sputum NNP NNP I-NEGATIVE
production NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
CP NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
abd NN NN I-NEGATIVE
pain NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
other NNP NNP I-NEGATIVE
complaints NNP NNP I-NEGATIVE
other NN NN O
than NN NN O
chronic NN NN O
right NNP NNP B-DIAGNOSIS
thigh NNP NNP I-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
last NN NN O
1-2 NN NN O
months NN NN O
. NN NN O

Daughter NN NN O
also NN NN O
reports NN NN O
med NN NN O
compliance NN NN O
and NN NN O
compliance NN NN O
with NN NN O
BiPap NN NN O
at NN NN O
night.Past NN NN O
Medical NN NN O
History NN NN O
:- NN NN O
CAD NNP NNP B-DIAGNOSIS
; NN NN O

s/p NN NN O
4 NN NN O
vessel NN NN O
CABG NNP NNP B-DIAGNOSIS
in NN NN O
[**2119**] NN NN O
- NN NN O
CHF NNP NNP B-DIAGNOSIS
; NN NN O

EF NN NN O
55% NN NN O
, NN NN O
mild NN NN O
AS NN NN O
- NN NN O
obesity NNP NNP B-DIAGNOSIS
hypoventilation NNP NNP I-DIAGNOSIS
syndrome NNP NNP I-DIAGNOSIS
- NN NN O
obstructive NNP NNP B-DIAGNOSIS
sleep NNP NNP I-DIAGNOSIS
apnea NNP NNP I-DIAGNOSIS
- NN NN O
DM2 NNP NNP B-DIAGNOSIS
- NN NN O
ventricular NNP NNP B-DIAGNOSIS
tachycardia NNP NNP I-DIAGNOSIS
; NN NN O

s/p NN NN O
ICD NNP NNP B-DIAGNOSIS
in NN NN O
[**2127**] NN NN O
- NN NN O
hypothyroidism NNP NNP B-DIAGNOSIS
- NN NN O
schizophrenia NNP NNP B-DIAGNOSIS
- NN NN O
COPD NNP NNP B-DIAGNOSIS
- NN NN O
Pneumona NNP NNP B-DIAGNOSIS
treated NN NN O
in NN NN O
[**4-7**] NN NN O
at NN NN O
[**Hospital1 NN NN O
** NN NN O
] NN NN O

70 NNP NNP B-AGE
year-old NNP NNP I-AGE
woman NNP NNP B-GENDER
with NN NN O
a NN NN O
history NN NN O
of NN NN O
CAD NNP NNP B-DIAGNOSIS
recently NN NN O
noted NN NN O
abdominal NNP NNP B-DIAGNOSIS
mass NNP NNP I-DIAGNOSIS
who NN NN O
presents NN NN O
with NN NN O
fevers NNP NNP B-DIAGNOSIS
/ NN NN O
rigors NNP NNP B-DIAGNOSIS
and NN NN O
bandemia NNP NNP B-DIAGNOSIS
. NN NN O

Over NN NN O
the NN NN O
last NN NN O
few NN NN O
weeks NN NN O
leading NN NN O
up NN NN O
to NN NN O
admission NN NN O
, NN NN O
she NNP NNP B-GENDER
has NN NN O
been NN NN O
experiencing NN NN O
mid NN NN O
- NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
, NN NN O
radiating NN NN O
to NN NN O
the NN NN O
left NN NN O
flank NN NN O
. NN NN O

It NN NN O
lasts NN NN O
throughout NN NN O
the NN NN O
day NN NN O
is NN NN O
not NN NN O
increased NN NN O
by NN NN O
eating NN NN O
though NN NN O
there NN NN O
is NN NN O
associated NN NN O
vomiting NNP NNP B-DIAGNOSIS
and NN NN O
is NN NN O
worsened NN NN O
with NN NN O
coughing NNP NNP B-DIAGNOSIS
. NN NN O

CT NN NN O
abdomen NN NN O
without NN NN O
contrast NN NN O
was NN NN O
then NN NN O
performed NN NN O
on NN NN O
[**4-20**] NN NN O
showing NN NN O
a NN NN O
large NN NN O
9.5 NN NN O
x NN NN O
7.5 NN NN O
x NN NN O
6.0-cm NN NN O
heterogeneous NNP NNP B-DIAGNOSIS
left NNP NNP I-DIAGNOSIS
upper NNP NNP I-DIAGNOSIS
abdominal NNP NNP I-DIAGNOSIS
mass NNP NNP I-DIAGNOSIS
. NN NN O

Patient NN NN O
underwent NN NN O
a NN NN O
EUS NN NN O
with NN NN O
biopsy NN NN O
. NN NN O

The NN NN O
results NN NN O
of NN NN O
the NN NN O
biopsy NN NN O
were NN NN O
consistent NN NN O
with NN NN O
pancreatic NNP NNP B-DIAGNOSIS
adenocarcinoma NNP NNP I-DIAGNOSIS
at NN NN O
the NN NN O
head NN NN O
of NN NN O
pancreas NN NN O
. NN NN O

Splenic NNP NNP B-DIAGNOSIS
flecture NNP NNP I-DIAGNOSIS
/ NN NN O
pancreatic NNP NNP B-DIAGNOSIS
tail NNP NNP I-DIAGNOSIS
mass NNP NNP I-DIAGNOSIS
was NN NN O
also NN NN O
seen NN NN O
on NN NN O
CT NN NN O
, NN NN O
likely NN NN O
diverticular NNP NNP B-DIAGNOSIS
abscess NNP NNP I-DIAGNOSIS
given NN NN O
the NN NN O
patients NN NN O
recent NN NN O
likely NN NN O
history NN NN O
of NN NN O
diverticulitis NNP NNP B-DIAGNOSIS
this NN NN O
was NN NN O
thought NN NN O
to NN NN O
be NN NN O
an NN NN O
infected NNP NNP B-DIAGNOSIS
fluid NNP NNP I-DIAGNOSIS
collection NNP NNP I-DIAGNOSIS
or NN NN O
abscess NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
was NN NN O
treated NN NN O
with NN NN O
IV NN NN O
antibiotics NN NN O
( NN NN O
Zosyn NN NN O
, NN NN O
then NN NN O
ceftriaxone NN NN O
and NN NN O
flagyl NN NN O
) NN NN O
and NN NN O
will NN NN O
continue NN NN O
on NN NN O
them NN NN O
until NN NN O
seen NN NN O
by NN NN O
ID NN NN O
as NN NN O
an NN NN O
outpatient.Past NN NN O
Medical NN NN O
History:1 NN NN O
. NN NN O

Coronary NNP NNP B-DIAGNOSIS
artery NNP NNP I-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
with NN NN O
history NN NN O
of NN NN O
angioplasty NNP NNP B-DIAGNOSIS
in NN NN O
[**State NN NN O
108**] NN NN O
one NN NN O
year NN NN O
ago2 NN NN O
. NN NN O

Mitral NNP NNP B-DIAGNOSIS
valve NNP NNP I-DIAGNOSIS
prolapse NNP NNP I-DIAGNOSIS

3 NN NN O
. NN NN O
Atrial NNP NNP B-DIAGNOSIS
fibrillation NNP NNP I-DIAGNOSIS

4 NN NN O
. NN NN O
Hyperlipemia NNP NNP B-DIAGNOSIS
. NN NN O

Hypertension NNP NNP B-DIAGNOSIS
. NN NN O

Chronic NNP NNP B-DIAGNOSIS
kidney NNP NNP I-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
( NN NN O
SCr NN NN O
2.1 NN NN O
in NN NN O
[**3-17**])7 NN NN O
. NN NN O

Hypothyroidism NNP NNP B-DIAGNOSIS
? NN NN O
( NN NN O
TSH NN NN O
10 NN NN O
in NN NN O
[**3-17**])8 NN NN O
. NN NN O

Anemia NNP NNP B-DIAGNOSIS
( NN NN O
HCT NN NN O
30.7 NN NN O
in NN NN O
[**3-17**] NN NN O
) NN NN O

79 NNP NNP B-AGE
yo NNP NNP I-AGE
F NNP NNP B-GENDER
with NN NN O
multifactorial NN NN O
chronic NN NN O
hypoxemia NNP NNP B-DIAGNOSIS
and NN NN O
dyspnea NNP NNP B-DIAGNOSIS
thought NN NN O
due NN NN O
to NN NN O
diastolic NNP NNP B-DIAGNOSIS
CHF NNP NNP I-DIAGNOSIS
, NN NN O
pulmonary NNP NNP B-DIAGNOSIS
hypertension NNP NNP I-DIAGNOSIS
thought NN NN O
secondary NN NN O
to NN NN O
a NN NN O
chronic NN NN O
ASD NNP NNP B-DIAGNOSIS
and NN NN O
COPD NNP NNP B-DIAGNOSIS
on NN NN O
5L NN NN O
home NN NN O
oxygen NN NN O
admitted NN NN O
with NN NN O
complaints NN NN O
of NN NN O
worsening NN NN O
shortness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
breath NNP NNP I-DIAGNOSIS
. NN NN O

Cardiology NN NN O
consult NN NN O
recommended NN NN O
a NN NN O
right NN NN O
heart NN NN O
cath NN NN O
for NN NN O
evaluation NN NN O
of NN NN O
response NN NN O
to NN NN O
sildenafil NN NN O
but NN NN O
the NN NN O
patient NN NN O
refused NN NN O
. NN NN O

Pulmonary NN NN O
consult NN NN O
recommended NN NN O
an NN NN O
empiric NN NN O
, NN NN O
compassionate NN NN O
sildenafil NN NN O
trial NN NN O
due NN NN O
to NN NN O
severe NN NN O
dyspneic NNP NNP B-DIAGNOSIS
symptomology NNP NNP I-DIAGNOSIS
preventing NN NN O
outpatient NN NN O
living NN NN O
, NN NN O
and NN NN O
the NN NN O
patient NN NN O
tolerated NN NN O
an NN NN O
inpatient NN NN O
trial NN NN O
without NN NN O
hypotension NNP NNP B-DIAGNOSIS
. NN NN O

Patient NN NN O
to NN NN O
f/u NN NN O
with NN NN O
pulmonology NN NN O
to NN NN O
start NN NN O
sildenifil NN NN O
chronically NN NN O
as NN NN O
outpatient NN NN O
as NN NN O
prior NN NN O
authorization NN NN O
is NN NN O
obtained.Past NN NN O
Medical NN NN O
History NN NN O
:- NN NN O
Atrial NNP NNP B-DIAGNOSIS
septal NNP NNP I-DIAGNOSIS
defect NNP NNP I-DIAGNOSIS
repair NN NN O
[**6-17**] NN NN O
complicated NN NN O
by NN NN O
sinus NNP NNP B-DIAGNOSIS
arrest NNP NNP I-DIAGNOSIS
with NN NN O
PPM NNP NNP B-DIAGNOSIS
placement NN NN O
. NN NN O

- NN NN O
Diastolic NN NN O
CHF NNP NNP B-DIAGNOSIS
, NN NN O
estimated NN NN O
dry NN NN O
weight NN NN O
of NN NN O
94kg NN NN O
- NN NN O
Pulm NN NN O
HTN NNP NNP B-DIAGNOSIS
( NN NN O
RSVP NN NN O
75 NN NN O
in NN NN O
[**11-24**] NN NN O
) NN NN O
thought NN NN O
secondary NN NN O
to NN NN O
longstanding NN NN O
ASD NNP NNP B-DIAGNOSIS
- NN NN O
COPD NNP NNP B-DIAGNOSIS
on NN NN O
home NN NN O
O2 NN NN O
( NN NN O
5L NN NN O
NC NN NN O
) NN NN O
with NN NN O
baseline NN NN O
saturation NN NN O
high NN NN O
80's NN NN O
to NN NN O
low NN NN O
90's NN NN O
on NN NN O
this NN NN O
therapy NN NN O
. NN NN O

- NN NN O
OSA NNP NNP B-DIAGNOSIS
, NN NN O
not NN NN O
CPAP NN NN O
compliant NN NN O
- NN NN O
Mild NN NN O
mitral NNP NNP B-DIAGNOSIS
regurgitation NNP NNP I-DIAGNOSIS
- NN NN O
Microcytic NNP NNP B-DIAGNOSIS
anemia NNP NNP I-DIAGNOSIS
- NN NN O
Hypothyroidism NNP NNP B-DIAGNOSIS
- NN NN O
S/p NN NN O
APPY NN NN O
, NN NN O
s/p NN NN O
CCY NN NN O
(' NN NN O
[**33**] NN NN O
)- NN NN O
Gallstone NNP NNP B-DIAGNOSIS
pancreatitis NNP NNP I-DIAGNOSIS
s/p NN NN O
ERCP NNP NNP B-DIAGNOSIS
, NN NN O
sphincterotomy NNP NNP B-DIAGNOSIS
- NN NN O
Elevated NN NN O
alk NN NN O
phos NN NN O
secondary NN NN O
to NN NN O
amiodarone NN NN O

64yo NNP NNP B-AGE
woman NNP NNP B-GENDER
with NN NN O
multiple NNP NNP B-DIAGNOSIS
myeloma NNP NNP I-DIAGNOSIS
, NN NN O
s/p NN NN O
allogeneic NN NN O
transplant NN NN O
with NN NN O
recurrent NN NN O
disease NN NN O
and NN NN O
with NN NN O
systemic NNP NNP B-DIAGNOSIS
amyloidosis NNP NNP I-DIAGNOSIS
( NN NN O
involvement NN NN O
of NN NN O
lungs NN NN O
, NN NN O
tongue NN NN O
, NN NN O
bladder NN NN O
, NN NN O
heart NN NN O
), NN NN O
on NN NN O
hemodialysis NN NN O
for NN NN O
ESRD NNP NNP B-DIAGNOSIS
who NN NN O
represents NN NN O
for NN NN O
malaise NNP NNP B-DIAGNOSIS
, NN NN O
weakness NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
generalized NN NN O
body NNP NNP B-DIAGNOSIS
aching NNP NNP I-DIAGNOSIS
x NN NN O
2 NN NN O
days NN NN O
. NN NN O

She NNP NNP B-GENDER
was NN NN O
admitted NN NN O
last NN NN O
week NN NN O
with NN NN O
hypercalcemia NNP NNP B-DIAGNOSIS
and NN NN O
treated NN NN O
with NN NN O
pamidronate NN NN O
30mg NN NN O
, NN NN O
calcitonin NN NN O
, NN NN O
and NN NN O
dialysis NN NN O
. NN NN O

Patient NN NN O
was NN NN O
Initially NN NN O
treated NN NN O
with NN NN O
melphalan NN NN O
and NN NN O
prednisone NN NN O
, NN NN O
followed NN NN O
by NN NN O
VAD NN NN O
regimen NN NN O
, NN NN O
and NN NN O
autologous NN NN O
stem NN NN O
cell NN NN O
transplant NN NN O
. NN NN O

With NN NN O
relapse NN NN O
of NN NN O
her NN NN O
myeloma NNP NNP B-DIAGNOSIS
, NN NN O
she NNP NNP B-GENDER
received NN NN O
thalidomide NN NN O
velcade NN NN O
and NN NN O
thalidomide NN NN O
, NN NN O
which NN NN O
were NN NN O
eventually NN NN O
also NN NN O
held NN NN O
due NN NN O
to NN NN O
worsening NN NN O
edema NNP NNP B-DIAGNOSIS
and NN NN O
kidney NN NN O
function NN NN O
. NN NN O

This NN NN O
is NN NN O
a NN NN O
78 NNP NNP B-AGE
year-old NNP NNP I-AGE
male NNP NNP B-GENDER
with NN NN O
h/o NN NN O
BPH NNP NNP B-DIAGNOSIS
s/p NN NN O
multiple NN NN O
urological NN NN O
procedures NN NN O
, NN NN O
including NN NN O
s/p NN NN O
Suprapubic NNP NNP B-DIAGNOSIS
prostatectomy NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
was NN NN O
noted NN NN O
to NN NN O
have NN NN O
low NNP NNP B-DIAGNOSIS
urine NNP NNP I-DIAGNOSIS
output NNP NNP I-DIAGNOSIS
and NN NN O
bladder NN NN O
scan NN NN O
showed NN NN O
360cc NN NN O
residual NN NN O
. NN NN O

It NN NN O
was NN NN O
impossible NN NN O
for NN NN O
staff NN NN O
to NN NN O
pass NN NN O
a NN NN O
foley NN NN O
. NN NN O

Urology NN NN O
was NN NN O
consulted NN NN O
, NN NN O
performed NN NN O
a NN NN O
flexible NN NN O
cystoscopy NN NN O
in NN NN O
the NN NN O
ICU NN NN O
and NN NN O
found NN NN O
severe NN NN O
2cm NN NN O
bulbar NNP NNP B-DIAGNOSIS
urethral NNP NNP I-DIAGNOSIS
stricture NNP NNP I-DIAGNOSIS
. NN NN O

They NN NN O
were NN NN O
able NN NN O
to NN NN O
pass NN NN O
small NN NN O
catheter NN NN O
through NN NN O
and NN NN O
left NN NN O
in NN NN O
place NN NN O
. NN NN O

The NN NN O
patient NN NN O
leaked NN NN O
around NN NN O
the NN NN O
catheter NN NN O
, NN NN O
the NN NN O
catheter NN NN O
eventually NN NN O
came NN NN O
out NN NN O
but NN NN O
he NNP NNP B-GENDER
continued NN NN O
to NN NN O
have NN NN O
good NN NN O
urine NN NN O
output NN NN O
and NN NN O
post-void NN NN O
bladder NN NN O
scans NN NN O
were NN NN O
performed NN NN O
q4h NN NN O
to NN NN O
ensure NN NN O
he NNP NNP B-GENDER
did NN NN O
not NN NN O
have NN NN O
high NN NN O
residual NN NN O
volume NN NN O
. NN NN O

Urology NN NN O
suggested NN NN O
that NN NN O
when NN NN O
patient NN NN O
is NN NN O
stable NN NN O
he NNP NNP B-GENDER
will NN NN O
have NN NN O
to NN NN O
be NN NN O
taken NN NN O
to NN NN O
the NN NN O
OR NN NN O
to NN NN O
have NN NN O
the NN NN O
stricture NNP NNP B-DIAGNOSIS
surgically NN NN O
fixed NN NN O
. NN NN O

65 NNP NNP B-AGE
yo NNP NNP I-AGE
man NNP NNP B-GENDER
with NN NN O
history NN NN O
of NN NN O
CAD NNP NNP B-DIAGNOSIS
and NN NN O
prior NN NN O
MI NNP NNP B-DIAGNOSIS
, NN NN O
HLD NNP NNP B-DIAGNOSIS
, NN NN O
HTN NNP NNP B-DIAGNOSIS
, NN NN O
ventricular NNP NNP B-DIAGNOSIS
tachycardia NNP NNP I-DIAGNOSIS
, NN NN O
and NN NN O
syncope NNP NNP B-DIAGNOSIS
was NN NN O
admitted NN NN O
earlier NN NN O
today NN NN O
evaluation NN NN O
of NN NN O
syncope NNP NNP B-DIAGNOSIS
and NN NN O
ventricular NNP NNP B-DIAGNOSIS
arrhythmias NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
was NN NN O
recently NN NN O
discharged NN NN O
after NN NN O
a NN NN O
negative NN NN O
work-up NN NN O
for NN NN O
syncope NNP NNP B-DIAGNOSIS
which NN NN O
included NN NN O
the NN NN O
implantation NN NN O
of NN NN O
a NN NN O
cardiac NN NN O
monitoring NN NN O
device NN NN O
. NN NN O

It NN NN O
was NN NN O
interrogated NN NN O
at NN NN O
the NN NN O
OSH NN NN O
and NN NN O
per NN NN O
report NN NN O
the NN NN O
monitor NN NN O
read NN NN O
from NN NN O
yesterday NN NN O
: NN NN O
40 NN NN O
seconds NN NN O
of NN NN O
VT NN NN O
and NN NN O
then NN NN O
bradycardia NNP NNP B-DIAGNOSIS
with NN NN O
a NN NN O
rate NN NN O
of NN NN O
39 NN NN O
shortly NN NN O
thereafter NN NN O
corresponding NN NN O
with NN NN O
his NN NN O
symptoms NN NN O
. NN NN O

Overnight NN NN O
, NN NN O
the NN NN O
patient NN NN O
went NN NN O
into NN NN O
monomorphic NNP NNP B-DIAGNOSIS
VT NNP NNP I-DIAGNOSIS
on NN NN O
telemetry NN NN O
. NN NN O

The NN NN O
patient NN NN O
was NN NN O
found NN NN O
to NN NN O
be NN NN O
unresponsive NN NN O
. NN NN O

CPR NN NN O
was NN NN O
initiated NN NN O
, NN NN O
unclear NN NN O
if NN NN O
the NN NN O
patient NN NN O
had NN NN O
a NN NN O
pulse NN NN O
. NN NN O

Within NN NN O
one NN NN O
minute NN NN O
the NN NN O
patient NN NN O
returned NN NN O
to NN NN O
sinus NN NN O
rhythm NN NN O
. NN NN O

The NN NN O
patient NN NN O
does NN NN O
not NN NN O
report NN NN O
any NN NN O
symptoms NN NN O
prior NN NN O
to NN NN O
this NN NN O
episode NN NN O
. NN NN O

Currently NN NN O
, NN NN O
the NN NN O
patient NN NN O
feels NN NN O
pre NNP NNP B-DIAGNOSIS
syncope NNP NNP I-DIAGNOSIS
and NN NN O
nausea NNP NNP B-DIAGNOSIS
, NN NN O
but NN NN O
denies NN NN O
chest NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
. NN NN O

Patient NN NN O
is NN NN O
to NN NN O
be NN NN O
transferred NN NN O
to NN NN O
the NN NN O
CCU NN NN O
for NN NN O
catheterization NN NN O
and NN NN O
EPS NNP NNP B-DIAGNOSIS
. NN NN O

A NN NN O
35-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
presents NN NN O
with NN NN O
history NN NN O
of NN NN O
acne NNP NNP B-DIAGNOSIS
and NN NN O
mild NN NN O
hirsutism NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
primary NN NN O
evaluation NN NN O
revealed NN NN O
elevated NN NN O
testosterone NN NN O
levels NN NN O
. NN NN O

She NNP NNP B-GENDER
recently NN NN O
noticed NN NN O
gradual NN NN O
enlargement NN NN O
of NN NN O
her NN NN O
hands NN NN O
and NN NN O
feet NN NN O
and NN NN O
recognized NN NN O
that NN NN O
her NN NN O
ring NN NN O
is NN NN O
getting NN NN O
small NN NN O
for NN NN O
her NN NN O
finger NN NN O
. NN NN O

There NN NN O
is NN NN O
some NN NN O
irregularity NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
her NNP NNP I-DIAGNOSIS
menstrual NNP NNP I-DIAGNOSIS
cycle NN NN O
as NN NN O
well NN NN O
as NN NN O
some NN NN O
nipple NNP NNP B-DIAGNOSIS
discharge NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
also NN NN O
has NN NN O
positive NN NN O
history NN NN O
for NN NN O
snoring NNP NNP B-DIAGNOSIS
and NN NN O
headache NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
physical NN NN O
examination NN NN O
revealed NN NN O
subtle NN NN O
facial NN NN O
features NN NN O
of NN NN O
acromegaly NNP NNP B-DIAGNOSIS
and NN NN O
prognathism NNP NNP B-DIAGNOSIS
. NN NN O

Visual NN NN O
fields NN NN O
are NN NN O
normal NN NN O
by NN NN O
confrontation NN NN O
. NN NN O

Hirsutism NNP NNP B-DIAGNOSIS
, NN NN O
soft NNP NNP B-DIAGNOSIS
tissue NNP NNP I-DIAGNOSIS
thickening NNP NNP I-DIAGNOSIS
and NN NN O
diaphoresis NNP NNP B-DIAGNOSIS
of NN NN O
the NN NN O
hands NN NN O
and NN NN O
feet NN NN O
are NN NN O
noted NN NN O
. NN NN O

Laboratory NN NN O
evaluation NN NN O
in NN NN O
the NN NN O
fasting NN NN O
state NN NN O
reveals NN NN O
IGF-1 NN NN O
of NN NN O
968 NN NN O
ng/mL NN NN O
and NN NN O
random NN NN O
GH NN NN O
of NN NN O
19.7 NN NN O
ng/mL NN NN O
. NN NN O

MRI NN NN O
reveals NN NN O
a NN NN O
macroadenoma NNP NNP B-DIAGNOSIS
with NN NN O
no NN NN O
invasion NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
on NN NN O
stable NN NN O
doses NN NN O
of NN NN O
octreotide NN NN O
LAR NN NN O
since NN NN O
her NN NN O
diagnosis NN NN O
was NN NN O
confirmed NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
married NN NN O
and NN NN O
has NN NN O
2 NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
using NN NN O
IUD NN NN O
as NN NN O
her NN NN O
contraceptive NN NN O
method NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
57-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
with NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
and NN NN O
vomiting NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
started NN NN O
gradually NN NN O
about NN NN O
20 NN NN O
hours NN NN O
ago NN NN O
in NN NN O
the NN NN O
epigastric NN NN O
and NN NN O
periumbilical NN NN O
regions NN NN O
, NN NN O
radiating NN NN O
to NN NN O
his NN NN O
back NN NN O
. NN NN O

He NNP NNP B-GENDER
drinks NN NN O
around NN NN O
60 NN NN O
units NN NN O
of NN NN O
alcohol NN NN O
per NN NN O
week NN NN O
and NN NN O
smokes NN NN O
22 NN NN O
cigarettes NN NN O
per NN NN O
day NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
healthy NN NN O
with NN NN O
no NNP NNP B-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
allergies NNP NNP I-NEGATIVE
or NN NN O
using NN NN O
any NN NN O
medications NN NN O
. NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
positive NN NN O
for NN NN O
type NNP NNP B-DIAGNOSIS
2 NNP NNP I-DIAGNOSIS
diabetes NNP NNP I-DIAGNOSIS
( NN NN O
his NN NN O
father NN NN O
and NN NN O
sister NN NN O
). NN NN O

He NNP NNP B-GENDER
lives NN NN O
alone NN NN O
and NN NN O
has NN NN O
no NN NN O
children NN NN O
. NN NN O

The NN NN O
abdomen NN NN O
is NN NN O
tender NN NN O
and NN NN O
soft NN NN O
. NN NN O

His NN NN O
bowel NN NN O
sounds NN NN O
are NN NN O
normal NN NN O
. NN NN O

His NN NN O
heart NN NN O
rate NN NN O
is NN NN O
115/min NN NN O
and NN NN O
blood NN NN O
pressure NN NN O
110/75 NN NN O
mmHg NN NN O
. NN NN O

The NN NN O
lab NN NN O
results NN NN O
are NN NN O
remarkable NN NN O
for NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
( NN NN O
19.5 NN NN O
), NN NN O
urea NN NN O
of NN NN O
8.5 NN NN O
, NN NN O
high NN NN O
CRP NN NN O
( NN NN O
145 NN NN O
), NN NN O
high NN NN O
amylase NN NN O
( NN NN O
1200 NN NN O
) NN NN O
and NN NN O
Glc NN NN O
level NN NN O
of NN NN O

15 NN NN O
. NN NN O
Cross-sectional NN NN O
imaging NN NN O
was NN NN O
negative NNP NNP B-NEGATIVE
for NNP NNP I-NEGATIVE
obstructive NNP NNP I-NEGATIVE
pancreatitis NNP NNP I-NEGATIVE
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
31-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
complaining NN NN O
of NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
started NN NN O
last NN NN O
night NN NN O
as NN NN O
diffuse NN NN O
abdominal NNP NNP B-DIAGNOSIS
discomfort NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
had NN NN O
poor NNP NNP B-DIAGNOSIS
appetite NNP NNP I-DIAGNOSIS
as NN NN O
well NN NN O
as NN NN O
malaise NN NN O
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
worsened NN NN O
in NN NN O
intensity NN NN O
and NN NN O
became NN NN O
sharp NN NN O
in NN NN O
the NN NN O
morning NN NN O
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
became NN NN O
localized NN NN O
to NN NN O
the NN NN O
right NN NN O
lower NN NN O
quadrant NN NN O
in NN NN O
the NN NN O
morning NN NN O
. NN NN O

The NN NN O
temperature NN NN O
is NN NN O
within NN NN O
the NN NN O
normal NN NN O
limits NN NN O
with NN NN O
normal NN NN O
vital NN NN O
signs NN NN O
. NN NN O

Focal NNP NNP B-DIAGNOSIS
tenderness NNP NNP I-DIAGNOSIS
and NN NN O
guarding NN NN O
were NN NN O
observed NN NN O
during NN NN O
palpation NN NN O
of NN NN O
the NN NN O
right NN NN O
lower NN NN O
quadrant NN NN O
. NN NN O

Palpation NN NN O
of NN NN O
the NN NN O
left NN NN O
lower NN NN O
quadrant NN NN O
causes NN NN O
pain NNP NNP B-DIAGNOSIS
on NN NN O
the NN NN O
right NN NN O
. NN NN O

Her NN NN O
lab NN NN O
work NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
. NN NN O

Computed NN NN O
Tomography NN NN O
of NN NN O
the NN NN O
abdomen NN NN O
with NN NN O
contrast NN NN O
shows NN NN O
the NN NN O
presence NN NN O
of NN NN O
a NN NN O
distended NNP NNP B-DIAGNOSIS
appendix NNP NNP I-DIAGNOSIS
with NN NN O
thickened NN NN O
appendiceal NN NN O
wall NN NN O
without NNP NNP B-NEGATIVE
perforation NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
abscess NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
gangrene NNP NNP I-NEGATIVE
. NN NN O

She NNP NNP B-GENDER
is NN NN O
a NN NN O
candidate NN NN O
for NN NN O
laparoscopic NN NN O
appendectomy NN NN O
under NN NN O
general NN NN O
anesthesia NN NN O
. NN NN O

A NN NN O
39-year-old NNP NNP B-AGE
man NNP NNP B-AGE
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
cough NNP NNP B-DIAGNOSIS
and NN NN O
shortness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
breath NNP NNP I-DIAGNOSIS
that NN NN O
was NN NN O
not NN NN O
relieved NN NN O
by NN NN O
his NN NN O
inhaler NN NN O
. NN NN O

He NNP NNP B-GENDER
had NN NN O
these NN NN O
symptoms NN NN O
for NN NN O
5 NN NN O
days NN NN O
during NN NN O
the NN NN O
past NN NN O
2 NN NN O
weeks NN NN O
. NN NN O

He NNP NNP B-GENDER
doubled NN NN O
his NN NN O
oral NN NN O
corticosteroids NN NN O
in NN NN O
the NN NN O
past NN NN O
week NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
a NN NN O
chef NN NN O
with NN NN O
a NN NN O
history NN NN O
of NN NN O
asthma NNP NNP B-DIAGNOSIS
for NN NN O
3 NN NN O
years NN NN O
, NN NN O
suffering NN NN O
from NN NN O
frequent NN NN O
cough NNP NNP B-DIAGNOSIS
, NN NN O
wheezing NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
shortness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
breath NNP NNP I-DIAGNOSIS
and NN NN O
chest NNP NNP B-DIAGNOSIS
tightness NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
symptoms NN NN O
become NN NN O
more NN NN O
bothersome NN NN O
within NN NN O
1-2 NN NN O
hours NN NN O
of NN NN O
starting NN NN O
work NN NN O
every NN NN O
day NN NN O
and NN NN O
worsen NN NN O
throughout NN NN O
the NN NN O
work NN NN O
week NN NN O
. NN NN O

His NN NN O
symptoms NN NN O
improve NN NN O
within NN NN O
1-2 NN NN O
hours NN NN O
outside NN NN O
the NN NN O
workplace NN NN O
. NN NN O

Spirometry NN NN O
was NN NN O
performed NN NN O
revealing NN NN O
a NN NN O
forced NN NN O
expiratory NN NN O
volume NN NN O
in NN NN O
the NN NN O
first NN NN O
second NN NN O
( NN NN O
FEV1 NN NN O
) NN NN O
of NN NN O
63% NN NN O
of NN NN O
the NN NN O
predicted NN NN O
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
significant NN NN O
for NN NN O
seasonal NNP NNP B-DIAGNOSIS
allergic NNP NNP I-DIAGNOSIS
rhinitis NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
summer NN NN O
. NN NN O

He NNP NNP B-GENDER
doesn't NN NN O
smoke NN NN O
or NN NN O
use NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
significant NN NN O
for NN NN O
asthma NNP NNP B-DIAGNOSIS
in NN NN O
his NN NN O
father NN NN O
and NN NN O
sister NN NN O
. NN NN O

He NNP NNP B-GENDER
currently NN NN O
uses NN NN O
inhaled NN NN O
corticosteroid NN NN O
( NN NN O
ICS NN NN O
) NN NN O
and NN NN O
fluticasone NN NN O
500 NN NN O
mcg/salmeterol NN NN O
50 NN NN O
mcg NN NN O
, NN NN O
one NN NN O
puff NN NN O
twice NN NN O
daily NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
55 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
man NNP NNP B-GENDER
visiting NN NN O
his NN NN O
primary NN NN O
care NN NN O
physician NN NN O
for NN NN O
lower NN NN O
urinary NN NN O
tract NN NN O
symptoms NN NN O
including NN NN O
frequency NNP NNP B-DIAGNOSIS
, NN NN O
urgency NNP NNP B-DIAGNOSIS
, NN NN O
weak NNP NNP B-DIAGNOSIS
stream NNP NNP I-DIAGNOSIS
, NN NN O
incomplete NNP NNP B-DIAGNOSIS
emptying NNP NNP I-DIAGNOSIS
and NN NN O
intermittent NNP NNP B-DIAGNOSIS
flow NNP NNP I-DIAGNOSIS
for NN NN O
the NN NN O
past NN NN O
9 NN NN O
months NN NN O
. NN NN O

Further NN NN O
evaluation NN NN O
revealed:IPSS NN NN O
score NN NN O
: NN NN O
15Post-void NN NN O
residual NN NN O
: NN NN O
70 NN NN O
mLProstate NN NN O
volume NN NN O
( NN NN O
TRUS NN NN O
): NN NN O
60 NN NN O
mLProstate-specific NN NN O
antigen NN NN O
( NN NN O
PSA NN NN O
) NN NN O
level NN NN O
: NN NN O
3.2 NN NN O
ng/mL10 NN NN O
mL/sec NN NN O
of NN NN O
maximum NN NN O
flow NN NN O
rate NN NN O
when NN NN O
urine NN NN O
volume NN NN O
was NN NN O
130 NN NN O
mLHe NN NN O
is NN NN O
otherwise NN NN O
healthy NN NN O
only NN NN O
using NN NN O
Vit NN NN O
D NN NN O
1000 NN NN O
units NN NN O
daily NN NN O
. NN NN O

His NN NN O
recent NN NN O
blood NN NN O
chemistry NN NN O
( NN NN O
3 NN NN O
days NN NN O
ago NN NN O
) NN NN O
was NN NN O
normal NN NN O
: NN NN O
Hgb NN NN O
: NN NN O
13.5 NN NN O
g/dlWBC NN NN O
: NN NN O
135000 NN NN O
/mm3Plt NN NN O
: NN NN O
350000 NN NN O
/mlPT NN NN O
: NN NN O
11 NN NN O
secondPTT NN NN O
: NN NN O
35 NN NN O
secondINR NN NN O
: NN NN O
0.9Creatinine NN NN O
: NN NN O
0.5 NN NN O
mg/dlBUN NN NN O
: NN NN O
10 NN NN O
mg/dlU/A:Color NN NN O
: NN NN O
yellowAppearance NN NN O
: NN NN O
cloudyPH NN NN O
: NN NN O
5.3Specific NN NN O
gravity NN NN O
: NN NN O
1.010Glc NN NN O
: NN NN O
100Nitrite NN NN O
: NN NN O
negativeKetone NN NN O
: NN NN O
noneLeukocyte NN NN O
esterase NN NN O
: NN NN O
negativeRBC NN NN O
: NN NN O
negativeWBC NN NN O
: NN NN O
2 NN NN O
WBCs/hpfU/C NN NN O
: NN NN O
negative NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
42 NNP NNP B-AGE
year-old NNP NNP I-AGE
postmenopausal NN NN O
woman NNP NNP B-GENDER
who NN NN O
had NN NN O
a NN NN O
screening NN NN O
sonogram NN NN O
which NN NN O
revealed NN NN O
an NN NN O
abnormality NNP NNP B-DIAGNOSIS
in NN NN O
the NN NN O
right NN NN O
breast NN NN O
. NN NN O

She NNP NNP B-GENDER
had NN NN O
no NNP NNP B-NEGATIVE
palpable NNP NNP I-NEGATIVE
masses NNP NNP I-NEGATIVE
on NN NN O
breast NN NN O
exam NN NN O
. NN NN O

Core NN NN O
biopsy NN NN O
was NN NN O
done NN NN O
and NN NN O
revealed NN NN O
a NN NN O
1.8 NN NN O
cm NN NN O
infiltrating NN NN O
ductal NN NN O
breast NNP NNP B-DIAGNOSIS
carcinoma NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
left NN NN O
upper NN NN O
outer NN NN O
quadrant NN NN O
. NN NN O

Lumpectomy NN NN O
was NN NN O
done NN NN O
and NN NN O
the NN NN O
surgical NN NN O
margins NN NN O
were NN NN O
clear NN NN O
. NN NN O

The NN NN O
tumor NNP NNP B-DIAGNOSIS
was NN NN O
HER2-positive NN NN O
and NN NN O
ER/PR NN NN O
negative NN NN O
. NN NN O

Axillary NN NN O
sampling NN NN O
revealed NN NN O
1 NN NN O
positive NN NN O
lymph NN NN O
node NN NN O
out NN NN O
of NN NN O
12 NN NN O
sampled NN NN O
. NN NN O

CXR NN NN O
was NN NN O
unremarkable NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
using NN NN O
well NN NN O
women NN NN O
multivitamins NN NN O
daily NN NN O
and NN NN O
no NN NN O
other NN NN O
medication NN NN O
. NN NN O

She NNP NNP B-GENDER
smokes NN NN O
frequently NN NN O
and NN NN O
consumes NN NN O
alcohol NN NN O
occasionally NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
in NN NN O
a NN NN O
relation NN NN O
with NN NN O
only NN NN O
one NN NN O
partner NN NN O
and NN NN O
has NN NN O
a NN NN O
history NN NN O
of NN NN O
3 NN NN O
pregnancies NNP NNP B-DIAGNOSIS
and NN NN O
live NN NN O
births NN NN O
. NN NN O

She NNP NNP B-GENDER
breastfed NN NN O
all NN NN O
three NN NN O
children NN NN O
. NN NN O

A NN NN O
45-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
was NN NN O
referred NN NN O
to NN NN O
the NN NN O
emergency NN NN O
department NN NN O
with NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
lasting NN NN O
about NN NN O
4 NN NN O
days NN NN O
accompanied NN NN O
by NN NN O
nausea NNP NNP B-DIAGNOSIS
and NN NN O
2 NN NN O
episodes NN NN O
of NN NN O
vomiting NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
is NN NN O
localized NN NN O
to NN NN O
the NN NN O
epigastric NN NN O
region NN NN O
and NN NN O
radiates NN NN O
to NN NN O
the NN NN O
right NN NN O
upper NN NN O
quadrant NN NN O
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
is NN NN O
worsening NN NN O
after NN NN O
eating NN NN O
fatty NN NN O
food NN NN O
. NN NN O

The NN NN O
patient NN NN O
experienced NN NN O
similar NN NN O
pain NNP NNP B-DIAGNOSIS
twice NN NN O
in NN NN O
the NN NN O
past NN NN O
year NN NN O
. NN NN O

Her NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
hypercholesterolemia NNP NNP B-DIAGNOSIS
and NN NN O
two NN NN O
C/sections NN NN O
. NN NN O

She NNP NNP B-GENDER
has NN NN O
2 NN NN O
children NN NN O
, NN NN O
and NN NN O
she NNP NNP B-GENDER
is NN NN O
menopausal NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
doesn't NN NN O
smoke NN NN O
, NN NN O
drink NN NN O
alcohol NN NN O
, NN NN O
or NN NN O
use NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
mildly NN NN O
febrile NNP NNP B-DIAGNOSIS
. NN NN O

Her NN NN O
BP NN NN O
is NN NN O
150/85 NN NN O
, NN NN O
HR NN NN O
115 NN NN O
, NN NN O
RR NN NN O
15 NN NN O
, NN NN O
T NN NN O
38.2 NN NN O
, NN NN O
SpO2 NN NN O
98% NN NN O
on NN NN O
RA NN NN O
. NN NN O

On NN NN O
palpation NN NN O
, NN NN O
she NNP NNP B-GENDER
experiences NN NN O
epigastric NN NN O
tenderness NNP NNP B-DIAGNOSIS
and NN NN O
tenderness NNP NNP B-DIAGNOSIS
in NN NN O
the NN NN O
right NN NN O
upper NN NN O
quadrant NN NN O
without NN NN O
rebound NN NN O
. NN NN O

Bowel NN NN O
sounds NN NN O
are NN NN O
normal NN NN O
. NN NN O

Laboratory NN NN O
analysis NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
elevated NNP NNP B-DIAGNOSIS
ESR NNP NNP I-DIAGNOSIS
and NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
with NN NN O
a NN NN O
left NN NN O
shift NN NN O
. NN NN O

The NN NN O
ultrasound NN NN O
revealed NN NN O
several NN NN O
gallstones NNP NNP B-DIAGNOSIS
and NN NN O
biliary NNP NNP B-DIAGNOSIS
sludge NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
largest NN NN O
gallstone NNP NNP B-DIAGNOSIS
is NN NN O
0.7cm NN NN O
. NN NN O

Surgery NN NN O
consultation NN NN O
recommends NN NN O
elective NN NN O
cholecystectomy NN NN O
. NN NN O

A NN NN O
53-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
presents NN NN O
with NN NN O
chronic NN NN O
HCV NNP NNP B-DIAGNOSIS
infection NNP NNP I-DIAGNOSIS
for NN NN O
the NN NN O
past NN NN O
2 NN NN O
years NN NN O
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
only NN NN O
significant NN NN O
for NN NN O
inguinal NN NN O
hernia NN NN O
surgery NN NN O
when NN NN O
he NNP NNP B-GENDER
was NN NN O
20 NN NN O
years NN NN O
old NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
on NN NN O
IFN NN NN O
( NN NN O
100 NN NN O
mg/week NN NN O
) NN NN O
plus NN NN O
RBV NN NN O
( NN NN O
400 NN NN O
mg/day NN NN O
) NN NN O
combination NN NN O
therapy NN NN O
for NN NN O
the NN NN O
past NN NN O
9 NN NN O
months NN NN O
. NN NN O

Direct NN NN O
antiviral NN NN O
drugs NN NN O
were NN NN O
added NN NN O
to NN NN O
his NN NN O
treatment NN NN O
6 NN NN O
months NN NN O
ago NN NN O
. NN NN O

His NN NN O
medical NN NN O
record NN NN O
shows NN NN O
previous NN NN O
positive NN NN O
HCV NNP NNP B-DIAGNOSIS
RNA NN NN O
tests NN NN O
as NN NN O
well NN NN O
as NN NN O
positive NNP NNP B-DIAGNOSIS
enzyme NNP NNP I-DIAGNOSIS
immunoassay NNP NNP I-DIAGNOSIS
for NN NN O
anti-HCV-antibodies NN NN O
. NN NN O

The NN NN O
recent NN NN O
biopsy NN NN O
was NN NN O
negative NN NN O
for NN NN O
hepatocellular NNP NNP B-DIAGNOSIS
carcinoma NNP NNP I-DIAGNOSIS
and NN NN O
was NN NN O
only NN NN O
remarkable NN NN O
for NN NN O
chronic NN NN O
inflammation NNP NNP B-DIAGNOSIS
compatible NN NN O
with NN NN O
a NN NN O
chronic NN NN O
viral NNP NNP B-DIAGNOSIS
hepatitis NNP NNP I-DIAGNOSIS
. NN NN O

There NN NN O
is NN NN O
no NNP NNP B-NEGATIVE
evidence NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
alcoholic NNP NNP I-NEGATIVE
liver NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
bleeding NNP NNP I-NEGATIVE
from NNP NNP I-NEGATIVE
esophageal NNP NNP I-NEGATIVE
varices NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
hemochromatosis NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
autoimmune NNP NNP I-NEGATIVE
hepatitis NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
metabolic NNP NNP I-NEGATIVE
liver NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
is NN NN O
an NN NN O
alert NN NN O
male NNP NNP B-GENDER
with NN NN O
no NNP NNP B-NEGATIVE
acute NNP NNP I-NEGATIVE
distress NNP NNP I-NEGATIVE
. NN NN O

His NN NN O
BP NN NN O
: NN NN O
130/75 NN NN O
, NN NN O
HR NN NN O
: NN NN O
90/min NN NN O
and NN NN O
BMI NN NN O
: NN NN O

27 NN NN O
. NN NN O
His NN NN O
abdomen NN NN O
is NN NN O
soft NN NN O
with NN NN O
no NN NN O
ascites NNP NNP B-DIAGNOSIS
or NN NN O
tenderness NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
lower NN NN O
extremities NN NN O
are NN NN O
normal NN NN O
with NN NN O
no NNP NNP B-NEGATIVE
edema NNP NNP I-NEGATIVE
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
60-year-old NNP NNP B-AGE
Spanish NN NN O
man NNP NNP B-GENDER
presenting NN NN O
with NN NN O
shortness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
breath NNP NNP I-DIAGNOSIS
about NN NN O
a NN NN O
day NN NN O
before NN NN O
. NN NN O

The NN NN O
symptoms NN NN O
began NN NN O
acutely NN NN O
and NN NN O
progressively NN NN O
worsened NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
a NN NN O
known NN NN O
case NN NN O
of NN NN O
COPD NNP NNP B-DIAGNOSIS
since NN NN O
2 NN NN O
years NN NN O
ago NN NN O
. NN NN O

The NN NN O
spirometry NN NN O
revealed NN NN O
post-bronchodilator NN NN O
FEV1/FVC NN NN O
= NN NN O
60% NN NN O
of NN NN O
predicted NN NN O
values NN NN O
. NN NN O

He NNP NNP B-GENDER
smokes NN NN O
20 NN NN O
cigarette NN NN O
per NN NN O
day NN NN O
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
BPH NNP NNP B-DIAGNOSIS
and NN NN O
he NNP NNP B-GENDER
is NN NN O
using NN NN O
Flomax NN NN O
for NN NN O
that NN NN O
. NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
positive NN NN O
for NN NN O
HTN NNP NNP B-DIAGNOSIS
in NN NN O
his NN NN O
brother NN NN O
. NN NN O

His NN NN O
medication NN NN O
includes NN NN O
Duo-Neb NN NN O
inhaled NN NN O
q4 NN NN O
hr NN NN O
PRN NN NN O
, NN NN O
Vit NN NN O
D3 NN NN O
1000 NN NN O
units NN NN O
per NN NN O
day NN NN O
and NN NN O
Flomax NN NN O
for NN NN O
his NN NN O
PBH NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
an NN NN O
obese NNP NNP B-DIAGNOSIS
man NNP NNP B-GENDER
who NN NN O
is NN NN O
acutely NNP NNP B-DIAGNOSIS
ill NNP NNP I-DIAGNOSIS
but NN NN O
oriented NN NN O
and NN NN O
conscious NN NN O
. NN NN O

The NN NN O
vital NN NN O
signs NN NN O
are NN NN O
as NN NN O
bellow:BP NN NN O
: NN NN O
135/80RR NN NN O
: NN NN O
25/minHR NN NN O
: NN NN O
75 NN NN O
bpmBMI NN NN O
: NN NN O
40O2sat NN NN O
: NN NN O
90% NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
24-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
who NN NN O
has NN NN O
had NN NN O
type NNP NNP B-DIAGNOSIS
1 NNP NNP I-DIAGNOSIS
diabetes NNP NNP I-DIAGNOSIS
for NN NN O
11 NN NN O
years NN NN O
. NN NN O

He NNP NNP B-GENDER
presents NN NN O
to NN NN O
the NN NN O
emergency NN NN O
room NN NN O
with NN NN O
hyperglycemia NNP NNP B-DIAGNOSIS
and NN NN O
concern NN NN O
for NN NN O
possible NN NN O
diabetic NNP NNP B-DIAGNOSIS
ketoacidosis NNP NNP I-DIAGNOSIS
after NN NN O
not NN NN O
taking NN NN O
his NN NN O
insulin NN NN O
for NN NN O
3 NN NN O
days NN NN O
. NN NN O

The NN NN O
patient NN NN O
reports NN NN O
that NN NN O
he NNP NNP B-GENDER
is NN NN O
currently NN NN O
homeless NN NN O
and NN NN O
has NN NN O
lost NN NN O
his NN NN O
supply NN NN O
of NN NN O
insulin NN NN O
, NN NN O
syringes NN NN O
, NN NN O
glucometer NN NN O
, NN NN O
and NN NN O
glucose NN NN O
testing NN NN O
supplies NN NN O
. NN NN O

The NN NN O
patient NN NN O
states NN NN O
that NN NN O
at NN NN O
the NN NN O
time NN NN O
of NN NN O
his NN NN O
initial NN NN O
diagnosis NN NN O
with NN NN O
type NNP NNP B-DIAGNOSIS
1 NNP NNP I-DIAGNOSIS
diabetes NNP NNP I-DIAGNOSIS
he NNP NNP B-GENDER
was NN NN O
hospitalized NN NN O
with NN NN O
a NN NN O
glucose NN NN O
value NN NN O
>1000 NN NN O
mg/dL NN NN O
. NN NN O

At NN NN O
the NN NN O
time NN NN O
, NN NN O
he NNP NNP B-GENDER
was NN NN O
experiencing NN NN O
polyuria NNP NNP B-DIAGNOSIS
, NN NN O
polydipsia NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
polyphagia NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
reports NN NN O
that NN NN O
he NNP NNP B-GENDER
has NN NN O
been NN NN O
on NN NN O
insulin NN NN O
since NN NN O
the NN NN O
time NN NN O
of NN NN O
his NN NN O
diagnosis NN NN O
, NN NN O
and NN NN O
he NNP NNP B-GENDER
has NN NN O
never NN NN O
been NN NN O
prescribed NN NN O
oral NN NN O
agents NN NN O
for NN NN O
diabetes NNP NNP B-DIAGNOSIS
management NN NN O
. NN NN O

Most NN NN O
recently NN NN O
, NN NN O
he NNP NNP B-GENDER
has NN NN O
been NN NN O
using NN NN O
insulin NN NN O
glargine NN NN O
55 NN NN O
units NN NN O
once NN NN O
daily NN NN O
, NN NN O
and NN NN O
insulin NN NN O
aspart NN NN O
sliding NN NN O
scale NN NN O
3 NN NN O
times NN NN O
daily NN NN O
. NN NN O

The NN NN O
patient NN NN O
has NN NN O
had NN NN O
previous NN NN O
episodes NN NN O
of NN NN O
diabetic NNP NNP B-DIAGNOSIS
ketoacidosis NNP NNP I-DIAGNOSIS
, NN NN O
for NN NN O
which NN NN O
he NNP NNP B-GENDER
was NN NN O
hospitalized NN NN O
. NN NN O

With NN NN O
this NN NN O
episode NN NN O
of NN NN O
hyperglycemia NNP NNP B-DIAGNOSIS
, NN NN O
he NNP NNP B-GENDER
is NN NN O
not NNP NNP B-NEGATIVE
experiencing NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
nausea NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
vomiting NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
abdominal NNP NNP I-NEGATIVE
discomfort NNP NNP I-NEGATIVE
, NN NN O
and NN NN O
he NNP NNP B-GENDER
appears NN NN O
well NN NN O
. NN NN O

His NN NN O
lab NN NN O
studies NN NN O
showed:A1c NN NN O
: NN NN O
11.3%Creatinine NN NN O
: NN NN O
0.9 NN NN O
mg/dL NN NN O
with NN NN O
eGFR NN NN O
>60 NN NN O
mL/minAspartate NN NN O
aminotransferase NN NN O
( NN NN O
AST NN NN O
): NN NN O
17 NN NN O
U/LAlanine NN NN O
aminotransferase NN NN O
( NN NN O
ALT NN NN O
): NN NN O
14 NN NN O
U/LBeta-hydroxybutyrate NN NN O
: NN NN O
0.1 NN NN O
mmol/LBicarbonate NN NN O
: NN NN O
25 NN NN O
mEq/LAnion NN NN O
Gap NN NN O
: NN NN O
14 NN NN O
mEq/L NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
33-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
complained NN NN O
of NN NN O
fatigue NNP NNP B-DIAGNOSIS
, NN NN O
weight NNP NNP B-DIAGNOSIS
gain NNP NNP I-DIAGNOSIS
and NN NN O
abnormal NNP NNP B-DIAGNOSIS
spotting NNP NNP I-DIAGNOSIS
between NN NN O
menses NN NN O
. NN NN O

No NNP NNP B-NEGATIVE
hirsutism NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
nipple NNP NNP I-NEGATIVE
discharge NNP NNP I-NEGATIVE
was NN NN O
detected NN NN O
. NN NN O

Her NN NN O
BMI NN NN O
was NN NN O

34 NN NN O
. NN NN O
Her NN NN O
lab NN NN O
results NN NN O
were NN NN O
remarkable NN NN O
for NN NN O
high NNP NNP B-DIAGNOSIS
TSH NNP NNP I-DIAGNOSIS
level NNP NNP I-DIAGNOSIS
( NN NN O
13 NN NN O
mU/L NN NN O
) NN NN O
and NN NN O
low NN NN O
free NN NN O
T4 NN NN O
level NN NN O
( NN NN O
0.2 NN NN O
ng/dl NN NN O
). NN NN O

Her NN NN O
anti-TPO NN NN O
levels NN NN O
were NN NN O
extremely NN NN O
high NN NN O
( NN NN O
120 NN NN O
IU/ml NN NN O
). NN NN O

She NNP NNP B-GENDER
was NN NN O
diagnosed NN NN O
with NN NN O
Hashimoto's NNP NNP B-DIAGNOSIS
thyroiditis NNP NNP I-DIAGNOSIS
. NN NN O

Her NN NN O
aunt NN NN O
, NN NN O
brother NN NN O
and NN NN O
mother NN NN O
have NN NN O
the NN NN O
same NN NN O
disease NN NN O
. NN NN O

After NN NN O
starting NN NN O
250 NN NN O
mcg NN NN O
Levothyroxine NN NN O
per NN NN O
day NN NN O
, NN NN O
her NN NN O
symptoms NN NN O
improved NN NN O
significantly NN NN O
and NN NN O
her NN NN O
periods NN NN O
are NN NN O
normal NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
still NN NN O
overweight NNP NNP B-DIAGNOSIS
with NN NN O
BMI NN NN O
of NN NN O

31 NN NN O
. NN NN O
Her NN NN O
most NN NN O
recent NN NN O
thyroid NN NN O
profile NN NN O
revealed NN NN O
all NN NN O
results NN NN O
except NN NN O
for NN NN O
anti-TPO NN NN O
within NN NN O
the NN NN O
normal NN NN O
range:TSH NN NN O
: NN NN O
2.35 NN NN O
mU/LFree NN NN O
T4 NN NN O
: NN NN O
2.7 NN NN O
ng/dlAnti-TPO NN NN O
: NN NN O
75 NN NN O
IU/ml NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
37-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
who NN NN O
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
for NN NN O
a NN NN O
routine NN NN O
Pap NN NN O
smear NN NN O
. NN NN O

The NN NN O
test NN NN O
revealed NN NN O
stage NN NN O
1B NN NN O
of NN NN O
cervical NNP NNP B-DIAGNOSIS
cancer NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
patient NN NN O
tested NN NN O
positive NN NN O
for NN NN O
HPV NNP NNP B-DIAGNOSIS

16 NN NN O
. NN NN O
She NNP NNP B-GENDER
has NN NN O
three NN NN O
sexual NN NN O
partners NN NN O
and NN NN O
four NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
underwent NN NN O
tubal NN NN O
ligation NN NN O
. NN NN O

She NNP NNP B-GENDER
smokes NN NN O
30 NN NN O
packs/year NN NN O
and NN NN O
drinks NN NN O
alcohol NN NN O
frequently NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
otherwise NN NN O
healthy NN NN O
. NN NN O

She NNP NNP B-GENDER
was NN NN O
offered NN NN O
a NN NN O
radical NN NN O
hysterectomy NN NN O
. NN NN O

A NN NN O
17 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
boy NNP NNP B-GENDER
complains NN NN O
of NN NN O
vomiting NNP NNP B-DIAGNOSIS
, NN NN O
non-bloody NNP NNP B-DIAGNOSIS
diarrhea NNP NNP I-DIAGNOSIS
, NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
, NN NN O
fever NNP NNP B-DIAGNOSIS
, NN NN O
chills NNP NNP B-DIAGNOSIS
and NN NN O
loss NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
appetite NNP NNP I-DIAGNOSIS
for NN NN O
the NN NN O
past NN NN O
3 NN NN O
days NN NN O
. NN NN O

He NNP NNP B-GENDER
ate NN NN O
a NN NN O
salad NN NN O
at NN NN O
a NN NN O
restaurant NN NN O
prior NN NN O
to NN NN O
his NN NN O
diarrhea NNP NNP B-DIAGNOSIS
onset NN NN O
. NN NN O

Physical NN NN O
exam NN NN O
was NN NN O
remarkable NN NN O
for NN NN O
pallor NNP NNP B-DIAGNOSIS
, NN NN O
jaundice NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
diffuse NN NN O
abdominal NNP NNP B-DIAGNOSIS
tenderness NNP NNP I-DIAGNOSIS
. NN NN O

Lab NN NN O
results NN NN O
were NN NN O
as NN NN O
follows:Hemoglobin NN NN O
: NN NN O
9.7 NN NN O
g/dLPlatelet NN NN O
: NN NN O
110,000 NN NN O
/cu.mmCreatinine NN NN O
: NN NN O
3.6 NN NN O
mg/dLblood NN NN O
urea NN NN O
nitrogen NN NN O
( NN NN O
BUN NN NN O
): NN NN O
73 NN NN O
mg/dLdirect NN NN O
bilirubin NN NN O
: NN NN O
2.4 NN NN O
mg/dLlactate NN NN O
dehydrogenase NN NN O
( NN NN O
LDH NN NN O
): NN NN O
881 NN NN O
IU/L NN NN O
( NN NN O
normal NN NN O
: NN NN O
110-265 NN NN O
IU/L)Peripheral NN NN O
blood NN NN O
smear NN NN O
showed NN NN O
a NN NN O
moderate NN NN O
number NN NN O
of NN NN O
schistocytes NN NN O
and NN NN O
helmet NN NN O
cells NN NN O
. NN NN O

Shiga-like NN NN O
toxin-producing NN NN O
E NN NN O
. NN NN O
coli NN NN O
( NN NN O
STEC NN NN O
) NN NN O
stx1/stx2 NN NN O
were NN NN O
found NN NN O
in NN NN O
stools NN NN O
. NN NN O

He NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
other NNP NNP B-NEGATIVE
underlying NNP NNP B-NEGATIVE
disease NNP NNP B-NEGATIVE
and NN NN O
he NNP NNP B-GENDER
is NN NN O
not NN NN O
on NN NN O
any NN NN O
medications NN NN O
. NN NN O

A NN NN O
42-year-old NNP NNP B-AGE
healthy NN NN O
woman NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
to NN NN O
have NN NN O
her NN NN O
flu NN NN O
shot NN NN O
in NN NN O
early NN NN O
October NN NN O
. NN NN O

She NNP NNP B-GENDER
works NN NN O
in NN NN O
a NN NN O
rehab NN NN O
center NN NN O
and NN NN O
has NN NN O
no NNP NNP B-NEGATIVE
underlying NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
. NN NN O

It's NN NN O
her NN NN O
first NN NN O
time NN NN O
getting NN NN O
the NN NN O
vaccine NN NN O
this NN NN O
year NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
married NN NN O
for NN NN O
5 NN NN O
years NN NN O
and NN NN O
uses NN NN O
barrier NN NN O
methods NN NN O
of NN NN O
contraception NN NN O
. NN NN O

Her NN NN O
menstrual NNP NNP B-DIAGNOSIS
cycle NNP NNP I-DIAGNOSIS
is NNP NNP I-DIAGNOSIS
irregular NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
smoke NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
not NN NN O
on NN NN O
any NN NN O
medications NN NN O
. NN NN O

She NNP NNP B-GENDER
exercises NN NN O
regularly NN NN O
for NN NN O
30 NN NN O
minutes NN NN O
a NN NN O
day NN NN O
at NN NN O
least NN NN O
5 NN NN O
days NN NN O
a NN NN O
week NN NN O
. NN NN O

She NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
allergies NNP NNP I-NEGATIVE
to NN NN O
any NN NN O
food NN NN O
or NN NN O
drugs NN NN O
. NN NN O

Her NN NN O
past NN NN O
surgical NN NN O
history NN NN O
is NN NN O
significant NN NN O
for NN NN O
tonsillectomy NN NN O
and NN NN O
she NNP NNP B-GENDER
is NN NN O
otherwise NN NN O
healthy NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
47-year-old NNP NNP B-AGE
Asian NN NN O
woman NNP NNP B-GENDER
complaining NN NN O
of NN NN O
persistent NN NN O
feelings NN NN O
of NN NN O
sadness NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
lost NN NN O
interest NN NN O
in NN NN O
activities NN NN O
she NNP NNP B-GENDER
used NN NN O
to NN NN O
enjoy NN NN O
. NN NN O

She NNP NNP B-GENDER
states NN NN O
that NN NN O
her NN NN O
mood NN NN O
is NN NN O
mostly NN NN O
depressed NNP NNP B-DIAGNOSIS
for NN NN O
the NN NN O
past NN NN O
3 NN NN O
weeks NN NN O
. NN NN O

She NNP NNP B-GENDER
also NN NN O
lost NNP NNP B-DIAGNOSIS
her NNP NNP I-DIAGNOSIS
appetite NNP NNP I-DIAGNOSIS
, NN NN O
which NN NN O
led NN NN O
to NN NN O
about NN NN O
5kg NN NN O
weight NNP NNP B-DIAGNOSIS
loss NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
complains NN NN O
of NN NN O
loss NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
energy NNP NNP I-DIAGNOSIS
and NN NN O
feelings NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
worthlessness NNP NNP I-DIAGNOSIS
nearly NN NN O
every NN NN O
day NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
not NN NN O
using NN NN O
any NN NN O
drugs NN NN O
and NN NN O
she NNP NNP B-GENDER
does NN NN O
not NN NN O
smoke NN NN O
. NN NN O

She NNP NNP B-GENDER
doesn't NN NN O
drink NN NN O
alcohol NN NN O
. NN NN O

She NNP NNP B-GENDER
used NN NN O
to NN NN O
exercise NN NN O
every NN NN O
day NN NN O
for NN NN O
at NN NN O
least NN NN O
30 NN NN O
min NN NN O
. NN NN O

But NN NN O
she NNP NNP B-GENDER
doesn't NN NN O
have NN NN O
enough NN NN O
energy NN NN O
to NN NN O
do NN NN O
so NN NN O
for NN NN O
the NN NN O
past NN NN O
3 NN NN O
weeks NN NN O
. NN NN O

She NNP NNP B-GENDER
also NN NN O
has NN NN O
some NN NN O
digestive NNP NNP B-DIAGNOSIS
issues NNP NNP I-DIAGNOSIS
recently NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
married NN NN O
and NN NN O
has NN NN O
4 NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
menopausal NNP NNP B-DIAGNOSIS
. NN NN O

Her NN NN O
husband NN NN O
was NN NN O
recently NN NN O
diagnosed NN NN O
with NN NN O
colon NNP NNP B-DIAGNOSIS
cancer NNP NNP I-DIAGNOSIS
and NN NN O
he NNP NNP B-GENDER
is NN NN O
starting NN NN O
his NN NN O
chemotherapy NN NN O
. NN NN O

There NN NN O
is NN NN O
nothing NN NN O
remarkable NN NN O
in NN NN O
her NN NN O
past NN NN O
medical NN NN O
history NN NN O
and NN NN O
her NN NN O
drug NN NN O
history NN NN O
is NN NN O
only NN NN O
positive NN NN O
for NN NN O
Vit NN NN O
D3 NN NN O
1000 NN NN O
units NN NN O
daily NN NN O
. NN NN O

Her NN NN O
family NN NN O
history NN NN O
is NN NN O
negative NNP NNP B-NEGATIVE
for NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
psychologic NNP NNP I-NEGATIVE
problems NNP NNP I-NEGATIVE
. NN NN O

Her NN NN O
HAM-D NN NN O
score NN NN O
is NN NN O
20 NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
15 NNP NNP B-AGE
year NNP NNP B-AGE
old NNP NNP B-AGE
girl NNP NNP B-GENDER
with NN NN O
the NN NN O
history NN NN O
of NN NN O
recurrent NN NN O
bilateral NN NN O
headache NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
attacks NN NN O
come NN NN O
2 NN NN O
times NN NN O
or NN NN O
more NN NN O
per NN NN O
week NN NN O
and NN NN O
each NN NN O
episode NN NN O
lasts NN NN O
around NN NN O
a NN NN O
day NN NN O
or NN NN O
a NN NN O
half NN NN O
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
is NN NN O
pulsating NN NN O
in NN NN O
quality NN NN O
and NN NN O
severe NN NN O
in NN NN O
intensity NN NN O
, NN NN O
causing NN NN O
trouble NN NN O
in NN NN O
her NN NN O
routine NN NN O
physical NN NN O
activity NN NN O
. NN NN O

The NN NN O
attacks NN NN O
are NN NN O
associated NN NN O
with NN NN O
nausea NNP NNP B-DIAGNOSIS
and NN NN O
photophobia NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
recently NN NN O
noticed NN NN O
that NN NN O
that NN NN O
there NN NN O
are NN NN O
more NN NN O
attacks NN NN O
around NN NN O
her NN NN O
menstrual NN NN O
period NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
diagnosed NN NN O
with NN NN O
the NN NN O
migraine NNP NNP B-DIAGNOSIS
headache NNP NNP I-DIAGNOSIS
and NN NN O
is NN NN O
under NN NN O
treatment.She NNP NNP B-GENDER
is NN NN O
a NN NN O
high-school NN NN O
student NN NN O
and NN NN O
living NN NN O
with NN NN O
her NN NN O
both NN NN O
parents NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
a NN NN O
book NN NN O
worm NN NN O
and NN NN O
spend NN NN O
her NN NN O
free NN NN O
time NN NN O
in NN NN O
a NN NN O
public NN NN O
library NN NN O
near NN NN O
her NN NN O
home NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
also NN NN O
interested NN NN O
in NN NN O
writing NN NN O
stories NN NN O
and NN NN O
has NN NN O
several NN NN O
short NN NN O
stories NN NN O
in NN NN O
English NN NN O
. NN NN O

She NNP NNP B-GENDER
rarely NN NN O
does NN NN O
exercise NN NN O
. NN NN O

Her NN NN O
BMI NN NN O
is NN NN O
21 NN NN O
with NN NN O
the NN NN O
BP NN NN O
of NN NN O
100/60 NN NN O
. NN NN O

There NN NN O
is NN NN O
nothing NN NN O
remarkable NN NN O
in NN NN O
her NN NN O
physical NN NN O
exam NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
32-year-old NNP NNP B-AGE
obese NNP NNP B-DIAGNOSIS
woman NNP NNP B-GENDER
who NN NN O
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
weight NN NN O
concerns NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
165 NN NN O
cm NN NN O
tall NN NN O
and NN NN O
her NN NN O
weight NN NN O
is NN NN O
113 NN NN O
kg NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
complaining NN NN O
of NN NN O
sleep NNP NNP B-DIAGNOSIS
apnea NNP NNP I-DIAGNOSIS
, NN NN O
PCO NNP NNP B-DIAGNOSIS
and NN NN O
dissatisfaction NNP NNP B-DIAGNOSIS
with NN NN O
her NN NN O
body NN NN O
shape NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
a NN NN O
high-school NN NN O
teacher NN NN O
married NN NN O
for NN NN O
5 NN NN O
years NN NN O
. NN NN O

She NNP NNP B-GENDER
doesn't NN NN O
use NN NN O
any NN NN O
contraceptive NN NN O
methods NN NN O
for NN NN O
the NN NN O
past NN NN O
4 NN NN O
months NN NN O
and NN NN O
she NNP NNP B-GENDER
had NN NN O
no NNP NNP B-NEGATIVE
prior NNP NNP I-NEGATIVE
pregnancies NNP NNP I-NEGATIVE
. NN NN O

She NNP NNP B-GENDER
doesn't NN NN O
smoke NN NN O
or NN NN O
use NN NN O
any NN NN O
drugs NN NN O
. NN NN O

She NNP NNP B-GENDER
likes NN NN O
to NN NN O
try NN NN O
diets NN NN O
and NN NN O
exercise NN NN O
to NN NN O
lose NN NN O
weight NN NN O
. NN NN O

She NNP NNP B-GENDER
completed NN NN O
the NN NN O
four NN NN O
square NN NN O
step NN NN O
test NN NN O
in NN NN O
14 NN NN O
seconds NN NN O
. NN NN O

Her NN NN O
BP NN NN O
: NN NN O
130/80 NN NN O
, NN NN O
HR NN NN O
: NN NN O
195/min NN NN O
and NN NN O
her NN NN O
BMI NN NN O
is NN NN O
: NN NN O
41.54 NN NN O
. NN NN O

Her NN NN O
labs:FBS NN NN O
: NN NN O
98 NN NN O
mg/dlTG NN NN O
: NN NN O
150 NN NN O
mg/dlCholesterol NN NN O
: NN NN O
180 NN NN O
mg/dlLDL NN NN O
: NN NN O
90 NN NN O
mg/dlHDL NN NN O
: NN NN O
35 NN NN O
mg/dlHer NN NN O
cardiac NN NN O
assessment NN NN O
is NN NN O
normal NN NN O
. NN NN O

Her NN NN O
joints NN NN O
and NN NN O
ROM NN NN O
are NN NN O
within NN NN O
normal NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
20 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
Caucasian NN NN O
female NNP NNP B-GENDER
presents NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
one-sided NNP NNP B-DIAGNOSIS
vision NNP NNP I-DIAGNOSIS
lost NNP NNP I-DIAGNOSIS
and NN NN O
facial NNP NNP B-DIAGNOSIS
weakness NNP NNP I-DIAGNOSIS
, NN NN O
dysarthria NNP NNP B-DIAGNOSIS
and NN NN O
numbness NNP NNP B-DIAGNOSIS
lasting NN NN O
for NN NN O
1 NN NN O
day NN NN O
. NN NN O

She NNP NNP B-GENDER
visited NN NN O
her NN NN O
PCP NN NN O
and NN NN O
underwent NN NN O
brain NN NN O
MRI NN NN O
which NN NN O
revealed NN NN O
a NN NN O
single NN NN O
plaque NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
the NNP NNP I-DIAGNOSIS
brainstem NNP NNP I-DIAGNOSIS
. NN NN O

After NN NN O
few NN NN O
months NN NN O
, NN NN O
she NNP NNP B-GENDER
experienced NN NN O
lower NNP NNP B-DIAGNOSIS
extremities NNP NNP I-DIAGNOSIS
weakness NNP NNP I-DIAGNOSIS
led NN NN O
to NN NN O
balance NNP NNP B-DIAGNOSIS
problem NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
second NN NN O
MRI NN NN O
revealed NN NN O
another NN NN O
lesion NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
the NNP NNP I-DIAGNOSIS
left NNP NNP I-DIAGNOSIS
cerebral NNP NNP I-DIAGNOSIS
hemisphere NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
diagnosis NN NN O
of NN NN O
Relapsing NNP NNP B-DIAGNOSIS
Remitting NNP NNP I-DIAGNOSIS
Multiple NNP NNP I-DIAGNOSIS
Sclerosis NNP NNP I-DIAGNOSIS
( NN NN O
RRMS NNP NNP B-DIAGNOSIS
) NN NN O
is NN NN O
confirmed NN NN O
after NN NN O
the NN NN O
second NN NN O
MRI NN NN O
. NN NN O

Her NN NN O
past NN NN O
surgical NN NN O
history NN NN O
is NN NN O
significant NN NN O
for NN NN O
a NN NN O
C-section NN NN O
2 NN NN O
years NN NN O
ago NN NN O
and NN NN O
she NNP NNP B-GENDER
has NN NN O
a NN NN O
one NN NN O
child NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
divorced NN NN O
and NN NN O
is NN NN O
not NN NN O
currently NN NN O
in NN NN O
any NN NN O
sexual NN NN O
relationship NN NN O
. NN NN O

She NNP NNP B-GENDER
smokes NN NN O
10 NN NN O
cigarettes NN NN O
per NN NN O
day NN NN O
and NN NN O
drinks NN NN O
alcohol NN NN O
occasionally NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
working NN NN O
as NN NN O
an NN NN O
editor NN NN O
in NN NN O
a NN NN O
publisher NN NN O
company NN NN O
and NN NN O
she NNP NNP B-GENDER
is NN NN O
happy NN NN O
that NN NN O
she NNP NNP B-GENDER
can NN NN O
keep NN NN O
working NN NN O
from NN NN O
home NN NN O
most NN NN O
of NN NN O
the NN NN O
time NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
under NN NN O
the NN NN O
treatment NN NN O
of NN NN O
RRMS NNP NNP B-DIAGNOSIS
from NN NN O
7 NN NN O
months NN NN O
ago NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
35-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
with NN NN O
myasthenia NNP NNP B-DIAGNOSIS
gravis NNP NNP I-DIAGNOSIS
, NNP NNP I-DIAGNOSIS
class NNP NNP I-DIAGNOSIS
IIa NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
complains NN NN O
of NN NN O
diplopia NNP NNP B-DIAGNOSIS
and NN NN O
fatigue NNP NNP B-DIAGNOSIS
and NN NN O
weakness NNP NNP B-DIAGNOSIS
that NN NN O
affects NN NN O
mainly NN NN O
her NN NN O
upper NN NN O
limbs NN NN O
. NN NN O

She NNP NNP B-GENDER
had NN NN O
a NN NN O
positive NN NN O
anti-AChR NN NN O
antibody NN NN O
test NN NN O
, NN NN O
and NN NN O
her NN NN O
single NN NN O
fiber NN NN O
electromyography NN NN O
( NN NN O
SFEMG NN NN O
) NN NN O
was NN NN O
positive NN NN O
. NN NN O

She NNP NNP B-GENDER
takes NN NN O
pyridostigmine NN NN O
60 NN NN O
mg NN NN O
three NN NN O
times NN NN O
a NN NN O
day NN NN O
. NN NN O

But NN NN O
she NNP NNP B-GENDER
still NN NN O
has NN NN O
some NN NN O
symptoms NN NN O
that NN NN O
interfere NN NN O
with NN NN O
her NN NN O
job NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
a NN NN O
research NN NN O
coordinator NN NN O
and NN NN O
has NN NN O
3 NN NN O
children NN NN O
. NN NN O

Her NN NN O
70-year-old NN NN O
father NN NN O
has NN NN O
hypertension NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
smoke NN NN O
or NN NN O
use NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

She NNP NNP B-GENDER
drinks NN NN O
alcohol NN NN O
occasionally NN NN O
at NN NN O
social NN NN O
events NN NN O
. NN NN O

Her NN NN O
physical NN NN O
exam NN NN O
and NN NN O
lab NN NN O
studies NN NN O
were NN NN O
not NN NN O
remarkable NN NN O
for NN NN O
any NN NN O
other NN NN O
abnormalities.BP NN NN O
: NN NN O
110/75Hgb NN NN O
: NN NN O
11 NN NN O
g/dlWBC NN NN O
: NN NN O
8000 NN NN O
/mm3Plt NN NN O
: NN NN O
300000 NN NN O
/mlCreatinine NN NN O
: NN NN O
0.5 NN NN O
mg/dlBUN NN NN O
: NN NN O
10 NN NN O
mg/dlBeta NN NN O
hcg NN NN O
: NN NN O
negative NN NN O
for NN NN O
pregnancy NN NN O

A NN NN O
3-day-old NNP NNP B-AGE
Asian NN NN O
female NNP NNP B-GENDER
infant NN NN O
presents NN NN O
with NN NN O
jaundice NNP NNP B-DIAGNOSIS
that NN NN O
started NN NN O
a NN NN O
day NN NN O
ago NN NN O
. NN NN O

She NNP NNP B-GENDER
was NN NN O
born NN NN O
at NN NN O
38w3d NN NN O
of NN NN O
gestation NN NN O
, NN NN O
after NN NN O
an NN NN O
uncomplicated NN NN O
pregnancy NN NN O
. NN NN O

The NN NN O
family NN NN O
history NN NN O
is NN NN O
unremarkable NN NN O
. NN NN O

The NN NN O
baby NN NN O
is NN NN O
breastfed.Vital NN NN O
signs NN NN O
are NN NN O
reported NN NN O
as NN NN O
: NN NN O
axillary NN NN O
temperature NN NN O
: NN NN O
36.3C NN NN O
, NN NN O
heart NN NN O
rate NN NN O
: NN NN O
154 NN NN O
beats/min NN NN O
, NN NN O
respiratory NN NN O
rate NN NN O
: NN NN O
37 NN NN O
breaths/min NN NN O
, NN NN O
and NN NN O
blood NN NN O
pressure NN NN O
: NN NN O
65/33 NN NN O
mm NN NN O
Hg NN NN O
. NN NN O

Her NN NN O
weight NN NN O
is NN NN O
3.2 NN NN O
kg NN NN O
, NN NN O
length NN NN O
is NN NN O
53 NN NN O
cm NN NN O
, NN NN O
and NN NN O
head NN NN O
circumference NN NN O
36 NN NN O
cm NN NN O
. NN NN O

Her NN NN O
sclera NN NN B-DIAGNOSIS
are NNP NNP I-DIAGNOSIS
yellow NNP NNP I-DIAGNOSIS
and NN NN O
her NN NN O
body NNP NNP B-DIAGNOSIS
is NNP NNP I-DIAGNOSIS
icteric NNP NNP I-DIAGNOSIS
. NN NN O

No NNP NNP B-NEGATIVE
murmurs NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
other NNP NNP I-NEGATIVE
abnormalities NNP NNP I-NEGATIVE
are NN NN O
detected NN NN O
in NN NN O
the NN NN O
heart NN NN O
and NN NN O
lung NN NN O
auscultation NN NN O
. NN NN O

Her NN NN O
liver NN NN O
and NN NN O
spleen NN NN O
are NN NN O
normal NN NN O
on NN NN O
palpation.Laboratory NN NN O
results NN NN O
are NN NN O
as NN NN O
follows NN NN O
: NN NN O
Serum NN NN O
total NN NN O
bilirubin NN NN O
: NN NN O
21.02 NN NN O
mg/dLDirect NN NN O
bilirubin NN NN O
of NN NN O
2.04 NN NN O
mg/dLAST NN NN O
: NN NN O
37 NN NN O
U/LALT NN NN O
: NN NN O
20 NN NN O
U/LGGT NN NN O
: NN NN O
745 NN NN O
U/LAlkaline NN NN O
phosphatase NN NN O
: NN NN O
531 NN NN O
U/LCreatinine NN NN O
: NN NN O
0.3 NN NN O
mg/dLUrea NN NN O
: NN NN O
29 NN NN O
mg/dLNa NN NN O
: NN NN O
147 NN NN O
mEq/LK NN NN O
: NN NN O
4.5 NN NN O
mEq/LCRP NN NN O
: NN NN O
3 NN NN O
mg/LComplete NN NN O
blood NN NN O
cell NN NN O
count NN NN O
within NN NN O
the NN NN O
normal NN NN O
range.She NNP NNP B-GENDER
is NN NN O
diagnosed NN NN O
with NN NN O
uncomplicated NN NN O
neonatal NNP NNP B-DIAGNOSIS
jaundice NNP NNP I-DIAGNOSIS
that NN NN O
may NN NN O
require NN NN O
phototherapy NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
60 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
man NNP NNP B-GENDER
complaining NN NN O
of NN NN O
frequent NN NN O
headaches NNP NNP B-DIAGNOSIS
, NN NN O
generalized NN NN O
bone NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
and NN NN O
difficulty NNP NNP B-DIAGNOSIS
chewing NNP NNP I-DIAGNOSIS
that NN NN O
started NN NN O
6 NN NN O
years NN NN O
ago NN NN O
and NN NN O
is NN NN O
worsening NN NN O
. NN NN O

Examination NN NN O
shows NN NN O
bilateral NN NN O
swellings NNP NNP B-DIAGNOSIS
around NN NN O
the NN NN O
molars NN NN O
. NN NN O

The NN NN O
swellings NNP NNP B-DIAGNOSIS
have NN NN O
increased NN NN O
since NN NN O
his NN NN O
last NN NN O
examination NN NN O
. NN NN O

Several NN NN O
extraoral NN NN O
lesions NNP NNP B-DIAGNOSIS
are NN NN O
detected NN NN O
in NN NN O
the NN NN O
head NN NN O
and NN NN O
face NN NN O
. NN NN O

The NN NN O
swellings NNP NNP B-DIAGNOSIS
are NN NN O
non-tender NN NN O
and NN NN O
attached NN NN O
to NN NN O
the NN NN O
underlying NN NN O
bone NN NN O
. NN NN O

Further NN NN O
evaluation NN NN O
shows NN NN O
increased NN NN O
uptake NN NN O
of NN NN O
radioactive NN NN O
substance NN NN O
as NN NN O
well NN NN O
as NN NN O
an NN NN O
increase NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
urinary NNP NNP I-DIAGNOSIS
pyridinoline NNP NNP I-DIAGNOSIS
. NN NN O

His NN NN O
serum NN NN O
alkaline NN NN O
phosphatase NN NN O
is NN NN O
300 NN NN O
IU/L NN NN O
( NN NN O
the NN NN O
normal NN NN O
range NN NN O
is NN NN O
44 NN NN O
- NN NN O
147 NN NN O
IU/L NN NN O
). NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
only NN NN O
significant NN NN O
for NN NN O
hypertension NNP NNP B-DIAGNOSIS
in NN NN O
his NN NN O
mother NN NN O
and NN NN O
DM NNP NNP B-DIAGNOSIS
type NNP NNP I-DIAGNOSIS
2 NNP NNP I-DIAGNOSIS
in NN NN O
his NN NN O
father NN NN O
. NN NN O

The NN NN O
diagnosis NN NN O
of NN NN O
Paget's NNP NNP B-DIAGNOSIS
Disease NNP NNP I-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
Bone NNP NNP I-DIAGNOSIS
was NN NN O
confirmed NN NN O
and NN NN O
Bisphosphonate NN NN O
will NN NN O
be NN NN O
started NN NN O
as NN NN O
first-line NN NN O
therapy NN NN O
. NN NN O

A NN NN O
57-year NNP NNP B-AGE
old NNP NNP I-AGE
farmer NN NN O
was NN NN O
diagnosed NN NN O
with NN NN O
Parkinson's NNP NNP B-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
a NN NN O
year NN NN O
ago NN NN O
. NN NN O

He NNP NNP B-GENDER
experiences NN NN O
slowness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
movement NNP NNP I-DIAGNOSIS
and NN NN O
tremors NNP NNP B-DIAGNOSIS
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
significant NN NN O
for NN NN O
hypertension NNP NNP B-DIAGNOSIS
and NN NN O
hypercholesterolemia NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
lives NN NN O
with NN NN O
his NN NN O
wife NN NN O
. NN NN O

They NN NN O
have NN NN O
three NN NN O
children NN NN O
. NN NN O

He NNP NNP B-GENDER
used NN NN O
to NN NN O
be NN NN O
active NN NN O
with NN NN O
planting NN NN O
and NN NN O
taking NN NN O
care NN NN O
of NN NN O
their NN NN O
farm NN NN O
animals NN NN O
before NN NN O
his NN NN O
diagnosis NN NN O
. NN NN O

The NN NN O
patient NN NN O
complains NN NN O
of NN NN O
shaking NNP NNP B-DIAGNOSIS
and NNP NNP I-DIAGNOSIS
slow NNP NNP I-DIAGNOSIS
movement NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
had NN NN O
difficulty NN NN O
entering NN NN O
through NN NN O
a NN NN O
door NN NN O
, NN NN O
as NN NN O
he NNP NNP B-GENDER
was NN NN O
frozen NN NN O
and NN NN O
needed NN NN O
guidance NN NN O
to NN NN O
step NN NN O
in NN NN O
. NN NN O

His NN NN O
handwriting NN NN O
is NN NN O
getting NN NN O
smaller NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
on NN NN O
Levodopa NN NN O
and NN NN O
Trihexyphenidyl NN NN O
. NN NN O

He NNP NNP B-GENDER
stated NN NN O
his NN NN O
medications NN NN O
help NN NN O
with NN NN O
shaking NNP NNP B-DIAGNOSIS
and NNP NNP I-DIAGNOSIS
slow NNP NNP I-DIAGNOSIS
movement NNP NNP I-DIAGNOSIS
. NN NN O

But NN NN O
he NNP NNP B-GENDER
still NN NN O
has NN NN O
difficulty NNP NNP B-DIAGNOSIS
initiating NNP NNP I-DIAGNOSIS
movements NNP NNP I-DIAGNOSIS
, NN NN O
stiffness NNP NNP B-DIAGNOSIS
and NN NN O
slowness NNP NNP B-DIAGNOSIS
in NN NN O
general NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
an NN NN O
alert NN NN O
and NN NN O
cooperative NN NN O
man NNP NNP B-GENDER
who NN NN O
doesn't NN NN O
have NN NN O
any NN NN O
signs NN NN O
of NN NN O
dementia NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
doesn't NN NN O
smoke NN NN O
or NN NN O
use NN NN O
any NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

19 NNP NNP B-AGE
yo NNP NNP I-AGE
Hispanic NN NN O
female NNP NNP B-GENDER
G1P1 NN NN O
at NN NN O
32+ NN NN O
6 NN NN O
weeks NN NN O
of NN NN O
gestational NN NN O
age NN NN O
presented NN NN O
to NN NN O
the NN NN O
OB NN NN O
clinic NN NN O
for NN NN O
routine NN NN O
follow NN NN O
up NN NN O
complaining NN NN O
of NN NN O
mild NN NN O
headache NNP NNP B-DIAGNOSIS
and NN NN O
leg NNP NNP B-DIAGNOSIS
swelling NNP NNP I-DIAGNOSIS
. NN NN O

Primary NN NN O
evaluation NN NN O
revealed NN NN O
BP NN NN O
of NN NN O
146/99 NN NN O
and NN NN O
urine NN NN O
dipstick NN NN O
with NN NN O
3+ NN NN O
proteins NN NN O
. NN NN O

Her NN NN O
BP NN NN O
and NN NN O
U/A NN NN O
were NN NN O
normal NN NN O
in NN NN O
previous NN NN O
visit NN NN O
. NN NN O

Repeat NN NN O
BP NN NN O
a NN NN O
few NN NN O
hours NN NN O
later NN NN O
is NN NN O
150/100 NN NN O
mmHg NN NN O
. NN NN O

Laboratory NN NN O
studies NN NN O
showed NN NN O
a NN NN O
normal NN NN O
hematocrit NN NN O
, NN NN O
platelet NN NN O
count NN NN O
, NN NN O
and NN NN O
liver NN NN O
transaminase NN NN O
levels NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
complaining NN NN O
of NN NN O
fatigue NNP NNP B-DIAGNOSIS
but NN NN O
no NNP NNP B-NEGATIVE
fever NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
chills NNP NNP I-NEGATIVE
. NN NN O

She NNP NNP B-GENDER
is NN NN O
also NN NN O
suffering NN NN O
of NN NN O
headache NNP NNP B-DIAGNOSIS
s NN NN O
with NN NN O
no NNP NNP B-NEGATIVE
vision NNP NNP I-NEGATIVE
changes NNP NNP I-NEGATIVE
. NN NN O

No NNP NNP B-NEGATIVE
shortness NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
breath NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
cough NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
chest NNP NNP I-NEGATIVE
pain NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
orthopnea NNP NNP I-NEGATIVE
and NNP NNP I-NEGATIVE
palpitations NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
skin NNP NNP I-NEGATIVE
rash NNP NNP I-NEGATIVE
were NN NN O
observed NN NN O
. NN NN O

Her NN NN O
physical NN NN O
exam NN NN O
was NN NN O
negative NNP NNP B-NEGATIVE
for NNP NNP I-NEGATIVE
abdominal NNP NNP I-NEGATIVE
pain NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
change NNP NNP I-NEGATIVE
in NNP NNP I-NEGATIVE
bowel NNP NNP I-NEGATIVE
habits NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
nausea NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
vomiting NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
dysuria NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
frequency NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
hematuria NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
frothy NNP NNP I-NEGATIVE
urine NNP NNP I-NEGATIVE
. NN NN O

Leg NNP NNP B-DIAGNOSIS
swelling NNO NNP I-DIAGNOSIS
was NN NN O
observed NN NN O
with NN NN O
no NN NN B-NEGATIVE
arthralgia NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
back NNP NNP I-NEGATIVE
pain NNP NNP I-NEGATIVE
. NN NN O

She NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
specific NNP NNP I-NEGATIVE
past NNP NNP I-NEGATIVE
medical NNP NNP I-NEGATIVE
issues NNP NNP I-NEGATIVE
and NN NN O
only NN NN O
uses NN NN O
prenatal NN NN O
vitamins NN NN O
. NN NN O

Her NN NN O
family NN NN O
history NN NN O
is NN NN O
positive NN NN O
for NN NN O
DM NNP NNP B-DIAGNOSIS
type NNP NNP I-DIAGNOSIS
2 NNP NNP I-DIAGNOSIS
and NN NN O
HTN NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
is NN NN O
a NN NN O
social NN NN O
alcohol NN NN O
consumer NN NN O
with NN NN O
the NN NN O
negative NNP NNP B-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
smoking NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
drug NNP NNP I-NEGATIVE
use NNP NNP I-NEGATIVE
. NN NN O

She NNP NNP B-GENDER
is NN NN O
only NN NN O
have NN NN O
one NN NN O
partner NN NN O
in NN NN O
past NN NN O
2 NN NN O
years NN NN O
and NN NN O
didn't NN NN O
have NN NN O
any NN NN O
contraceptive NN NN O
methods NN NN O
since NN NN O
2 NN NN O
years NN NN O
ago NN NN O
. NN NN O

Her NN NN O
BMI NN NN O
was NN NN O
24 NN NN O
at NN NN O
the NN NN O
first NN NN O
visit NN NN O
when NN NN O
she NNP NNP B-GENDER
was NN NN O
at NN NN O
6 NN NN O
weeks NN NN O
of NN NN O
gestational NN NN O
age NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
getting NN NN O
weight NN NN O
normally NN NN O
during NN NN O
her NN NN O
pregnancies NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
60-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
admitted NN NN O
to NN NN O
the NN NN O
stroke NN NN O
department NN NN O
with NN NN O
a NN NN O
recent NN NN O
history NN NN O
of NN NN O
a NN NN O
second NN NN O
course NN NN O
of NN NN O
intravenous NN NN O
antibiotics NN NN O
for NN NN O
aspiration NNP NNP B-DIAGNOSIS
pneumonia NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
is NN NN O
febrile NNP NNP B-DIAGNOSIS
and NN NN O
complained NN NN O
of NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
and NN NN O
diarrhea NNP NNP B-DIAGNOSIS
( NN NN O
bowel NN NN O
movements NN NN O
eight NN NN O
times NN NN O
in NN NN O
3 NN NN O
hours NN NN O
, NN NN O
large NN NN O
volumes NN NN O
of NN NN O
greenish NN NN O
, NN NN O
liquid NN NN O
stool NN NN O
each NN NN O
time NN NN O
). NN NN O

The NN NN O
patient's NN NN O
abdomen NN NN O
is NN NN O
generally NN NN O
tender NN NN O
and NN NN O
distend NN NN O
with NN NN O
hyperactive NNP NNP B-DIAGNOSIS
bowel NNP NNP I-DIAGNOSIS
sounds NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
is NN NN O
febrile NNP NNP B-DIAGNOSIS
( NN NN O
38.4C NN NN O
), NN NN O
tachycardic NNP NNP B-DIAGNOSIS
( NN NN O
113/min NN NN O
) NN NN O
and NN NN O
hypotensive NNP NNP B-DIAGNOSIS
( NN NN O
80/40 NN NN O
mmHg NN NN O
). NN NN O

The NN NN O
stool NN NN O
samples NN NN O
must NN NN O
were NN NN O
positive NN NN O
for NN NN O
Clostridium NNP NNP B-DIAGNOSIS
difficile NNP NNP I-DIAGNOSIS
toxin NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
14-year-old NNP NNP B-AGE
boy NNP NNP B-GENDER
complaining NN NN O
of NN NN O
scoliosis NNP NNP B-DIAGNOSIS
and NN NN O
back NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
other NNP NNP I-NEGATIVE
medical NNP NNP I-NEGATIVE
condition NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
used NN NN O
to NN NN O
be NN NN O
able NN NN O
to NN NN O
play NN NN O
routine NN NN O
activities NN NN O
such NN NN O
as NN NN O
basketball NN NN O
and NN NN O
soccer NN NN O
, NN NN O
however NN NN O
, NN NN O
he NNP NNP B-GENDER
recently NN NN O
has NN NN O
problem NN NN O
doing NN NN O
them NN NN O
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
is NN NN O
in NN NN O
his NN NN O
leg NN NN O
and NN NN O
back NN NN O
and NN NN O
aggravated NN NN O
by NN NN O
physical NN NN O
activities NN NN O
. NN NN O

He NNP NNP B-GENDER
prefer NN NN O
lying NN NN O
down NN NN O
most NN NN O
of NN NN O
the NN NN O
time NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
not NN NN O
happy NN NN O
with NN NN O
his NN NN O
body NN NN O
gesture NN NN O
and NN NN O
complaints NN NN O
of NN NN O
shoulder NNP NNP B-DIAGNOSIS
imbalance NNP NNP I-DIAGNOSIS
and NN NN O
shifting NN NN O
his NN NN O
head NN NN O
to NN NN O
right NN NN O
. NN NN O

Patient NN NN O
is NN NN O
a NN NN O
well-dressed NN NN O
and NN NN O
well-nourished NN NN O
adolescent NNP NNP B-AGE
who NN NN O
is NN NN O
alert NN NN O
and NN NN O
cooperative NN NN O
. NN NN O

The NN NN O
left NN NN O
shoulder NN NN O
is NN NN O
slightly NN NN O
higher NN NN O
than NN NN O
the NN NN O
right NN NN O
shoulder NN NN O
. NN NN O

The NN NN O
scoliotic NNP NNP B-DIAGNOSIS
curve NNP NNP I-DIAGNOSIS
is NN NN O
measured NN NN O
as NN NN O
45 NN NN O
degree NN NN O
. NN NN O

The NN NN O
patients NN NN O
is NN NN O
candidate NN NN O
for NN NN O
scoliosis NNP NNP B-DIAGNOSIS
surgery NN NN O
according NN NN O
to NN NN O
perioperative NN NN O
MEP NN NN O
monitoring NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
34-year-old NNP NNP B-AGE
African NN NN O
American NN NN O
man NNP NNP B-GENDER
with NN NN O
the NN NN O
known NN NN O
history NN NN O
of NN NN O
Sickle NNP NNP B-DIAGNOSIS
cell NNP NNP I-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
comes NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
severe NN NN O
bone NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
patient NN NN O
had NN NN O
severe NN NN O
pain NNP NNP B-DIAGNOSIS
in NN NN O
his NN NN O
lower NN NN O
back NN NN O
that NN NN O
radiated NN NN O
to NN NN O
both NN NN O
thighs NN NN O
scored NN NN O
9 NN NN O
out NN NN O
of NN NN O

10 NN NN O
. NN NN O
The NN NN O
patient NN NN O
has NN NN O
had NN NN O
positive NN NN O
history NN NN O
of NN NN O
sickle NNP NNP B-DIAGNOSIS
cell NNP NNP I-DIAGNOSIS
crises NNP NNP I-DIAGNOSIS
since NN NN O
childhood NN NN O
. NN NN O

He NNP NNP B-GENDER
also NN NN O
had NN NN O
the NN NN O
same NN NN O
symptoms NN NN O
in NN NN O
past NN NN O
two NN NN O
weeks NN NN O
treated NN NN O
with NN NN O
oxycodone NN NN O
which NN NN O
was NN NN O
not NN NN O
beneficial NN NN O
to NN NN O
his NN NN O
pain NNP NNP B-DIAGNOSIS
. NN NN O

His NN NN O
PCP NN NN O
sent NN NN O
him NN NN O
to NN NN O
the NN NN O
emergency NN NN O
department NN NN O
to NN NN O
receive NN NN O
intra NN NN O
venous NN NN O
pain NNP NNP B-DIAGNOSIS
modulators NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
afebrile NNP NNP B-DIAGNOSIS
within NN NN O
the NN NN O
normal NN NN O
blood NN NN O
pressure NN NN O
. NN NN O

No NN NN O
splenomegaly NNP NNP B-DIAGNOSIS
was NN NN O
detected NN NN O
in NN NN O
the NN NN O
physical NN NN O
exam NN NN O
. NN NN O

He NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
positive NNP NNP I-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
drug NNP NNP I-NEGATIVE
allergy NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
won't NN NN O
smoke NN NN O
or NN NN O
uses NN NN O
any NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

The NN NN O
lab NN NN O
study NN NN O
is NN NN O
as NN NN O
bellow:Hgb NN NN O
: NN NN O
8 NN NN O
g/dlWBC NN NN O
: NN NN O
10000 NN NN O
/mm3Plt NN NN O
: NN NN O
300000 NN NN O
/mlMCV NN NN O
: NN NN O
106 NN NN O
fLHemoglobine NN NN O
electrophoresis NN NN O
: NN NN O
91% NN NN O
HbS NN NN O
6%HbF NN NN O
3%HbA2AST NN NN O
: NN NN O
22 NN NN O
U/LALT NN NN O
: NN NN O
43 NN NN O
U/LAlk NN NN O
P NN NN O
: NN NN O
53 NN NN O
U/LFerritin NN NN O
: NN NN O
1200 NN NN O
ng/ml NN NN O

Patient NN NN O
A NN NN O
is NN NN O
a NN NN O
30-year-old NNP NNP B-AGE
male NNP NNP B-GENDER
who NN NN O
was NN NN O
admitted NN NN O
to NN NN O
the NN NN O
hospital NN NN O
after NN NN O
10 NN NN O
days NN NN O
of NN NN O
cough NNP NNP B-DIAGNOSIS
, NN NN O
profuse NNP NNP B-DIAGNOSIS
nocturnal NNP NNP I-DIAGNOSIS
sweating NNP NNP I-DIAGNOSIS
and NN NN O
loss NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
appetite NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
had NN NN O
traveled NN NN O
to NN NN O
India NN NN O
1 NN NN O
months NN NN O
ago NN NN O
and NN NN O
has NN NN O
not NN NN O
any NN NN O
positive NN NN O
history NN NN O
of NN NN O
TB NN NN O
vaccination NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
a NN NN O
previously NN NN O
healthy NN NN O
man NNP NNP B-GENDER
, NN NN O
working NN NN O
as NN NN O
an NN NN O
engineer NN NN O
in NN NN O
a NN NN O
high NN NN O
tech NN NN O
company NN NN O
. NN NN O

He NNP NNP B-GENDER
doesn't NN NN O
smoke NN NN O
o NN NN O
use NN NN O
any NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

He NNP NNP B-GENDER
was NN NN O
febrile NNP NNP B-DIAGNOSIS
( NN NN O
38 NN NN O
c NN NN O
) NN NN O
with NN NN O
heart NN NN O
rate NN NN O
of NN NN O
115 NN NN O
b/min NN NN O
, NN NN O
respiratory NN NN O
rate NN NN O
of NN NN O
22 NN NN O
, NN NN O
BP NN NN O
of NN NN O
125/75 NN NN O
mmHg NN NN O
and NN NN O
O2 NN NN O
sat NN NN O
of NN NN O
97% NN NN O
. NN NN O

Chest NN NN O
X-ray NN NN O
showed NN NN O
infiltrate NN NN O
in NN NN O
the NN NN O
middle NN NN O
of NN NN O
left NN NN O
lung NN NN O
with NN NN O
diameter NN NN O
of NN NN O
1.8 NN NN O
cm NN NN O
with NN NN O
signs NN NN O
of NN NN O
cavitation NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
sputum NN NN O
smear NN NN O
revealed NN NN O
positive NN NN O
sputum NN NN O
culture NN NN O
for NN NN O
Mycobacterium NNP NNP B-DIAGNOSIS
tuberculosis NNP NNP I-DIAGNOSIS
which NN NN O
are NN NN O
sensitive NN NN O
of NN NN O
the NN NN O
first-line NN NN O
TB NN NN O
drugs NN NN O
( NN NN O
isoniazid NN NN O
, NN NN O
streptomycin NN NN O
, NN NN O
rifampicin NN NN O
and NN NN O
ethambutol NN NN O
). NN NN O

Lab NN NN O
study NN NN O
is NN NN O
reported NN NN O
bellow:Hgb NN NN O
: NN NN O
13 NN NN O
g/dlWBC NN NN O
: NN NN O
14000 NN NN O
/mm3Plt NN NN O
: NN NN O
300000 NN NN O
/mlAST NN NN O
: NN NN O
13 NN NN O
U/LALT NN NN O
: NN NN O
15 NN NN O
U/LAlk NN NN O
P NN NN O
: NN NN O
53 NN NN O
U/LBill NN NN O
total NN NN O
: NN NN O
0.6 NN NN O
mg/dlNa NN NN O
: NN NN O
137 NN NN O
mEq/lK NN NN O
: NN NN O
4 NN NN O
mEq/lCreatinine NN NN O
: NN NN O
0.5 NN NN O
mg/dlBUN NN NN O
: NN NN O
10 NN NN O
mg/dlESR NN NN O
: NN NN O
120 NN NN O
mm/hr NN NN O

A NN NN O
62-year-old NNP NNP B-AGE
African-American NN NN O
man NNP NNP B-GENDER
presented NN NN O
with NN NN O
left NN NN O
upper NN NN O
and NN NN O
lower NN NN O
extremity NNP NNP B-DIAGNOSIS
weakness NNP NNP I-DIAGNOSIS
, NN NN O
associated NN NN O
with NN NN O
dark NNP NNP B-DIAGNOSIS
visual NNP NNP I-DIAGNOSIS
spot NNP NNP I-DIAGNOSIS
in NN NN O
right NN NN O
eye NN NN O
, NN NN O
right NN NN O
facial NN NN O
numbness NNP NNP B-DIAGNOSIS
, NN NN O
facial NNP NNP B-DIAGNOSIS
drop NNP NNP I-DIAGNOSIS
and NN NN O
slurred NNP NNP B-DIAGNOSIS
speech NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
denied NNP NNP B-NEGATIVE
dyspnea NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
headache NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
palpitations NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
chest NNP NNP I-NEGATIVE
pain NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
fever NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
dizziness NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
bowel NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
urinary NNP NNP I-NEGATIVE
incontinence NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
loss NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
consciousness NNP NNP I-NEGATIVE
. NN NN O

His NN NN O
medical NN NN O
history NN NN O
was NN NN O
significant NN NN O
for NN NN O
hypertension NNP NNP B-DIAGNOSIS
, NN NN O
hyperlipidemia NNP NNP B-DIAGNOSIS
and NN NN O
hypothyroidism NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
smokes NN NN O
cigarette NN NN O
1 NN NN O
pack NN NN O
per NN NN O
day NN NN O
for NN NN O
40 NN NN O
years NN NN O
and NN NN O
alcohol NN NN O
consumption NN NN O
of NN NN O
5 NN NN O
to NN NN O
6 NN NN O
beers NN NN O
per NN NN O
week NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
not NN NN O
aware NN NN O
about NN NN O
his NN NN O
family NN NN O
history NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
using NN NN O
Levothyroxine NN NN O
, NN NN O
Atorvastatin NN NN O
and NN NN O
HTCZ NN NN O
. NN NN O

His NN NN O
vital NN NN O
signs NN NN O
were NN NN O
stable NN NN O
in NN NN O
the NN NN O
primary NN NN O
evaluation NN NN O
. NN NN O

Left-sided NN NN O
facial NNP NNP B-DIAGNOSIS
droop NNP NNP I-DIAGNOSIS
, NN NN O
dysarthria NNP NNP B-DIAGNOSIS
, NN NN O
and NN NN O
left-sided NN NN O
hemiplegia NNP NNP B-DIAGNOSIS
were NN NN O
seen NN NN O
in NN NN O
the NN NN O
physical NN NN O
exam NN NN O
. NN NN O

His NN NN O
National NN NN O
Institutes NN NN O
of NN NN O
Health NN NN O
Stroke NNP NNP B-DIAGNOSIS
Scale NN NN O
( NN NN O
NIHSS NN NN O
) NN NN O
score NN NN O
was NN NN O
calculated NN NN O
as NN NN O

7 NN NN O
. NN NN O
Initial NN NN O
CT NN NN O
angiogram NN NN O
of NN NN O
head NN NN O
and NN NN O
neck NN NN O
reported NN NN O
no NNP NNP B-NEGATIVE
acute NNP NNP I-NEGATIVE
intracranial NNP NNP I-NEGATIVE
findings NNP NNP I-NEGATIVE
. NN NN O

Intravenous NN NN O
recombinant NN NN O
tissue NN NN O
plasminogen NN NN O
activator NN NN O
( NN NN O
t-PA NN NN O
) NN NN O
was NN NN O
administered NN NN O
as NN NN O
well NN NN O
as NN NN O
high-dose NN NN O
statin NN NN O
therapy NN NN O
. NN NN O

The NN NN O
patient NN NN O
was NN NN O
admitted NN NN O
to NN NN O
the NN NN O
intensive NN NN O
care NN NN O
unit NN NN O
to NN NN O
be NN NN O
monitored NN NN O
for NN NN O
24 NN NN O
hours NN NN O
. NN NN O

MRI NN NN O
of NN NN O
the NN NN O
head NN NN O
revealed NN NN O
an NN NN O
acute NN NN O
1.7-cm NN NN O
infarct NNP NNP B-DIAGNOSIS
of NN NN O
the NN NN O
right NN NN O
periventricular NN NN O
white NN NN O
matter NN NN O
and NN NN O
posterior NN NN O
right NN NN O
basal NN NN O
ganglia NN NN O
. NN NN O

Fernandez NN NN O
is NN NN O
a NN NN O
41 NNP NNP B-AGE
year NNP NNP I-AGE
man NNP NNP B-GENDER
who NN NN O
is NN NN O
a NN NN O
professional NN NN O
soccer NN NN O
player NN NN O
. NN NN O

He NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
itchy NNP NNP B-DIAGNOSIS
foot NNP NNP I-DIAGNOSIS
. NN NN O

Physical NN NN O
exam NN NN O
revealed NN NN O
localized NN NN O
scaling NNP NNP B-DIAGNOSIS
and NN NN O
maceration NNP NNP B-DIAGNOSIS
between NN NN O
the NN NN O
third NN NN O
and NN NN O
fourth NN NN O
of NN NN O
his NN NN O
right NN NN O
toe NN NN O
. NN NN O

It NN NN O
became NN NN O
inflamed NNP NNP B-DIAGNOSIS
and NN NN O
sore NNP NNP B-DIAGNOSIS
, NN NN O
with NN NN O
mild NN NN O
fissuring NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
dorsum NN NN O
and NN NN O
sole NN NN O
of NN NN O
the NN NN O
foot NN NN O
was NN NN O
unaffected NN NN O
. NN NN O

There NN NN O
is NN NN O
no NNP NNP B-NEGATIVE
pus NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
tearing NNP NNP I-NEGATIVE
in NN NN O
the NN NN O
affected NN NN O
area NN NN O
. NN NN O

He NNP NNP B-GENDER
didn't NN NN O
use NN NN O
ant NN NN O
topical NN NN O
ointment NN NN O
on NN NN O
the NN NN O
lesion NN NN O
and NN NN O
has NN NN O
no NNP NNP B-NEGATIVE
positive NNP NNP I-NEGATIVE
history NNP NNP I-NEGATIVE
for NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
underlying NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
such NNP NNP I-NEGATIVE
as NNP NNP I-NEGATIVE
DM NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
smokes NN NN O
15 NN NN O
cigarettes NN NN O
per NN NN O
day NN NN O
and NN NN O
drinks NN NN O
a NN NN O
beer NN NN O
per NN NN O
day NN NN O
. NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
positive NN NN O
for NN NN O
hyperlipidemia NNP NNP B-DIAGNOSIS
in NN NN O
her NN NN O
mother NN NN O
and NN NN O
MI NNP NNP B-DIAGNOSIS
in NN NN O
her NN NN O
father NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
in NN NN O
relation NN NN O
with NN NN O
several NN NN O
partners NN NN O
and NN NN O
use NN NN O
condom NN NN O
during NN NN O
the NN NN O
intercourse NN NN O
. NN NN O

His NN NN O
physical NN NN O
exam NN NN O
and NN NN O
lab NN NN O
studies NN NN O
were NN NN O
normal NN NN O
otherwise NN NN O
. NN NN O

Tinea NNP NNP B-DIAGNOSIS
pedis NNP NNP I-DIAGNOSIS
infection NNP NNP I-DIAGNOSIS
confirmed NN NN O
as NN NN O
his NN NN O
diagnosis NN NN O
by NN NN O
the NN NN O
observation NN NN O
of NN NN O
segmented NNP NNP B-DIAGNOSIS
fungal NNP NNP I-DIAGNOSIS
hyphae NNP NNP I-DIAGNOSIS
during NN NN O
a NN NN O
microscopic NN NN O
KOH NN NN O
wet NN NN O
mount NN NN O
examination NN NN O
. NN NN O

A NN NN O
12 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
girl NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
her NN NN O
mother NN NN O
, NN NN O
complaining NN NN O
of NN NN O
short NNP NNP B-DIAGNOSIS
stature NNP NNP I-DIAGNOSIS
, NN NN O
delayed NNP NNP B-DIAGNOSIS
in NNP NNP I-DIAGNOSIS
puberty NNP NNP I-DIAGNOSIS
and NN NN O
developmental NNP NNP B-DIAGNOSIS
delay NNP NNP I-DIAGNOSIS
. NN NN O

Her NN NN O
karyotype NN NN O
study NN NN O
revealed NN NN O
45X NN NN O
and NN NN O
confirmed NN NN O
the NN NN O
diagnosis NN NN O
of NN NN O
Turner NNP NNP B-DIAGNOSIS
syndrome NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
is NN NN O
treating NN NN O
with NN NN O
GH NN NN O
since NN NN O
6 NN NN O
months NN NN O
ago NN NN O
without NN NN O
estrogen NN NN O
therapy NN NN O
to NN NN O
avoid NN NN O
menarche NN NN O
and NN NN O
reach NN NN O
the NN NN O
ideal NN NN O
height NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
an NN NN O
obese NNP NNP B-DIAGNOSIS
, NN NN O
mentally NNP NNP B-DIAGNOSIS
retarded NNP NNP I-DIAGNOSIS
girl NN NN O
in NN NN O
the NN NN O
physical NN NN O
exam NN NN O
. NN NN O

Her NN NN O
breast NN NN O
bulb NN NN O
were NN NN O
in NN NN O
stage NN NN O
1 NN NN O
with NN NN O
no NNP NNP B-NEGATIVE
course NNP NNP I-NEGATIVE
hair NNP NNP I-NEGATIVE
in NN NN O
the NN NN O
pubic NN NN O
or NN NN O
axillary NN NN O
. NN NN O

Her NN NN O
TSH NN NN O
was NN NN O
3 NN NN O
and NN NN O
FBS NN NN O
was NN NN O
75 NN NN O
in NN NN O
the NN NN O
latest NN NN O
lab NN NN O
study NN NN O
. NN NN O

A NN NN O
5 NNP NNP B-AGE
months NNP NNP I-AGE
old NNP NNP I-AGE
male NNP NNP B-GENDER
brought NN NN O
to NN NN O
the NN NN O
pediatrics NN NN O
surgery NN NN O
clinic NN NN O
with NN NN O
the NN NN O
complaint NN NN O
of NN NN O
empty NNP NNP B-DIAGNOSIS
scrotum NNP NNP I-DIAGNOSIS
at NNP NNP I-DIAGNOSIS
the NNP NNP I-DIAGNOSIS
right NNP NNP I-DIAGNOSIS
side NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
baby NN NN O
boy NNP NNP B-GENDER
is NN NN O
a NN NN O
first NN NN O
child NN NN O
who NN NN O
was NN NN O
born NN NN O
at NN NN O
the NN NN O
age NNP NNP B-AGE
of NNP NNP I-AGE
38 NNP NNP I-AGE
weeks NN NN O
with NN NN O
NVD NNP NNP B-DIAGNOSIS
from NN NN O
a NN NN O
healthy NN NN O
mother NN NN O
. NN NN O

The NN NN O
mother NN NN O
had NN NN O
a NN NN O
normal NN NN O
pregnancy NNP NNP B-DIAGNOSIS
with NN NN O
no NN NN O
complication NN NN O
. NN NN O

The NN NN O
baby NN NN O
boy NN NN O
weighted NN NN O
3200 NN NN O
gr NN NN O
with NN NN O
the NN NN O
height NN NN O
of NN NN O
50 NN NN O
cm NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
breast NN NN O
feeding NN NN O
and NN NN O
now NN NN O
weighted NN NN O
as NN NN O
6.5 NN NN O
kg NN NN O
with NN NN O
the NN NN O
height NN NN O
of NN NN O
62 NN NN O
cm NN NN O
. NN NN O

He NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
developmental NNP NNP I-NEGATIVE
delay NNP NNP I-NEGATIVE
in NN NN O
the NN NN O
physical NN NN O
assessment NN NN O
. NN NN O

There NN NN O
is NN NN O
a NN NN O
palpable NNP NNP B-DIAGNOSIS
testis NNP NNP I-DIAGNOSIS
is NN NN O
the NN NN O
left NN NN O
scrotum NN NN O
with NN NN O
non-palpable NNP NNP B-DIAGNOSIS
testis NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
right NN NN O
scrotum NN NN O
. NN NN O

The NN NN O
penis NN NN O
is NN NN O
normal NN NN O
in NN NN O
shape NN NN O
and NN NN O
size NN NN O
and NN NN O
he NNP NNP B-GENDER
is NN NN O
not NN NN O
circumcised NN NN O
. NN NN O

The NN NN O
diagnostic NN NN O
laparoscopy NN NN O
showed NN NN O
an NN NN O
abdominal NNP NNP B-DIAGNOSIS
undescended NNP NNP I-DIAGNOSIS
testis NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
patients NN NN O
is NN NN O
a NN NN O
25-year-old NNP NNP B-AGE
G1 NN NN O
P1 NN NN O
pregnant NNP NNP B-DIAGNOSIS
woman NNP NNP B-GENDER
who NN NN O
is NN NN O
24W3D NN NN O
gestational NN NN O
old NN NN O
who NN NN O
developed NN NN O
a NN NN O
sudden NN NN O
unset NN NN O
of NN NN O
fever NNP NNP B-DIAGNOSIS
and NN NN O
chills NNP NNP B-DIAGNOSIS
, NN NN O
accompany NN NN O
with NN NN O
nausea NNP NNP B-DIAGNOSIS
and NN NN O
vomiting NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
also NN NN O
complains NN NN O
of NN NN O
dysuria NNP NNP B-DIAGNOSIS
, NN NN O
urgency NN NN O
and NN NN O
frequency NN NN O
. NN NN O

She NNP NNP B-GENDER
also NN NN O
reports NN NN O
some NN NN O
severe NN NN O
pain NNP NNP B-DIAGNOSIS
in NN NN O
the NN NN O
flank NN NN O
. NN NN O

Her NN NN O
vital NN NN O
signs NN NN O
are NN NN O
: NN NN O
T NN NN O
= NN NN O
39.7C NN NN O
, NN NN O
P NN NN O
= NN NN O
117 NN NN O
, NN NN O
R NN NN O
= NN NN O
20 NN NN O
, NN NN O
and NN NN O
BP NN NN O
= NN NN O
113/74 NN NN O
mm NN NN O
Hg NN NN O
. NN NN O

Physical NN NN O
examination NN NN O
reveals NN NN O
tenderness NNP NNP B-DIAGNOSIS
on NN NN O
palpation NN NN O
of NN NN O
both NN NN O
costovertebral NN NN O
angles NN NN O
. NN NN O

She NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
recurrent NNP NNP I-NEGATIVE
UTI NNP NNP I-NEGATIVE
prior NNP NNP I-NEGATIVE
to NNP NNP I-NEGATIVE
her NNP NNP I-NEGATIVE
pregnancy NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
other NNP NNP I-NEGATIVE
underlying NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
. NN NN O

The NN NN O
urine NN NN O
culture NN NN O
showed NN NN O
Gram-negative NN NN O
rod-shaped NN NN O
bacterial NN NN O
cells NN NN O
, NN NN O
leukocytes NN NN O
, NN NN O
and NN NN O
leukocyte NN NN O
casts NN NN O
. NN NN O

The NN NN O
blood NN NN O
culture NN NN O
is NN NN O
negative NN NN O
. NN NN O

A NN NN O
CBC NN NN O
shows NN NN O
Hb NN NN O
12.9 NN NN O
g/dL NN NN O
, NN NN O
Hct NN NN O
39% NN NN O
, NN NN O
MCV NN NN O
76 NN NN O
fL NN NN O
, NN NN O
WBC NN NN O
count NN NN O
14,120/L NN NN O
. NN NN O

A NN NN O
34 NNP NNP B-AGE
year NNP NNP I-AGE
old NNP NNP I-AGE
man NNP NNP B-GENDER
comes NN NN O
to NN NN O
the NN NN O
clinic NN NN O
complaining NN NN O
of NN NN O
dizziness NNP NNP B-DIAGNOSIS
and NN NN O
severe NN NN O
diarrhea NNP NNP B-DIAGNOSIS
since NN NN O
yesterday NN NN O
. NN NN O

He NNP NNP B-GENDER
has NN NN O
returned NN NN O
from NN NN O
an NN NN O
international NN NN O
trip NN NN O
few NN NN O
days NN NN O
ago NN NN O
and NN NN O
was NN NN O
living NN NN O
in NN NN O
a NN NN O
camp NN NN O
in NN NN O
Sudan NN NN O
for NN NN O
a NN NN O
month NN NN O
. NN NN O

He NNP NNP B-GENDER
developed NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
followed NN NN O
by NN NN O
bloating NNP NNP B-DIAGNOSIS
and NN NN O
nausea NNP NNP B-DIAGNOSIS
as NN NN O
well NN NN O
as NN NN O
loose NN NN O
bowel NN NN O
movements NN NN O
. NN NN O

Soon NN NN O
he NNP NNP B-GENDER
was NN NN O
having NN NN O
profuse NN NN O
watery NN NN O
diarrhea NNP NNP B-DIAGNOSIS
without NN NN O
odor NN NN O
. NN NN O

The NN NN O
stool NN NN O
is NN NN O
watery NN NN O
and NN NN O
white NN NN O
but NN NN O
the NN NN O
patient NN NN O
has NN NN O
no NNP NNP B-NEGATIVE
fever NNP NNP B-NEGATIVE
. NN NN O

Blood NN NN O
pressure NN NN O
is NN NN O
95/62 NN NN O
lying NN NN O
down NN NN O
and NN NN O
drops NN NN O
to NN NN O
75/40 NN NN O
standing NN NN O
. NN NN O

The NN NN O
skin NN NN O
turgor NN NN O
has NN NN O
reduced NN NN O
. NN NN O

HR NN NN O
is NN NN O
110 NN NN O
and NN NN O
he NNP NNP B-GENDER
looks NN NN O
ill NN NN O
with NN NN O
dry NN NN O
mucosa NN NN O
. NN NN O

V NN NN O
. NN NN O
cholerae NN NN O
was NN NN O
seen NN NN O
in NN NN O
dark-field NN NN O
microscopy NN NN O
of NN NN O
a NN NN O
fresh NN NN O
stool NN NN O
specimen NN NN O
. NN NN O

The NN NN O
lab NN NN O
study NN NN O
is NN NN O
as NN NN O
bellow:Sodium NN NN O
137 NN NN O
meq/LPotassium NN NN O
2 NN NN O
meq/LChloride NN NN O
94meq/LCO2 NN NN O
15 NN NN O
meq/LFecal NN NN O
leukocytes NN NN O
None NN NN O
seenFecal NN NN O
occult NN NN O
blood NN NN O
Negative NN NN O

Patient NN NN O
is NN NN O
a NN NN O
34-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
from NN NN O
Jordan NN NN O
who NN NN O
comes NN NN O
to NN NN O
clinic NN NN O
with NN NN O
some NN NN O
general NN NN O
and NN NN O
non-specific NN NN O
bones NNP NNP B-DIAGNOSIS
and NNP NNP I-DIAGNOSIS
joints NNP NNP I-DIAGNOSIS
pain NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
is NN NN O
married NN NN O
and NN NN O
has NN NN O
3 NN NN O
children NN NN O
. NN NN O

Her NN NN O
past NN NN O
medical NN NN O
and NN NN O
drug NN NN O
history NN NN O
are NN NN O
unremarkable NN NN O
. NN NN O

Her NN NN O
BMI NN NN O
is NN NN O
23 NN NN O
, NN NN O
BP NN NN O
: NN NN O
120/75 NN NN O
, NN NN O
HR NN NN O
: NN NN O
75/min NN NN O
. NN NN O

Her NN NN O
laboratory NN NN O
study NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
Vit NN NN O
D NN NN O
: NN NN O
14ng/ml NN NN O
and NN NN O
otherwise NN NN O
healthy NN NN O
. NN NN O

( NN NN O
Ca NN NN O
: NN NN O
9.2mg/dl NN NN O
, NN NN O
Phosphorus NN NN O
: NN NN O
3.2mg/dl NN NN O
, NN NN O
PTH NN NN O
: NN NN O
28pg/ml NN NN O
) NN NN O

A NN NN O
57-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
was NN NN O
admitted NN NN O
to NN NN O
the NN NN O
clinic NN NN O
because NN NN O
of NN NN O
weight NNP NNP B-DIAGNOSIS
loss NNP NNP I-DIAGNOSIS
and NN NN O
persistent NN NN O
dry NNP NNP B-DIAGNOSIS
cough NNP NNP I-DIAGNOSIS
4 NN NN O
months NN NN O
ago NN NN O
. NN NN O

Chest NN NN O
computed NN NN O
topography NN NN O
showed NN NN O
bilateral NN NN O
multiple NN NN O
infiltrates NNP NNP B-DIAGNOSIS
in NN NN O
the NN NN O
upper NN NN O
lobes NN NN O
and NN NN O
thickened NNP NNP B-DIAGNOSIS
bronchial NNP NNP I-DIAGNOSIS
walls NNP NNP I-DIAGNOSIS
. NN NN O

There NN NN O
is NN NN O
a NN NN O
documented NN NN O
positive NN NN O
serum NN NN O
MPO-ANCA NN NN O
in NN NN O
his NN NN O
medical NN NN O
record NN NN O
. NN NN O

Transbronchial NN NN O
biopsy NN NN O
revealed NN NN O
necrotic NNP NNP B-DIAGNOSIS
granulomas NNP NNP I-DIAGNOSIS
with NN NN O
multinucleated NN NN O
giant NN NN O
cells NN NN O
and NN NN O
the NN NN O
Wegener's NNP NNP B-DIAGNOSIS
granulomatosis NNP NNP I-DIAGNOSIS
was NN NN O
diagnosed NN NN O
for NN NN O
him NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
treating NN NN O
with NN NN O
corticosteroid NN NN O
and NN NN O
cyclophosphamides NN NN O
since NN NN O
4 NN NN O
months NN NN O
ago NN NN O
. NN NN O

His NN NN O
Birmingham NN NN O
Vasculitis NN NN O
Activity NN NN O
Score NN NN O
( NN NN O
BVAS NN NN O
) NN NN O
is NN NN O
above NN NN O
4 NN NN O
since NN NN O
the NN NN O
beginning NN NN O
of NN NN O
his NN NN O
disease NN NN O
. NN NN O

His NN NN O
last NN NN O
physical NN NN O
exam NN NN O
and NN NN O
lab NN NN O
study NN NN O
was NN NN O
performed NN NN O
yesterday NN NN O
and NN NN O
showed NN NN O
the NN NN O
results NN NN O
bellow:A NN NN O
wellbeing NNP NNP B-DIAGNOSIS
, NN NN O
well-nourished NNP NNP B-DIAGNOSIS
man NNP NNP B-GENDER
, NN NN O
non-icteric NNP NNP B-DIAGNOSIS
, NN NN O
cooperative NN NN O
and NN NN O
alertWeight NN NN O
: NN NN O
73 NN NN O
kgHeight NN NN O
: NN NN O
177BP NN NN O
: NN NN O
120/80HR NN NN O
: NN NN O
90/minRR NN NN O
: NN NN O
22/minHgb NN NN O
: NN NN O
13 NN NN O
g/dlWBC NN NN O
: NN NN O
8000 NN NN O
/mm3 NN NN O
( NN NN O
Neutrophil NN NN O
: NN NN O
2700/mm3)Plt NN NN O
: NN NN O
300000 NN NN O
/mlAST NN NN O
: NN NN O
40 NN NN O
U/LALT NN NN O
: NN NN O
56 NN NN O
U/LAlk NN NN O
P NN NN O
: NN NN O
147 NN NN O
U/LBill NN NN O
total NN NN O
: NN NN O
1.2 NN NN O
mg/dlESR NN NN O
: NN NN O
120 NN NN O
mm/hrMPO-ANCA NN NN O
: NN NN O
153 NN NN O
EU NN NN O

A NN NN O
22-year-old NNP NNP B-AGE
Caucasian NN NN O
man NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
Clinic NN NN O
with NN NN O
a NN NN O
history NN NN O
of NN NN O
tremors NNP NNP B-DIAGNOSIS
since NN NN O
a NN NN O
year NN NN O
ago NN NN O
. NN NN O

The NN NN O
tremor NNP NNP B-DIAGNOSIS
was NN NN O
first NN NN O
in NN NN O
his NN NN O
right NN NN O
hand NN NN O
while NN NN O
holding NN NN O
something NN NN O
. NN NN O

Later NN NN O
the NN NN O
tremor NNP NNP B-DIAGNOSIS
became NN NN O
continuous NN NN O
and NN NN O
extended NN NN O
to NN NN O
both NN NN O
hands NN NN O
and NN NN O
legs NN NN O
and NN NN O
even NN NN O
at NN NN O
rest NN NN O
. NN NN O

The NN NN O
Kayser-Fleischer NNP NNP B-DIAGNOSIS
' NNP NNP I-DIAGNOSIS
ring NNP NNP I-DIAGNOSIS
was NN NN O
detected NN NN O
in NN NN O
the NN NN O
ophthalmologic NN NN O
exam NN NN O
. NN NN O

The NN NN O
physical NN NN O
exam NN NN O
revealed NN NN O
jaundice NNP NNP B-DIAGNOSIS
, NN NN O
hepatosplenomegaly NNP NNP B-DIAGNOSIS
and NN NN O
hypotonia NNP NNP B-DIAGNOSIS
of NN NN O
the NN NN O
upper NN NN O
limbs NN NN O
. NN NN O

He NNP NNP B-GENDER
had NN NN O
a NN NN O
constant NN NN O
smile NN NN O
on NN NN O
his NN NN O
face NN NN O
, NN NN O
however NN NN O
, NN NN O
he NNP NNP B-GENDER
has NN NN O
aggressive NNP NNP B-DIAGNOSIS
behavior NNP NNP I-DIAGNOSIS
according NN NN O
to NN NN O
his NN NN O
parents NN NN O
' NN NN O
explanation NN NN O
. NN NN O

His NN NN O
laboratory NN NN O
study NN NN O
was NN NN O
significant NN NN O
for NN NN O
a NN NN O
low NN NN O
serum NN NN O
caeruloplasmin NN NN O
( NN NN O
0.05 NN NN O
g/l NN NN O
), NN NN O
and NN NN O
a NN NN O
raised NN NN O
24 NN NN O
hour NN NN O
urine NN NN O
copper NN NN O
excretion NN NN O
( NN NN O
120 NN NN O
g/24 NN NN O
h NN NN O
). NN NN O

Wilson NNP NNP B-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
was NN NN O
confirmed NN NN O
by NN NN O
high NN NN O
liver NN NN O
copper NN NN O
concentration NN NN O
( NN NN O
305 NN NN O
g/g NN NN O
dry NN NN O
weight NN NN O
of NN NN O
liver NN NN O
). NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
41-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
and NN NN O
a NN NN O
known NN NN O
case NN NN O
of NN NN O
Acromegaly NNP NNP B-DIAGNOSIS
who NN NN O
underwent NN NN O
transsphenoidal NN NN O
surgery NN NN O
4 NN NN O
months NN NN O
ago NN NN O
. NN NN O

He NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
for NN NN O
the NN NN O
follow NN NN O
up NN NN O
lab NN NN O
studies NN NN O
after NN NN O
his NN NN O
primary NN NN O
resection NN NN O
surgery NN NN O
. NN NN O

His NN NN O
lab NN NN O
study NN NN O
shows NN NN O
the NN NN O
IGF-1 NN NN O
level NN NN O
of NN NN O
4.5 NN NN O
ULN NN NN O
adjusted NN NN O
by NN NN O
sex NN NN O
and NN NN O
age NN NN O
. NN NN O

His NN NN O
random NN NN O
GH NN NN O
level NN NN O
is NN NN O
4 NN NN O
ug/L NN NN O
. NN NN O

The NN NN O
recent NN NN O
brain NN NN O
MRI NN NN O
confirmed NN NN O
the NN NN O
residual NNP NNP B-DIAGNOSIS
pituitary NNP NNP I-DIAGNOSIS
tumor NNP NNP I-DIAGNOSIS
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
only NN NN O
significant NN NN O
for NN NN O
acromegaly NNP NNP B-DIAGNOSIS
due NN NN O
to NN NN O
pituitary NNP NNP B-DIAGNOSIS
adenoma NNP NNP I-DIAGNOSIS
and NN NN O
the NN NN O
recent NN NN O
surgery NN NN O
. NN NN O

After NN NN O
his NN NN O
surgery NN NN O
he NNP NNP B-GENDER
takes NN NN O
only NN NN O
vitamin NN NN O
D NN NN O
and NN NN O
multivitamins NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
41-year-old NNP NNP B-AGE
obese NNP NNP B-DIAGNOSIS
woman NNP NNP B-GENDER
coming NN NN O
to NN NN O
the NN NN O
emergency NN NN O
room NN NN O
with NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
and NN NN O
vomiting NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
that NN NN O
started NN NN O
gradually NN NN O
yesterday NN NN O
is NN NN O
located NN NN O
in NN NN O
the NN NN O
epigastric NN NN O
and NN NN O
periumbilical NN NN O
regions NN NN O
, NN NN O
radiating NN NN O
to NN NN O
her NN NN O
back NN NN O
. NN NN O

She NNP NNP B-GENDER
drinks NN NN O
alcohol NN NN O
frequently NN NN O
and NN NN O
does NN NN O
not NN NN O
smoke NN NN O
. NN NN O

She NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
history NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
allergies NNP NNP I-NEGATIVE
and NN NN O
uses NN NN O
only NN NN O
multivitamins NN NN O
daily NN NN O
. NN NN O

Her NN NN O
family NN NN O
history NN NN O
is NN NN O
positive NN NN O
for NN NN O
hypertension NNP NNP B-DIAGNOSIS
( NN NN O
her NN NN O
mother NN NN O
). NN NN O

She NNP NNP B-GENDER
lives NN NN O
with NN NN O
her NN NN O
husband NN NN O
and NN NN O
has NN NN O
3 NN NN O
children NN NN O
. NN NN O

The NN NN O
abdomen NN NN O
is NN NN O
tender NN NN O
and NN NN O
soft NN NN O
. NN NN O

Her NN NN O
bowel NN NN O
sounds NN NN O
are NN NN O
normal NN NN O
. NN NN O

Her NN NN O
heart NN NN O
rate NN NN O
is NN NN O
115/min NN NN O
and NN NN O
blood NN NN O
pressure NN NN O
110/75 NN NN O
mmHg NN NN O
. NN NN O

The NN NN O
lab NN NN O
studies NN NN O
are NN NN O
remarkable NN NN O
for NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
( NN NN O
19.5 NN NN O
), NN NN O
urea NN NN O
of NN NN O
8.5 NN NN O
, NN NN O
high NN NN O
CRP NN NN O
( NN NN O
145 NN NN O
), NN NN O
high NN NN O
amylase NN NN O
( NN NN O
1200 NN NN O
) NN NN O
and NN NN O
Glucose NN NN O
level NN NN O
of NN NN O

15 NN NN O
. NN NN O
Her NN NN O
abdominal NN NN O
CT NN NN O
scan NN NN O
revealed NN NN O
acute NN NN O
edematous NNP NNP B-DIAGNOSIS
interstitial NNP NNP I-DIAGNOSIS
pancreatitis NNP NNP I-DIAGNOSIS
with NN NN O
enlarged NN NN O
common NN NN O
bile NN NN O
duct NN NN O
and NN NN O
intrahepatic NN NN O
duct NN NN O
confirming NN NN O
gall NNP NNP B-DIAGNOSIS
stone NNP NNP I-DIAGNOSIS
pancreatitis NNP NNP I-DIAGNOSIS
. NN NN O

Her NN NN O
pregnancy NN NN O
test NN NN O
is NN NN O
negative NN NN O
and NN NN O
she NNP NNP B-GENDER
is NN NN O
not NN NN O
breastfeeding NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
17-year-old NNP NNP B-AGE
boy NNP NNP B-GENDER
complaining NN NN O
of NN NN O
severe NN NN O
migratory NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
right NN NN O
lower NN NN O
quadrant NN NN O
of NN NN O
his NN NN O
abdomen NN NN O
that NN NN O
started NN NN O
four NN NN O
days NN NN O
ago NN NN O
. NN NN O

The NN NN O
pain NNP NNP B-DIAGNOSIS
is NN NN O
accompanied NN NN O
by NN NN O
nausea NNP NNP B-DIAGNOSIS
and NN NN O
vomiting NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
was NN NN O
febrile NNP NNP B-DIAGNOSIS
with NN NN O
tenderness NNP NNP B-DIAGNOSIS
, NN NN O
rebound NN NN O
tenderness NNP NNP B-DIAGNOSIS
and NN NN O
guarding NN NN O
on NN NN O
palpation NN NN O
. NN NN O

His NN NN O
WBC NN NN O
was NN NN O
elevated NN NN O
with NN NN O
dominant NN NN O
neutrophils NNP NNP B-DIAGNOSIS
. NN NN O

CT NN NN O
scan NN NN O
showed NN NN O
evidence NN NN O
of NN NN O
acute NN NN O
perforated NN NN O
appendicitis NNP NNP B-DIAGNOSIS
with NN NN O
free NN NN O
fluid NN NN O
in NN NN O
the NN NN O
pelvis NN NN O
. NN NN O

Diagnostic NN NN O
laparoscopy NN NN O
revealed NN NN O
phlegmon NNP NNP B-DIAGNOSIS
with NN NN O
no NNP NNP B-NEGATIVE
other NNP NNP I-NEGATIVE
abdominal NNP NNP I-NEGATIVE
abnormalities NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
is NN NN O
now NN NN O
a NN NN O
candidate NN NN O
for NN NN O
emergent NN NN O
laparoscopic NN NN O
appendectomy NN NN O
under NN NN O
general NN NN O
anesthesia NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
15-year-old NNP NNP B-AGE
boy NNP NNP B-GENDER
with NN NN O
asthma NNP NNP B-DIAGNOSIS
diagnosed NN NN O
a NN NN O
year NN NN O
ago NN NN O
. NN NN O

He NNP NNP B-GENDER
presents NN NN O
with NN NN O
shortness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
breath NNP NNP I-DIAGNOSIS
, NN NN O
chest NNP NNP B-DIAGNOSIS
tightening NNP NNP I-DIAGNOSIS
and NN NN O
cough NNP NNP B-DIAGNOSIS
. NN NN O

According NN NN O
to NN NN O
his NN NN O
mother NN NN O
, NN NN O
he NNP NNP B-GENDER
didn't NN NN O
respond NN NN O
to NN NN O
the NN NN O
usual NN NN O
corticosteroid NN NN O
inhaler NN NN O
. NN NN O

He NNP NNP B-GENDER
was NN NN O
admitted NN NN O
to NN NN O
the NN NN O
emergency NN NN O
department NN NN O
with NN NN O
diagnosis NN NN O
of NN NN O
severe NN NN O
asthma NNP NNP B-DIAGNOSIS
exacerbation NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
is NN NN O
a NN NN O
candidate NN NN O
for NN NN O
general NN NN O
corticosteroid NN NN O
therapy NN NN O
. NN NN O

Spirometry NN NN O
revealed NN NN O
a NN NN O
forced NN NN O
expiratory NN NN O
volume NN NN O
in NN NN O
the NN NN O
first NN NN O
second NN NN O
( NN NN O
FEV1 NN NN O
) NN NN O
of NN NN O
60% NN NN O
of NN NN O
the NN NN O
predicted NN NN O
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
non-significant NN NN O
. NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
significant NN NN O
for NN NN O
asthma NNP NNP B-DIAGNOSIS
in NN NN O
his NN NN O
mother NN NN O
and NN NN O
his NN NN O
uncle NN NN O
. NN NN O

He NNP NNP B-GENDER
used NN NN O
to NN NN O
be NN NN O
treated NN NN O
with NN NN O
combination NN NN O
of NN NN O
inhaled NN NN O
corticosteroids NN NN O
and NN NN O
Zafirlukast NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
63-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
presenting NN NN O
to NN NN O
the NN NN O
Emergency NN NN O
Department NN NN O
with NN NN O
a NN NN O
history NN NN O
of NN NN O
acute NN NN O
urinary NNP NNP B-DIAGNOSIS
retention NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
past NN NN O
2 NN NN O
days NN NN O
. NN NN O

Abdominopelvic NN NN O
CT NN NN O
scan NN NN O
revealed NN NN O
a NN NN O
large NNP NNP B-DIAGNOSIS
prostate NNP NNP I-DIAGNOSIS
and NN NN O
a NN NN O
bladder NN NN O
filled NN NN O
with NN NN O
urine NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
a NN NN O
candidate NN NN O
for NN NN O
urethral NN NN O
catheterization NN NN O
and NN NN O
TURP NN NN O
. NN NN O

Further NN NN O
evaluation NN NN O
revealed:Post-void NN NN O
residual NN NN O
: NN NN O
71 NN NN O
mLProstate NN NN O
volume NN NN O
( NN NN O
TRUS NN NN O
): NN NN O
63 NN NN O
mLProstate-specific NN NN O
antigen NN NN O
( NN NN O
PSA NN NN O
) NN NN O
level NN NN O
: NN NN O
3.5 NN NN O
ng/mLHis NN NN O
recent NN NN O
blood NN NN O
chemistry NN NN O
( NN NN O
3 NN NN O
days NN NN O
ago NN NN O
) NN NN O
was NN NN O
normal NN NN O
: NN NN O
Hgb NN NN O
: NN NN O
13.6 NN NN O
g/dlWBC NN NN O
: NN NN O
133000 NN NN O
/mm3Plt NN NN O
: NN NN O
370000 NN NN O
/mlPT NN NN O
: NN NN O
12 NN NN O
secondPTT NN NN O
: NN NN O
34 NN NN O
secondINR NN NN O
: NN NN O
0.9Creatinine NN NN O
: NN NN O
0.5 NN NN O
mg/dlBUN NN NN O
: NN NN O
10 NN NN O
mg/dlU/A:Color NN NN O
: NN NN O
yellowAppearance NN NN O
: NN NN O
cloudyPH NN NN O
: NN NN O
5.3Specific NN NN O
gravity NN NN O
: NN NN O
1.010Glc NN NN O
: NN NN O
100Nitrite NN NN O
: NN NN O
negativeKetone NN NN O
: NN NN O
noneLeukocyte NN NN O
esterase NN NN O
: NN NN O
negativeRBC NN NN O
: NN NN O
negativeWBC NN NN O
: NN NN O
2 NN NN O
WBCs/hpfU/C NN NN O
: NN NN O
negative NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
45-year-old NNP NNP B-AGE
postmenopausal NN NN O
woman NNP NNP B-GENDER
with NN NN O
cytologically NN NN O
confirmed NN NN O
breast NNP NNP B-DIAGNOSIS
cancer NNP NNP I-DIAGNOSIS
. NN NN O

A NN NN O
core NN NN O
biopsy NN NN O
revealed NN NN O
a NN NN O
3 NN NN O
cm NN NN O
invasive NN NN O
ductal NN NN O
breast NNP NNP B-DIAGNOSIS
carcinoma NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
left NN NN O
upper NN NN O
outer NN NN O
quadrant NN NN O
. NN NN O

The NN NN O
tumor NNP NNP B-DIAGNOSIS
is NN NN O
HER2-positive NN NN O
and NN NN O
ER/PR NN NN O
negative NN NN O
. NN NN O

Axillary NN NN O
sampling NN NN O
revealed NN NN O
5 NN NN O
positive NN NN O
lymph NN NN O
nodes NN NN O
. NN NN O

CXR NN NN O
was NN NN O
remarkable NN NN O
for NN NN O
metastatic NNP NNP B-DIAGNOSIS
lesions NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
using NN NN O
multivitamins NN NN O
and NN NN O
iron NN NN O
supplements NN NN O
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
smoke NN NN O
or NN NN O
consume NN NN O
alcohol NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
not NN NN O
sexually NN NN O
active NN NN O
and NN NN O
has NN NN O
no NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
a NN NN O
candidate NN NN O
for NN NN O
tumor NNP NNP B-DIAGNOSIS
resection NN NN O
and NN NN O
agrees NN NN O
to NN NN O
do NN NN O
so NN NN O
prior NN NN O
to NN NN O
chemotherapy NN NN O
. NN NN O

A NN NN O
46-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
presents NN NN O
with NN NN O
dizziness NNP NNP B-DIAGNOSIS
and NN NN O
frequent NN NN O
headaches NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
has NN NN O
a NN NN O
family NN NN O
history NN NN O
of NN NN O
CAD NNP NNP B-DIAGNOSIS
, NN NN O
but NN NN O
no NNP NNP B-NEGATIVE
other NNP NNP I-NEGATIVE
cardiovascular NNP NNP I-NEGATIVE
risk NNP NNP I-NEGATIVE
factors NNP NNP I-NEGATIVE
such NNP NNP I-NEGATIVE
as NNP NNP I-NEGATIVE
smoking NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
high NNP NNP I-NEGATIVE
blood NNP NNP I-NEGATIVE
pressure NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
and NNP NNP I-NEGATIVE
diabetes NNP NNP I-NEGATIVE
mellitus NNP NNP I-NEGATIVE
and NN NN O
is NN NN O
physically NN NN O
active NN NN O
. NN NN O

The NN NN O
patient's NN NN O
LDL-C NN NN O
and NN NN O
HDL-C NN NN O
levels NN NN O
were NN NN O
545 NN NN O
and NN NN O
53mg/dL NN NN O
, NN NN O
respectively NN NN O
. NN NN O

His NN NN O
fasting NN NN O
glucose NN NN O
and NN NN O
triglyceride NN NN O
levels NN NN O
( NN NN O
85 NN NN O
and NN NN O
158mg/dL NN NN O
, NN NN O
resp NN NN O
. NN NN O

) NN NN O
were NN NN O
within NN NN O
normal NN NN O
limits.The NN NN O
patient NN NN O
reported NN NN O
no NNP NNP B-NEGATIVE
use NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
lipid-lowering NNP NNP I-NEGATIVE
medications NNP NNP I-NEGATIVE
. NN NN O
Neck NN NN O
auscultation NN NN O
revealed NN NN O
a NN NN O
systolic NNP NNP B-DIAGNOSIS
murmur NNP NNP I-DIAGNOSIS
3+/6+ NN NN O
in NN NN O
the NN NN O
neck NN NN O
, NN NN O
radiating NN NN O
to NN NN O
the NN NN O
skull NN NN O
. NN NN O

Ultrasonography NN NN O
of NN NN O
the NN NN O
carotid NN NN O
arteries NN NN O
, NN NN O
revealed NN NN O
severe NNP NNP B-DIAGNOSIS
stenosis NNP NNP I-DIAGNOSIS
in NN NN O
the NN NN O
left NN NN O
internal NN NN O
carotid NN NN O
artery NN NN O
( NN NN O
LICA NN NN O
), NN NN O
as NN NN O
well NN NN O
as NN NN O
moderate NN NN O
stenosis NNP NNP B-DIAGNOSIS
in NN NN O
the NN NN O
right NN NN O
internal NN NN O
carotid NN NN O
artery NN NN O
( NN NN O
RICA NN NN O
) NN NN O
estimated NN NN O
between NN NN O
40% NN NN O
and NN NN O
50% NN NN O
. NN NN O

For NN NN O
the NN NN O
LICA NN NN O
, NN NN O
the NN NN O
peak-systolic NN NN O
( NN NN O
PSV NN NN O
) NN NN O
and NN NN O
end-diastolic NN NN O
velocity NN NN O
( NN NN O
EDV NN NN O
) NN NN O
cutoff NN NN O
values NN NN O
were NN NN O
208.5cm/s NN NN O
and NN NN O
54.5cm/s NN NN O
, NN NN O
respectively NN NN O
; NN NN O

RICA NN NN O
PSV NN NN O
was NN NN O
91.72cm/s NN NN O
and NN NN O
RICA NN NN O
EDV NN NN O
was NN NN O
37.37cm/s NN NN O
. NN NN O

Plaque NNP NNP B-DIAGNOSIS
was NN NN O
observed NN NN O
in NN NN O
the NN NN O
anterior NN NN O
and NN NN O
posterior NN NN O
walls NN NN O
of NN NN O
the NN NN O
internal NN NN O
carotid NN NN O
artery NN NN O
and NN NN O
common NN NN O
carotid NN NN O
artery NN NN O
, NN NN O
which NN NN O
were NN NN O
characterized NN NN O
as NN NN O
bulky NN NN O
plates NN NN O
extending NN NN O
to NN NN O
the NN NN O
middle NN NN O
third NN NN O
of NN NN O
the NN NN O
internal NN NN O
coronary NN NN O
arteries NN NN O
( NN NN O
ICAs NN NN O
) NN NN O
and NN NN O
as NN NN O
predominantly NN NN O
echogenic NN NN O
and NN NN O
hyperechoic NN NN O
, NN NN O
with NN NN O
less NN NN O
than NN NN O
50% NN NN O
of NN NN O
the NN NN O
area NN NN O
being NN NN O
echolucent NN NN O
with NN NN O
uneven NN NN O
surfaces NN NN O
. NN NN O

A NN NN O
54-year-old NNP NNP B-AGE
obese NNP NNP B-DIAGNOSIS
woman NNP NNP B-GENDER
admitted NN NN O
to NN NN O
the NN NN O
emergency NN NN O
department NN NN O
with NN NN O
abdominal NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
that NN NN O
started NN NN O
4 NN NN O
days NN NN O
ago NN NN O
with NN NN O
nausea NNP NNP B-DIAGNOSIS
and NN NN O
vomiting NNP NNP B-DIAGNOSIS
. NN NN O

The NN NN O
epigastric NNP NNP B-DIAGNOSIS
pain NNP NNP I-DIAGNOSIS
radiates NN NN O
to NN NN O
the NN NN O
right NN NN O
upper NN NN O
quadrant NN NN O
, NN NN O
getting NN NN O
worse NN NN O
after NN NN O
eating NN NN O
fatty NN NN O
food NN NN O
. NN NN O

The NN NN O
patient NN NN O
experienced NN NN O
similar NN NN O
pain NNP NNP B-DIAGNOSIS
twice NN NN O
in NN NN O
the NN NN O
past NN NN O
year NN NN O
. NN NN O

Her NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
hypercholesterolemia NNP NNP B-DIAGNOSIS
and NN NN O
2 NN NN O
NVDs NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
has NN NN O
2 NN NN O
children NN NN O
, NN NN O
and NN NN O
she NNP NNP B-GENDER
is NN NN O
menopausal NNP NNP B-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
smoke NN NN O
, NN NN O
drink NN NN O
alcohol NN NN O
, NN NN O
or NN NN O
use NN NN O
illicit NN NN O
drugs NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
mildly NN NN O
febrile NNP NNP B-DIAGNOSIS
. NN NN O

Her NN NN O
BP NN NN O
is NN NN O
150/85 NN NN O
, NN NN O
HR NN NN O
115 NN NN O
, NN NN O
RR NN NN O
15 NN NN O
, NN NN O
T NN NN O
38.2 NN NN O
, NN NN O
SpO2 NN NN O
98% NN NN O
on NN NN O
RA NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
an NN NN O
obese NNP NNP B-DIAGNOSIS
woman NNP NNP B-GENDER
with NN NN O
no NNP NNP B-NEGATIVE
acute NNP NNP I-NEGATIVE
distress NNP NNP I-NEGATIVE
. NN NN O

On NN NN O
palpation NN NN O
, NN NN O
she NNP NNP B-GENDER
experiences NN NN O
epigastric NNP NNP B-DIAGNOSIS
tenderness NNP NNP I-DIAGNOSIS
and NN NN O
tenderness NNP NNP B-DIAGNOSIS
in NN NN O
the NN NN O
right NN NN O
upper NN NN O
quadrant NN NN O
without NN NN O
rebound NN NN O
. NN NN O

Bowel NN NN O
sounds NN NN O
are NN NN O
normal NN NN O
. NN NN O

Laboratory NN NN O
analysis NN NN O
is NN NN O
remarkable NN NN O
for NN NN O
elevated NNP NNP B-DIAGNOSIS
ESR NNP NNP B-DIAGNOSIS
and NN NN O
leukocytosis NNP NNP B-DIAGNOSIS
with NN NN O
a NN NN O
left NN NN O
shift NN NN O
. NN NN O

The NN NN O
ultrasound NN NN O
revealed NN NN O
several NN NN O
gallstones NNP NNP B-DIAGNOSIS
, NN NN O
biliary NNP NNP B-DIAGNOSIS
sludge NNP NNP I-DIAGNOSIS
and NN NN O
CBD NNP NNP B-DIAGNOSIS
stones NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
smallest NN NN O
stone NN NN O
is NN NN O
14mm NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
55-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
diagnosed NN NN O
with NN NN O
HCV NNP NNP B-DIAGNOSIS
2 NN NN O
years NN NN O
ago NN NN O
and NN NN O
the NN NN O
recent NN NN O
coinfection NNP NNP B-DIAGNOSIS
with NNP NNP I-DIAGNOSIS
HBV NNP NNP I-DIAGNOSIS
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
non-significant NN NN O
. NN NN O

He NNP NNP B-GENDER
is NN NN O
on NN NN O
IFN NN NN O
, NN NN O
RBV NN NN O
and NN NN O
direct NN NN O
antiviral NN NN O
drugs NN NN O
for NN NN O
the NN NN O
past NN NN O
6 NN NN O
months NN NN O
. NN NN O

The NN NN O
patient NN NN O
takes NN NN O
no NN NN O
other NN NN O
medications NN NN O
. NN NN O

His NN NN O
medical NN NN O
records NN NN O
show NN NN O
previous NN NN O
positive NN NN O
HCV NNP NNP B-DIAGNOSIS
RNA NN NN O
tests NN NN O
and NN NN O
a NN NN O
positive NNP NNP B-DIAGNOSIS
enzyme NNP NNP I-DIAGNOSIS
immunoassay NNP NNP I-DIAGNOSIS
for NNP NNP I-DIAGNOSIS
anti NNP NNP I-DIAGNOSIS
- NNP NNP I-DIAGNOSIS
HCV NNP NNP I-DIAGNOSIS
- NNP NNP I-DIAGNOSIS
antibodies NNP NNP I-DIAGNOSIS
. NN NN O

The NN NN O
recent NN NN O
biopsy NN NN O
was NN NN O
negative NNP NNP B-NEGATIVE
for NNP NNP I-NEGATIVE
hepatocellular NNP NNP I-NEGATIVE
carcinoma NNP NNP I-NEGATIVE
and NN NN O
was NN NN O
only NN NN O
remarkable NN NN O
for NN NN O
chronic NN NN O
inflammation NNP NNP B-DIAGNOSIS
compatible NN NN O
with NN NN O
a NN NN O
chronic NN NN O
viral NNP NNP B-DIAGNOSIS
hepatitis NNP NNP I-DIAGNOSIS
. NN NN O

There NN NN O
is NN NN O
no NNP NNP B-NEGATIVE
evidence NNP NNP I-NEGATIVE
of NNP NNP I-NEGATIVE
alcoholic NNP NNP I-NEGATIVE
liver NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
bleeding NNP NNP I-NEGATIVE
from NNP NNP I-NEGATIVE
esophageal NNP NNP I-NEGATIVE
varices NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
hemochromatosis NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
autoimmune NNP NNP I-NEGATIVE
hepatitis NNP NNP I-NEGATIVE
, NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
metabolic NNP NNP I-NEGATIVE
liver NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
. NN NN O

He NNP NNP B-GENDER
is NN NN O
an NN NN O
alert NN NN O
male NNP NNP B-GENDER
with NN NN O
no NNP NNP B-NEGATIVE
acute NNP NNP I-NEGATIVE
distress NNP NNP I-NEGATIVE
. NN NN O

His NN NN O
BP NN NN O
: NN NN O
130/75 NN NN O
, NN NN O
HR NN NN O
: NN NN O
90/min NN NN O
and NN NN O
BMI NN NN O
: NN NN O

27 NN NN O
. NN NN O
His NN NN O
abdomen NN NN O
is NN NN O
soft NN NN O
with NN NN O
no NNP NNP B-NEGATIVE
ascites NNP NNP I-NEGATIVE
or NNP NNP I-NEGATIVE
tenderness NNP NNP I-NEGATIVE
. NN NN O

The NN NN O
lower NN NN O
extremities NN NN O
are NN NN O
normal NN NN O
with NN NN O
no NNP NNP B-NEGATIVE
edema NNP NNP I-NEGATIVE
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
25-year-old NNP NNP B-GENDER
man NNP NNP B-GENDER
with NN NN O
type NNP NNP B-DIAGNOSIS
1 NNP NNP I-DIAGNOSIS
diabetes NNP NNP I-DIAGNOSIS
confirmed NN NN O
with NN NN O
molecular NN NN O
analysis NN NN O
7 NN NN O
years NN NN O
ago NN NN O
. NN NN O

He NNP NNP B-GENDER
presents NN NN O
to NN NN O
the NN NN O
clinic NN NN O
with NN NN O
shortness NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
breath NNP NNP I-DIAGNOSIS
and NN NN O
fatigue NNP NNP B-DIAGNOSIS
during NN NN O
activities NN NN O
. NN NN O

He NNP NNP B-GENDER
claims NN NN O
mild NN NN O
dyspnea NNP NNP B-DIAGNOSIS
after NN NN O
climbing NN NN O
3 NN NN O
floors NN NN O
, NN NN O
no NNP NNP B-NEGATIVE
dyspnea NNP NNP I-NEGATIVE
at NN NN O
rest NN NN O
and NN NN O
no NNP NNP B-NEGATIVE
angina NNP NNP B-NEGATIVE
( NN NN O
New NN NN O
York NN NN O
Heart NN NN O
Association NN NN O
class NN NN O
2 NN NN O
). NN NN O

He NNP NNP B-GENDER
is NN NN O
diagnosed NN NN O
with NN NN O
cardiomyopathy NNP NNP B-DIAGNOSIS
that NN NN O
will NN NN O
be NN NN O
treated NN NN O
with NN NN O
ACE NN NN O
inhibitors NN NN O
and NN NN O
Beta NN NN O
blockers NN NN O
. NN NN O

His NN NN O
takes NN NN O
70/30 NN NN O
Insulin NN NN O
and NN NN O
vitamin NN NN O
D NN NN O
supplements NN NN O
. NN NN O

His NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
not NN NN O
significant NN NN O
for NN NN O
any NN NN O
other NN NN O
medical NN NN O
issues NN NN O
. NN NN O

His NN NN O
family NN NN O
history NN NN O
is NN NN O
positive NN NN O
for NN NN O
DM NNP NNP B-DIAGNOSIS
type NNP NNP I-DIAGNOSIS
1 NNP NNP I-DIAGNOSIS
in NN NN O
his NN NN O
uncle NN NN O
and NN NN O
his NN NN O
grandfather NN NN O
. NN NN O

His NN NN O
lab NN NN O
study NN NN O
is NN NN O
as NN NN O
bellow:FBS NN NN O
: NN NN O
100 NN NN O
mg/dlHbA1c NN NN O
: NN NN O
6.5%Cholesterol NN NN O
: NN NN O
190 NN NN O
mg/dlTG NN NN O
: NN NN O
140 NN NN O
mg/dlLDL NN NN O
: NN NN O
125 NN NN O
mg/dlHDL NN NN O
: NN NN O
40 NN NN O
mg/dl NN NN O

A NN NN O
16-year-old NNP NNP B-AGE
girl NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
complaining NN NN O
of NN NN O
weight NNP NNP B-DIAGNOSIS
gain NNP NNP I-DIAGNOSIS
and NN NN O
abnormal NNP NNP B-DIAGNOSIS
menstrual NNP NNP I-DIAGNOSIS
cycles NNP NNP I-DIAGNOSIS
. NN NN O

Her NN NN O
BMI NN NN O
was NN NN O
24 NN NN O
, NN NN O
but NN NN O
she NNP NNP B-GENDER
has NN NN O
gained NN NN O
5 NN NN O
kg NN NN O
in NN NN O
the NN NN O
past NN NN O
few NN NN O
weeks NN NN O
. NN NN O

She NNP NNP B-GENDER
gets NN NN O
tired NN NN O
more NN NN O
frequently NN NN O
and NN NN O
does NN NN O
not NN NN O
have NN NN O
energy NN NN O
to NN NN O
go NN NN O
dancing NN NN O
with NN NN O
her NN NN O
friends NN NN O
. NN NN O

Her NN NN O
lab NN NN O
results NN NN O
were NN NN O
remarkable NN NN O
for NN NN O
high NNP NNP B-DIAGNOSIS
TSH NNP NNP I-DIAGNOSIS
levels NNP NNP I-DIAGNOSIS
( NN NN O
15 NN NN O
mU/L NN NN O
) NN NN O
and NN NN O
low NNP NNP B-DIAGNOSIS
free NNP NNP I-DIAGNOSIS
T4 NNP NNP I-DIAGNOSIS
levels NNP NNP I-DIAGNOSIS
( NN NN O
0.18 NN NN O
ng/dl NN NN O
). NN NN O

Her NN NN O
anti-TPO NN NN O
levels NN NN O
were NN NN O
extremely NN NN O
high NN NN O
( NN NN O
136 NN NN O
IU/ml NN NN O
). NN NN O

She NNP NNP B-GENDER
was NN NN O
diagnosed NN NN O
with NN NN O
Hashimoto NNP NNP B-DIAGNOSIS
disease NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
smoke NN NN O
and NN NN O
she NNP NNP B-GENDER
is NN NN O
not NN NN O
sexually NN NN O
active NN NN O
. NN NN O

A NN NN O
Pap NN NN O
smear NN NN O
in NN NN O
a NN NN O
54-year-old NNP NNP B-AGE
woman NNP NNP B-GENDER
revealed NN NN O
abnormal NNP NNP B-DIAGNOSIS
cervical NNP NNP I-DIAGNOSIS
squamous NNP NNP I-DIAGNOSIS
intraepithelial NNP NNP I-DIAGNOSIS
/ NNP NNP I-DIAGNOSIS
glandular NNP NNP I-DIAGNOSIS
lesion NNP NNP I-DIAGNOSIS
. NN NN O

She NNP NNP B-GENDER
tested NN NN O
positive NN NN O
for NN NN O
HPV NNP NNP B-DIAGNOSIS

16 NN NN O
. NN NN O
She NNP NNP B-GENDER
is NN NN O
sexually NN NN O
active NN NN O
with NN NN O
her NN NN O
husband NN NN O
and NN NN O
has NN NN O
4 NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
menopausal NNP NNP B-DIAGNOSIS
and NN NN O
uses NN NN O
no NN NN O
contraception NN NN O
. NN NN O

She NNP NNP B-GENDER
smokes NN NN O
and NN NN O
drinks NN NN O
alcohol NN NN O
frequently NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
otherwise NN NN O
healthy NN NN O
. NN NN O

She NNP NNP B-GENDER
was NN NN O
offered NN NN O
conization NN NN O
. NN NN O

The NN NN O
patient NN NN O
is NN NN O
a NN NN O
23-year-old NNP NNP B-AGE
man NNP NNP B-GENDER
who NN NN O
came NN NN O
to NN NN O
the NN NN O
hospital NN NN O
with NN NN O
high NNP NNP B-DIAGNOSIS
blood NNP NNP I-DIAGNOSIS
pressure NNP NNP I-DIAGNOSIS
( NN NN O
175/95mmHg NN NN O
) NN NN O
and NN NN O
signs NN NN O
of NN NN O
septicemia NNP NNP B-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
developed NN NN O
respiratory NNP NNP B-DIAGNOSIS
failure NNP NNP I-DIAGNOSIS
requiring NN NN O
mechanical NN NN O
ventilation NN NN O
and NN NN O
renal NNP NNP B-DIAGNOSIS
failure NNP NNP I-DIAGNOSIS
requiring NN NN O
hemodialysis NN NN O
. NN NN O

His NN NN O
blood NN NN O
smear NN NN O
showed NN NN O
microangiopathic NNP NNP B-DIAGNOSIS
hemolytic NNP NNP I-DIAGNOSIS
anemia NNP NNP I-DIAGNOSIS
and NN NN O
thrombocytopenia NNP NNP B-DIAGNOSIS
. NN NN O

His NN NN O
blood NN NN O
tests NN NN O
revealed NN NN O
elevated NNP NNP B-DIAGNOSIS
lactate NNP NNP I-DIAGNOSIS
dehydrogenase NNP NNP I-DIAGNOSIS
and NN NN O
reduced NN NN O
human NN NN O
complement NN NN O
C3 NN NN O
levels NN NN O
with NN NN O
a NN NN O
normal NN NN O
coagulation NN NN O
profile NN NN O
. NN NN O

He NNP NNP B-GENDER
was NN NN O
diagnosed NN NN O
with NN NN O
atypical NN NN O
hemolytic NNP NNP B-DIAGNOSIS
uremic NNP NNP I-DIAGNOSIS
syndrome NNP NNP I-DIAGNOSIS
. NN NN O

He NNP NNP B-GENDER
was NN NN O
treated NN NN O
with NN NN O
plasma NN NN O
exchange NN NN O
and NN NN O
corticosteroids NN NN O
. NN NN O

He NNP NNP B-GENDER
has NN NN O
been NN NN O
previously NN NN O
vaccinated NN NN O
with NN NN O
meningococcal NN NN O
group NN NN O
ACWY NN NN O
conjugate NN NN O
vaccine NN NN O
and NN NN O
meningococcal NN NN O
group NN NN O
B NN NN O
vaccine NN NN O
. NN NN O

The NN NN O
genetic NN NN O
survey NN NN O
revealed NN NN O
ADAMTS13 NN NN O
>10% NN NN O
. NN NN O

A NN NN O
67-year-old NNP NNP B-AGE
healthy NN NN O
woman NNP NNP B-GENDER
came NN NN O
to NN NN O
the NN NN O
clinic NN NN O
to NN NN O
have NN NN O
her NN NN O
flu NN NN O
shot NN NN O
in NN NN O
early NN NN O
October NN NN O
. NN NN O

She NNP NNP B-GENDER
works NN NN O
at NN NN O
a NN NN O
rehab NN NN O
center NN NN O
and NN NN O
has NN NN O
no NNP NNP B-NEGATIVE
underlying NNP NNP I-NEGATIVE
disease NNP NNP I-NEGATIVE
. NN NN O

It NN NN O
is NN NN O
her NN NN O
first NN NN O
vaccination NN NN O
this NN NN O
year NN NN O
. NN NN O

she NNP NNP B-GENDER
is NN NN O
menopausal NNP NNP B-DIAGNOSIS
and NN NN O
has NN NN O
4 NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
some NN NN O
. NN NN O

She NNP NNP B-GENDER
takes NN NN O
daily NN NN O
multivitamins NN NN O
and NN NN O
anti NN NN O
- NN NN O
hypertensive NNP NNP B-DIAGNOSIS
drugs NN NN O
. NN NN O

She NNP NNP B-GENDER
exercises NN NN O
regularly NN NN O
for NN NN O
30 NN NN O
minutes NN NN O
a NN NN O
day NN NN O
at NN NN O
least NN NN O
5 NN NN O
days NN NN O
a NN NN O
week NN NN O
. NN NN O

She NNP NNP B-GENDER
has NN NN O
no NNP NNP B-NEGATIVE
allergies NNP NNP I-NEGATIVE
to NN NN O
any NN NN O
food NN NN O
or NN NN O
drugs NN NN O
. NN NN O

A NN NN O
46-year-old NNP NNP B-AGE
Asian NN NN O
woman NNP NNP B-GENDER
with NN NN O
MDD NNP NNP B-DIAGNOSIS
complains NN NN O
of NN NN O
persistent NN NN O
feelings NN NN O
of NN NN O
sadness NNP NNP B-DIAGNOSIS
and NN NN O
loss NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
interest NNP NNP I-DIAGNOSIS
in NN NN O
daily NN NN O
activities NN NN O
. NN NN O

She NNP NNP B-GENDER
states NN NN O
that NN NN O
her NN NN O
mood NN NN O
is NN NN O
still NN NN O
depressed NNP NNP B-DIAGNOSIS
most NN NN O
of NN NN O
the NN NN O
days NN NN O
. NN NN O

She NNP NNP B-GENDER
complains NN NN O
of NN NN O
loss NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
energy NNP NNP I-DIAGNOSIS
and NN NN O
feelings NNP NNP B-DIAGNOSIS
of NNP NNP I-DIAGNOSIS
worthlessness NNP NNP I-DIAGNOSIS
nearly NN NN O
every NN NN O
day NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
on NN NN O
anti-depressants NN NN O
for NN NN O
the NN NN O
past NN NN O
6 NN NN O
months NN NN O
, NN NN O
but NN NN O
the NN NN O
symptoms NN NN O
are NN NN O
still NN NN O
present NN NN O
. NN NN O

She NNP NNP B-GENDER
does NN NN O
not NN NN O
drink NN NN O
alcohol NN NN O
or NN NN O
smoke NN NN O
. NN NN O

She NNP NNP B-GENDER
used NN NN O
to NN NN O
exercise NN NN O
every NN NN O
day NN NN O
for NN NN O
at NN NN O
least NN NN O
30 NN NN O
min NN NN O
., NN NN O
but NN NN O
she NNP NNP B-GENDER
doesn't NN NN O
have NN NN O
enough NN NN O
energy NN NN O
to NN NN O
do NN NN O
so NN NN O
for NN NN O
the NN NN O
past NN NN O
3 NN NN O
weeks NN NN O
. NN NN O

She NNP NNP B-GENDER
also NN NN O
has NN NN O
some NN NN O
digestive NNP NNP B-DIAGNOSIS
issues NNP NNP I-DIAGNOSIS
recently NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
married NN NN O
and NN NN O
has NN NN O
4 NN NN O
children NN NN O
. NN NN O

She NNP NNP B-GENDER
is NN NN O
menopausal NNP NNP B-DIAGNOSIS
. NN NN O

Her NN NN O
husband NN NN O
was NN NN O
diagnosed NN NN O
with NN NN O
colon NNP NNP B-DIAGNOSIS
cancer NNP NNP I-DIAGNOSIS
a NN NN O
year NN NN O
ago NN NN O
and NN NN O
is NN NN O
undergoing NN NN O
chemotherapy NN NN O
. NN NN O

Her NN NN O
past NN NN O
medical NN NN O
history NN NN O
is NN NN O
unremarkable NN NN O
. NN NN O

Her NN NN O
family NN NN O
history NN NN O
is NN NN O
negative NNP NNP B-NEGATIVE
for NNP NNP I-NEGATIVE
any NNP NNP I-NEGATIVE
psychologic NNP NNP I-NEGATIVE
problems NNP NNP I-NEGATIVE
. NN NN O

Her NN NN O
HAM-D NN NN O
score NN NN O
is NN NN O
20 NN NN O
. NN NN O

